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ABSTRACT 
 
REGULATORY MECHANISMS IN BORRELIA BURGDORFERI-INDUCED ARTHRITIS 
 
by 
 
Emily Hansen 
 
The University of Wisconsin-Milwaukee, 2016 
Under the Supervision of Professor Dean T. Nardelli, PhD 
 
 
Lyme arthritis is a common symptom of Lyme borreliosis that involves inflammation of 
the synovial joints.  Elucidating the immune events involved in Lyme arthritis is 
complicated by the fact that not all individuals infected with B. burgdorferi develop 
arthritis.  Additionally, Lyme arthritis manifests in different severities between affected 
individuals.  It is known that an inflammatory response is initiated by B. burgdorferi 
infection and that inflammatory T cells contribute to the development of arthritis.  
However, the anti-inflammatory mechanisms that regulate the pathogenic T cells’ 
response are not entirely understood. Here, the hypothesis that a dysregulated immune 
response results in an excessive inflammatory response and the development of 
arthritis following B. burgdorferi infection was tested.  Interleukin-10 (IL-10) is involved in 
regulating the immune response during infection with B. burgdorferi.  We demonstrate 
that IL-10 regulates the development of Lyme arthritis through inhibition of interleukin-17 
(IL-17) production.  We also demonstrate that IL-10 regulates the production of IL-17 by 
Borrelia-primed CD4+ cells early after interaction with Lyme spirochetes in vitro, and 
that infection of Borrelia-primed mice with B. burgdorferi leads to significant production 
of IL-17 that contributes to the development of severe arthritis. Further, we demonstrate 
that regulatory T (Treg) cell depletion prior to infection results in hind paw swelling and 
  iii 
the development of arthritis along with an increased B. burgdorferi-specific antibody 
response in an arthritis-resistant mouse model. We further demonstrate that Treg cells 
inhibit paw swelling and inflammatory cytokine production during the course of B. 
burgdorferi infection, but may not modulate severity of arthritis in established disease. 
Based on our findings, this suggests that Treg cells present prior to B. burgdorferi 
infection results in regulation of IL-17 by IL-10, thereby inhibiting pathology. Our findings 
identify novel regulatory mechanisms that may be responsible for resistance to Lyme 
arthritis, and suggest that modulation of Treg cells may prove useful in the development 
of new strategies for treatment and/or prevention of Lyme arthritis. 
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CHAPTER 1: INTRODUCTION 
Lyme Borreliosis 
Lyme borreliosis, often known as Lyme disease, is caused by infection with the 
spirochete Borrelia burgdorferi. B. burgdorferi is a microaerophilic organism 
approximately 20 µm long and 0.2-0.5 µm wide (Johnson et al. 1984).  The bacteria are 
motile due to the presence of 7 to 10 periplasmic flagella, allowing the organism to 
travel throughout the host from the initial site of infection (Johnson et al. 1984).  Sites 
such as the skin, ligaments, tendons, and synovial tissue are often affected, as the 
microbe is able to bind to collagen along with other components of the extracellular 
matrix (Barthold et al. 1993, Zambrano et al. 2004). B. burgdorferi infection can cause 
pathology of the neurological, cardiovascular, and musculoskeletal systems in humans.  
Lyme borreliosis is the most common tick-borne illness in the United States and Europe 
(Centers for Disease Control and Prevention 2015), with approximately 30,000 reports 
of Lyme borreliosis confirmed in the United States annually. However, due to difficulty in 
diagnosing Lyme borreliosis, a large number of cases go undiagnosed and unreported.  
Using clinical laboratory records of the number of people who have tested positive for 
Lyme borreliosis along with insurance company claims of diagnosis, it is estimated that 
approximately 300,000 cases occur annually (Nelson et al. 2015; Centers for Disease 
Control and Prevention 2015).  The increased estimate suggests that Lyme borreliosis 
is a greater public health problem than previously thought.   
 
Lyme borreliosis is endemic to several regions of the United States, including the 
Northeast, Mid-Atlantic, Upper Midwest, and Far West (Centers for Disease Control and 
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Prevention 2015).  Endemic regions include areas where the infected Ixodes tick 
vectors and animal reservoirs, including small rodents (typically mice), deer, foxes, and 
other mammalian hosts, live.  In the Northeastern and Upper Midwestern United States, 
B. burgdorferi is transmitted to humans by I. scapularis.  Deer are particularly important 
for the spread of B. burgdorferi, as they are capable of hosting a large number of ticks 
and traveling longer distances than smaller hosts; however, they do not display any 
signs of disease (Stanek et al. 2012).  In the Western United States, lizards occasionally 
serve as a reservoir, and the bacteria are transmitted via I. pacificus (Swei et al. 2011).  
Moreover, birds have been identified as carriers of B. burgdorferi, providing a means for 
the bacteria to spread farther distances (Anderson et al. 1986).  
 
B. burgdorferi is transmitted to humans from ticks through injection of the bacteria into 
the skin during feeding (Stanek et al. 2012).  Transmission most commonly occurs 
between the months of May and August, during the nymphal stage of tick development, 
when the ticks are relatively small and difficult to observe (Steere et al. 2004).  Although 
rare, transmission by adult ticks can occur (Steere et al. 2004).  In endemic areas, up to 
25% of Ixodes ticks may be infected (Committee on Lyme Disease and Other Tick-
Borne Diseases 2011), but the average risk of human infection in an endemic area is 
approximately 5% (Sood et al. 1997).  This is due to the fact that an infected tick must 
be attached to its host for several days in order to transmit B. burgdorferi effectively 
(Bhate & Schwartz 2011a).  Specifically, transmission most often occurs when the tick is 
attached between 48 and 72 hours (Vazquez et al. 2008).  Patients diagnosed with 
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Lyme borreliosis often do not recall having been bitten by a tick, which leads to delayed 
treatment of the infection. 
 
Untreated Lyme borreliosis progresses through three stages: early localized infection, 
early disseminated infection, and late persistent infection.  The first stage of Lyme 
borreliosis occurs in the days to weeks following infection.  During early localized 
infection, approximately 75% of individuals develop a rash called erythema migrans 
(EM) (Centers for Disease Control and Prevention 2015).  EM is a flat, painless rash 
that spreads to an average diameter of 10-16 cm, occasionally with central clearing that 
exhibits a bulls-eye appearance (Bhate & Schwartz 2011a).  Other symptoms of early 
localized infection are generally mild and include fatigue, fever, aches, and 
neuromuscular symptoms (Donta 2012).  In the absence of EM, these vague symptoms 
may prevent a correct diagnosis, leading to disease progression. 
 
The second stage, early disseminated disease, may occur in the weeks to months after 
a tick bite.  Progression to this stage can be indicated by the presence of multiple EM 
lesions, which are typically observed in areas other than the site of the tick bite (Steere 
et al. 2004).  Additionally, more severe symptoms may occur, including musculoskeletal 
pain and swelling, cardiac involvement exhibited by atrioventricular block, and 
neurological abnormalities such as numbness or tingling of the extremities, visual 
disturbances, and partial paralysis of facial muscles (Steere et al. 2004, Earl 2010, 
Halperin 2011).  While these symptoms eventually resolve in many individuals (Halperin 
2011), disease in some patients will continue to progress in the absence of treatment.  
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Late persistent infection, the third stage of disease, involves intensified neuropathies, 
cardiac involvement, and arthralgia that can occur months to years following infection.  
Profound neurological symptoms may include memory loss, fluctuations in mood, and 
peripheral neuropathy that can affect nearly every cranial nerve (Bhate and Schwartz 
2011a).  Cardiac manifestations may also intensify to include myocarditis and heart 
failure, which, although rare, has recently been identified as a cause of death (Centers 
for Disease Control and Prevention 2013).   In addition, individuals at this stage may 
exhibit intense joint pain and swelling, occasionally with degradation of cartilage and 
erosion of the bone (Bhate and Schwartz 2011a).  Of the many manifestations of Lyme 
borreliosis, arthritis is the most frequent clinical presentation (Steere et al. 1987).   
 
Lyme borreliosis is treated using antimicrobial therapy.  Generally, 2 to 3 weeks of oral 
doxycycline is used, but a more aggressive therapy of intravenous ceftriaxone for 2 to 4 
weeks may be prescribed for patients with neurological or other later stage symptoms, 
or who do not respond to doxycycline (Bhate & Schwartz 2011b).  However, some 
patients continue to experience symptoms after clearance of the infection by antibiotic 
therapy.  These patients are considered to be free of active infection, as determined by 
negative polymerase chain reaction (PCR) results of synovial fluid (Steere & Angelis 
2006).  Additional rounds of antibiotic treatments may not improve symptoms (Klempner 
et al. 2001), so these patients may have limited treatment opportunities available. Non-
steroidal anti-inflammatory agents are recommended to alleviate inflammation and pain 
associated with symptoms of antibiotic-refractory Lyme arthritis (Wormser et al. 2006).  
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Some patients who have exhausted these options resort to athroscopic synovectomies, 
in which the synovial lining of the affected joints is removed (Schoen et al. 1991).  The 
development of new treatment approaches is necessary for patients who continue to 
display symptoms after antimicrobial therapy in order to prevent invasive procedures 
and unwarranted continuation of antibiotic therapy. 
 
Lyme Arthritis 
The most common clinician presentation of Lyme borreliosis is Lyme arthritis, which 
presents as swelling of the synovial joints, typically the knee (Arvikar & Steere 2015).  
Lyme arthritis affects approximately 60% of individuals not treated for B. burgdorferi 
infection (Steere et al. 2004).  Lyme arthritis involves intermittent inflammatory episodes 
of the synovial tissue, ligaments, and tendons that ensue weeks to months following 
infection, with each occurrence lasting approximately one week (Steere et al. 1987).  
These attacks typically occur every few months and may continue for years (Steere et 
al. 2004).  Approximately 10% of untreated patients with Lyme arthritis will experience 
disease progression to a chronic, destructive arthritis that involves cartilage degradation 
and bone erosion (Steere et al. 1987).  For most patients, antimicrobial therapy is 
sufficient to treat the infection and alleviate symptoms of Lyme arthritis.  Others, 
however, continue to experience arthritic bouts despite multiple courses of antimicrobial 
therapy (Steere & Angelis 2006).  Patients who continue to display proliferative synovitis 
despite receiving antibiotic therapy are said to have “antibiotic-refractory” or “slow-
resolving” arthritis (Steere & Angelis 2006).  Antibiotic-refractory arthritis is hypothesized 
to be the result of residual borrelial proteins or nonviable organisms that remain and 
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continue to elicit an immune response after the infection is treated, or to be the result of 
autoimmunity induced by B. burgdorferi infection (Wormser et al. 2012, Drouin et al. 
2013).  Although the cause of persistent symptoms of arthritis is not known, the immune 
events that contribute to Lyme arthritis have been studied.   
 
Innate immune cells are responsible for the initial inflammatory response to B. 
burgdorferi and contribute to the development of Lyme arthritis.  Innate immune cells, 
especially macrophages, often encounter the bacteria at the site of the tick bite (Steere 
et al. 2004).  B. burgdorferi signaling occurs mainly through recognition of tripalmitoyl-S-
glyceryl-cysteine (Pam3Cys)-modified lipoprotein portion of outer surface protein A 
(OspA) by toll-like receptor (TLR) 2 on macrophages (Yoder et al. 2003). Macrophages 
promote an inflammatory response through the production of cytokines, including 
interleukin-1-beta (IL-1β), interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-α) 
(Ma et al. 1994).  Additionally, macrophages are important for antigen presentation and 
activation of the T cell response that leads to Lyme arthritis (DuChateau et al. 1999).  
Notably, the number of macrophages in the joint increases with the development of 
arthritis and decreases during resolution of disease (Lasky et al. 2015b).  As a result, 
macrophages are important contributors to the inflammatory response following B. 
burgdorferi infection. 
 
Neutrophils also play a major role in the inflammatory response to B. burgdorferi, as 
activation of these cells leads to the production of inflammatory cytokines, including IL-
1β, TNF-α, and interleukin-17 (IL-17), which are believed to contribute to the 
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development of Lyme arthritis (Wormser et al. 2006, Werner et al. 2011).  Neutrophils 
are also capable of phagocytosing and killing spirochetes at both the initial site of 
infection and after dissemination (Benach et al. 1984), which may contribute to Lyme 
arthritis through recruitment of inflammatory cells.  Synovial fluid samples from patients 
with Lyme arthritis contain large amounts of neutrophil chemotactic factors (Georgilis et 
al. 1991), and large numbers of neutrophils are found in the synovial tissues of patients 
infected with B. burgdorferi (Steere & Glickstein 2004).  Importantly, infiltration of 
neutrophils into the joint tissue contributes to the induction of Lyme arthritis, likely 
through the recruitment of T cells (Brown et al. 2003).  Collectively, these findings 
demonstrate the contribution of neutrophils to the pro-inflammatory environment that 
occurs in the development of Lyme arthritis.  
 
While the innate immune response reacts to the initial infection, adaptive immunity is 
critical for the control of B. burgdorferi infection; however, it can also contribute to the 
development of Lyme arthritis.  δγ T cells are also important components of the immune 
response to B. burgdorferi infection.  Like macrophages, δγ T cells express TLR2 and 
are activated following binding of OspA (Collins et al. 2008).  δγ T cells activated 
following B. burgdorferi infection stimulate dendritic cells, which in turn, trigger pathways 
that induce adaptive immunity (Shi et al. 2011, Filgueira et al. 1996).  Notably, mice 
deficient in δγ T cells display decreased T and B cell responses following B. burgdorferi 
infection and an increased bacterial burden in the tissues (Shi et al. 2011).  By 
activating additional adaptive immune cells, δγ T cells may also contribute to the 
development of Lyme arthritis.  δγ T cells in the synovial fluid of patients with Lyme 
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arthritis proliferate in response to stimulation with B. burgdorferi (Glatzel et al. 2002).  
Additionally, increased numbers of δγ T cells are found within the joints of patients with 
antibiotic-refractory Lyme arthritis (Vincent et al. 1996).  While other reports indicate that 
δγ T cells do not directly contribute to severity of arthritis (Bockenstedt et al. 2003), they 
have been show to contribute to the inflammatory response. 
 
Other forms of T cells, specifically CD4+ T cells, have been shown to contribute to 
pathology in Lyme disease (McKisic et al. 2000). Later-stage Lyme arthritis is caused, in 
part, by the inflammatory effects of type 1 T helper (Th1) cells through the production of 
their signature cytokine, interferon-gamma (IFN-γ).  Increased numbers of Th1 cells and 
levels of IFN-γ are present in mice after infection with B. burgdorferi (Dong et al. 1997, 
Keane-Myers & Nickell 1995).  IFN-γ produced by CD4+ T cells is involved in the 
development of arthritis and increases the severity of disease in a mouse model 
(Sonderegger et al. 2012).  In addition, increased numbers of Th1 cells and levels of 
IFN-γ have been observed in the synovial tissue, synovial fluid, and peripheral blood of 
patients with Lyme arthritis (Gross et al. 1998; Matyniak and Reiner 1995; Yssel et al. 
1991; Shen et al. 2010).  In fact, Th1 cells were found to comprise the majority of T cells 
in the synovial fluid of Lyme arthritis patients (Shen et al. 2010).  Additionally, an 
increased Th1 response, as indicated by increased IFN-γ production, is associated with 
the development of antibiotic-refractory arthritis (Strle et al. 2012).  These findings 
indicate that Th1 cells and IFN-γ are likely involved in the development of Lyme arthritis.   
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Other cells, however, also contribute to disease, as mice genetically deficient in IFN-γ, 
its receptor, or its signaling pathway have been shown to develop arthritis after B. 
burgdorferi infection (Brown and Reiner 1999; Christopherson et al. 2003).  Notably, 
arthritis-resistant C57BL/6 mice developed severe, destructive arthritis in the absence of 
IFN-γ in a model of T cell-driven arthritis (Christopherson et al. 2003).  Although the lack 
of IFN-γ does not prevent arthritis, only minimal inflammation is seen in animals 
depleted of CD4+ T cells before infection with B. burgdorferi (Lim et al. 1995a), 
suggesting that T helper cells are involved.  In support of this, transfer of Borrelia-
primed CD4+ T cells into recipient animals increases pathology following infection (Lim 
et al. 1995b).  These reports suggest that CD4+ T cell-associated inflammatory factors 
in addition to IFN-γ may contribute to the pathogenesis of Lyme arthritis.  
 
Another subset of helper T cell, the type 17 T helper (Th17) cell, is characterized by 
production of the inflammatory cytokine IL-17 (Park et al. 2005) and may also contribute 
to the development of Lyme arthritis. IL-17 is an important mediator of several 
arthritides, including rheumatoid arthritis (Chabaud et al. 2000), juvenile idiopathic 
arthritis (Aggarwal et al. 2008), antigen-induced arthritis (Pinto et al. 2010), and 
collagen-induced arthritis (Lubberts et al. 2004).  While the arthritic potential of these 
cells has yet to be examined fully following B. burgdorferi infection, research suggests 
that Th17 cells may play a potentially pathogenic role in the immune response to the 
spirochete. Neutralization of IL-17 reduces paw swelling and prevents arthritis in a 
model of B. burgdorferi-induced arthritis in mice (Burchill et al. 2003; Nardelli et al., 
2004, Nardelli et al. 2008a).  Additionally, borrelial proteins have been shown to 
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stimulate production of IL-17 in vitro from T cells collected from the synovial fluid of 
patients with Lyme arthritis (Infante-Duarte et al. 2000).  Moreover, exposure to borrelial 
antigens causes dendritic cells to produce interleukin-23 (IL-23), a survival factor for 
Th17 cells (Stritesky et al. 2008).  Neutralization of IL-23 has been shown to inhibit IL-
17 production from B. burgdorferi-stimulated immune cells (Knauer et al. 2007) and 
prevents the development of Lyme arthritis in mice following infection with B. burgdorferi 
(Kotloski et al. 2008).  Similarly, neutrophil-activating protein A (NapA) expressed by B. 
burgdorferi leads to production of IL-6 and transforming growth factor beta (TGF-β) by 
monocytes, which drive production of IL-17 (Codolo et al. 2008).  Neutralization of IL-6 
and TGF-β also prevented development of disease in a model of late-stage Lyme 
arthritis (Nardelli et al., 2008).   
 
Th17 cells typically comprise approximately 10% of the CD4+ T cell population in the 
synovial fluid of humans with Lyme arthritis (Codolo et al. 2008; Shen et al. 2010). While 
the arthritic potential of Th17 cells has yet to be examined fully, some reports have 
suggested that these cells may not contribute to disease. For example, C3H mice have 
low levels of IL-17 in the serum following B. burgdorferi infection, and administration of 
anti-IL-17 antibodies to these mice led to increased arthritis (Nardelli et al. 2010).  
Additionally, mice deficient in the IL-17 receptor A subunit developed the same degree 
of arthritis after infection as wild-type mice that possessed effective IL-17 signaling 
pathways (Lasky et al. 2015a).  Likewise, a recent study found that mice deficient in IL-
17 still develop arthritis in a model of late-stage Lyme arthritis (Kuo et al. 2016).  In 
addition, peripheral blood mononuclear cells isolated from patients with a single 
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nucleotide polymorphism of the IL-23 receptor (Arg381Gln) produced less IL-17 in 
response to B. burgdorferi stimulation (Oosting et al. 2011).  Despite reduced IL-17 
production in vitro, no difference in severity of arthritis was observed between people 
with the polymorphism and those with the wild-type (WT) IL-23 receptor (Oosting et al. 
2011). While the exact contribution of Th17 cells and IL-17 in Lyme arthritis remains 
uncertain, research suggests that in certain individuals, Th17 cells and IL-17 may 
contribute to the development of arthritis.   
 
Th1 and Th17 cells have been investigated for their roles in B. burgdorferi-induced 
arthritis, and increased numbers and cytokines produced by these cells are often 
observed in disease.  While an inflammatory immune response contributes to clearing 
B. burgdorferi infection, how this response leads to pathology in only some patients 
remains uncertain.  Ineffective regulation of the adaptive immune response following B. 
burgdorferi infection may lead to an excessive inflammatory environment that results in 
arthritis. CD4+CD25+Foxp3+ regulatory T (Treg) cells regulate the inflammatory 
response by inhibiting Th1 and Th17 cells, in part, through production of interleukin-10 
(IL-10) (Rubtsov et al. 2008). Both IL-10 and Treg cells have been proposed as 
regulators of inflammation in Lyme arthritis.  IL-10-deficient mice develop more severe 
arthritis following B. burgdorferi infection than WT mice (Brown et al. 1999).  Notably, 
CD4+ T cells have been identified as a major source of IL-10 within the joint tissue of B. 
burgdorferi-infected mice (Sonderegger et al. 2012).  Additionally, administration of anti-
IL-17 antibody in B. burgdorferi-infected IFN-γ-deficient mice results in an increase of 
CD4+CD25+ putative Treg cells and prevents the development of arthritis in a murine 
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model of Lyme arthritis (Nardelli et al. 2004).  Adoptive transfer of this cell population to 
B. burgdorferi-infected mice prevents arthritis (Nardelli et al. 2005). A role for Treg cells 
in human disease has also been described.  Patients with antibiotic-refractory Lyme 
arthritis who experience a longer duration of joint inflammation have fewer numbers of 
Treg cells in the synovial fluid than patients whose arthritis resolved following antibiotic 
therapy (Shen et al. 2010, Vudattu et al. 2013). Therefore, it is possible that a 
dysregulated immune response may result in more severe disease.  Future studies 
regarding immune regulation in B. burgdorferi-induced arthritis will require consideration 
of these anti-inflammatory cells.  Further characterization of the immune events involved 
in Lyme arthritis, specifically on the prevention or resolution of inflammation, is vital for 
identifying novel therapeutic treatments for the disease. 
 
Regulatory T Cells  
Treg cells were initially identified for their role in maintaining tolerance and controlling 
autoimmune disease (Sakaguchi et al. 1995); however, Treg cells are also important 
mediators of the immune response through inhibition of inflammation and prevention of 
tissue destruction.  Treg cells comprise 5-10% of the peripheral T cell population 
(Baecher-Allan et al. 2001).  Treg cells were previously identified by the expression of 
surface molecules CD4 and CD25 (Sakaguchi et al. 1995).  However, activated effector 
T cells also express CD25 (Fazekas De St. Groth et al. 2004). Currently, expression of 
forkhead box P3 (Foxp3) is the most specific indicator of Treg cell phenotype (Fontenot 
et al. 2005).  Foxp3 expression by Treg cells was first discovered in scurfy mice, as 
these mice display an overproliferation and dysregulation of CD4+ T cells.  
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Characterization of the genome of scurfy mice led to the identification of a genetic 
mutation in the FoxP3 gene, which results in ineffective Treg cell development 
(Brunkow et al, 2001).  Similarly, a Foxp3 gene mutation was found to result in the 
human autoimmune disease equivalent of scurfy known as immune dysregulation, 
polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) (Bennett et al. 2001).  
Additionally, Treg cells have been implicated in a variety of other diseases, with 
decreased suppressive function or reduced numbers occurring in multiple sclerosis 
(Viglietta et al. 2004), rheumatoid arthritis (Van amelsfort et al. 2004), myasthenia gravis 
(Gertel-Lapter et al. 2013), autoimmune hepatitis (Longhi et al. 2004), and polyglandular 
syndrome type 2 (Kriegel et al. 2004).   
 
The mechanisms by which Treg cells modulate inflammation have not been fully 
elucidated; however, the major mechanisms appear to be inhibition of antigen 
presentation, direct suppression of effector cells, and production of anti-inflammatory 
cytokines.  Treg cells can inhibit antigen-presenting cells (APCs) by directly binding to 
them, thereby preventing APCs from activating effector T cells (Cederborn et al. 2000, 
Misra et al. 2004).  Specifically, cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) 
expression by Treg cells induces a downregulation of costimulatory molecules on the 
surface of dendritic cells following binding, which prevents activation and proliferation of 
effector T cells (Misra et al. 2004).  Increased CTLA-4 binding also leads to increased 
expression of indoleamine 2,3-dioxygenase (IDO) by dendritic cells (Schmidt et al. 
2012). IDO degrades tryptophan to kynurenines, and tryptophan depletion leads to cell 
cycle arrest of effector T cells (Schmidt et al. 2012).  Additionally, Treg cells can have 
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increase expression of CD27, which then binds to CD70 on the surface of dendritic cells 
(Dhainaut et al. 2015).  Interaction between the receptors leads to downregulation of 
CD70, as interaction with CD27 suppresses CD70 transcription (Kuka et al. 2013). 
CD70 expression by APCs is required for effective Th1 cell priming, and a 
downregulation of the receptor leads to decreased Th1 cell activation (Dhainaut & 
Moser 2015).  By inhibiting costimulatory molecules, Treg cells are able to render APCs 
ineffective, thereby reducing effector T cell activation. 
 
In addition to inhibiting antigen presentation, Treg cells can directly suppress effector T 
cells.  During infection, Treg cells migrate to the draining lymph nodes and encounter 
effector T cells (Zhang et al. 2009).  Treg cells inhibit effector T cells through direct 
interaction between TGF-β1 on their cell surface with TGF-βR on effector T cells 
(Nakamura et al. 2001).  Treg cells also migrate to tissue sites, where they reduce the 
number of activated CD4+ and CD8+ T cells through direct killing by the release of 
granzyme A using the perforin/granzyme pathway (Grossman et al. 2004).  It has also 
been suggested that Treg cells compete with effector T cells for interleukin-2 (IL-2) and 
other cytokines necessary for survival, which leads to apoptosis of effector T cells 
(Pandiyan et al. 2007).  However, others have found that while IL-2 is required for Treg 
cell suppression of effector T cell proliferation, it does not lead to apoptosis (Szymczak-
Workman et al. 2011, Vercoulen et al. 2009).  Interestingly, IL-2-deficient mice display 
an overproliferation of both CD4+ and CD8+ T cells, which indicates that IL-2 is not 
required for effector T cell proliferation (Sadlack et al. 1993).  Additionally, IL-2 
consumption was found to have no effect on the suppressive abilities of human Treg 
  15 
cells (Tran et al. 2009).  Additionally, Treg consumption of IL-2 has been reported to 
promote Th17 cell differentiation with no effect on proliferation (Pandiyan et al. 2011).  It 
has also been suggested that Treg cell consumption of IL-2 only affects effector T cell 
proliferation when IL-2 is extremely limited (de la Rosa et al. 2004).  Collectively, these 
reports suggest that while inducing apoptosis of effector T cells is not a major 
mechanism of Treg cell-mediated suppression, it may occur under specific conditions to 
further suppress the effector T cell response. 
 
Additionally, Treg cells exert suppression on effector T cells indirectly through 
production of anti-inflammatory cytokines. IL-10, the major cytokine produced by Treg 
cells, leads to decreased antigen presentation by downregulating major 
histocompatibility complex (MHC) class II expression on APCs (Chattopadhyay & 
Shevach 2013) and inhibits effector T cell activation via CD28 co-stimulation (Joss et al. 
2000).  IL-10 produced by Treg cells inhibits Th17 cell proliferation (Chaudhry et al. 
2011) and leads to decreased production of IFN-γ by Th1 cells (Fiorentino et al. 1991, 
Sojka & Fowell 2011).  However, Treg cells isolated from IL-10-deficient mice inhibit 
effector cells equally as well as those isolated from wild-type mice, indicating that IL-10 
production is not the only method of cytokine suppression (Sojka & Fowell 2011, 
Thornton & Shevach 1998). Treg cells not only produce IL-10, but also TGF-β, which 
can inhibit the activation and differentiation of both Th1 and Th17 cells (Li et al. 2007).  
While IL-10 is not required for Treg cells to exhibit inhibitory effects, suppression by 
Treg cells is dependent on TGF-β.  In fact, mice that were adoptively transferred Treg 
cells could not control inflammation following anti-TGF-β antibody treatment (Powrie et 
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al. 1996).  More recently, interleukin-35 (IL-35) has been identified as an essential 
cytokine for contact-independent suppression by Treg cells (Chaturvedi et al. 2011).  IL-
35 suppresses the proliferation of Th1 and Th17 cells and inhibits IFN-γ and IL-17 
production by these cells, respectively (Niedbala et al. 2007, Nakano et al. 2014).   
Collectively, Treg cells utilize a variety of mechanisms to suppress effector T cells.  The 
redundancy of these suppressive mechanisms suggests Treg cells play a vital role in 
regulating the immune response.     
 
Immunoregulation in Spirochete Infection 
 
Spirochetes encompass six genera of bacteria, some of which are pathogenic.  
Pathogenic spirochetes include Borrelia, Leptospira, Brachyspira, and Treponema.  
Spirochetes, like other bacterial infections, induce an inflammatory immune response.  
T cells and the cytokines they produce are critical components in the immune response 
to bacterial infection (D’Elios et al. 2011) and are induced by spirochete infection.  Mice 
infected with B. burgdorferi have greater levels of IFN-γ than uninfected mice (Ilipoulou 
et al. 2007).  Likewise, humans infected with B. burgdorferi who develop arthritis have 
increased numbers of Th1 cells in the synovial fluid (Shen et al. 2010).  Moreover, IL-17 
levels are elevated in the cerebral spinal fluid (CSF) of patients with neuroborreliosis, 
suggesting a role for Th17 cells in the disease (Henningsson et al. 2011).  Similarly, 
infection with Leptospira interrogans, which causes leptospirosis, leads to an increase in 
inflammatory CD4+ T cells in the spleen and lungs of infected mice (Pereira et al., 1998) 
(Richer et al. 2015).  Additionally, patients with leptospirosis have significantly greater 
percentages of Th1 cells compared to healthy controls (Volz et al, 2015). Infection with 
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Brachyspira hyodysenteriae, which causes gasteroenteritis, also results in an 
upregulation of inflammatory T cells at the onset of disease in swine (Jergens et al. 
2006) and leads to increased levels of T effector cells in swine (Hontecillas et al. 2005, 
Jonasson et al. 2004).  Moreover, CD4+ T cells isolated from the lymph nodes of B. 
hyodsenteriae-infected mice produce IFN-γ following restimulation with the spirochete 
(Jergens et al. 2006; Hontecillas et al. 2003).  Also, clearance of Treponema pallidum 
infection is mediated by Th1 cells through production of IFN-γ (Arroll et al. 1999).  
Patients with chronic periodontitis resulting from infection with Treponema denticola 
also have increased IFN-γ production and Treponema-specific CD4+ T cells (Shin et al. 
2013).  Together, the findings of these studies suggest that CD4+ T cells, especially 
Th1 cells, are important components of the immune response to spirochete infection. 
 
However, research suggests that long-term spirochetal infection is associated with a 
reduced immune response.  Patients with post-treatment Lyme borreliosis have lower 
numbers of Th1 cells compared to asymptomatic individuals (Jarefors et al. 2007), 
indicating that chronic Lyme borreliosis symptoms may result from an inadequate 
immune response to the infection.  Additionally, following infection with Brachyspira 
hodystenteriae, pigs that develop dysentery had decreased CD4+ T cell numbers 
compared to those that did not develop disease (Jonasson et al. 2004).  Decreased T 
cell responses are also observed in Treoponema infection, as T. pallidum-infected 
hamsters display atrophy of the thymus and a decreased T cell response during the first 
14 days following infection (Bagasra et al. 1985).  In addition, T cell blastogenesis is 
reduced during active infection, yet increases in disease remission (Pavia et al. 1976).  
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Also, cells isolated from patients infected with Treponema species displayed a 
decreased lymphocyte response to stimulation with concanavalin A (Con A) compared 
to healthy controls (From et al. 1976).  Additionally, incubation of normal lymphocytes 
with the plasma of patients with syphilis before treatment reduced T cell proliferation 
following stimulation, while serum collected 2-6 months after treatment had no effect 
(From et al. 1976). These findings indicate that immune factors in the plasma during 
active infection are repressing the T cell response.  Patients with syphilis that have 
reduced numbers of CD4+ T cells due to HIV infection are more likely to experience 
neurological involvement than those without HIV infection, suggesting that lack of an 
effector T cell response may lead to treponemal dissemination (Li et al. 2013).  
Together, these findings indicate that a reduced immune response during spirochetal 
infection may intensify the length or severity of disease.   
 
CD4+ T cells are important for bacterial clearance, but when inflammation becomes 
excessive, it may lead to pathology.  IL-10 has been described in spirochetal infection 
as an important mediator of the immune response to prevent pathogenesis.  B. 
burgdorferi-infected C57BL/6 mice, which are resistant to the development of Lyme 
arthritis, have greater IL-10 production and decreased inflammatory cytokine production 
than arthritis-susceptible C3H/HeN mice (Brown et al. 1999).  Increased IL-10 
production is also associated with decreased inflammation and the prevention of severe 
disease in patients with leptospirosis (Volz et al. 2015).  Moreover, higher levels of IL-10 
correlated with decreased inflammatory cytokines and the disappearance of clinical 
symptoms in B. hyodysenteriae infection (Kruse et al. 2008).  Collectively, these 
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findings suggest that IL-10 production is important for modulating disease severity in 
spirochete infection.  
 
Treg cells prevent pathological changes, in part, through production of IL-10, and may 
contribute to immune regulation in spirochete infection.  Mice deficient in CD28, a co-
stimulatory molecule required for the differentiation of Treg cells, have 80% fewer Treg 
cells than WT mice (Tang et al. 2003).  CD28-deficient mice display a longer, more 
chronic course of Lyme arthritis (Iliopoulou et al. 2007).  Additionally, B. burgdorferi-
primed and -infected IFN-γ-deficient mice treated with antibodies against IL-17 
developed increased numbers of CD4+CD25+ T cells in the lymph nodes and did not 
develop arthritis. These were not observed in mice that did not receive anti-IL-17 
antibodies (Nardelli et al. 2004).  Moreover, Borrelia-primed and -infected mice that 
received CD4+CD25+ T cells isolated from infected mice treated with anti-IL-17 
antibody did not develop arthritis; however, administration of CD4+CD25- cells led to 
pathology (Nardelli et al. 2005).  Depletion of CD25-expressing cells in B. burgdorferi-
infected mice treated with anti-IL-17 antibodies resulted in destructive arthritis (Nardelli 
et al. 2004); however, depletion of CD25-expressing cells in the same mouse model in 
which IL-17 was not neutralized had no effect on pathology (Nardelli et al. 2006).   
 
Treg cells and Th17 cells develop from a common precursor in a reciprocal manner 
(Bettelli et al. 2006). Therefore, it is likely that the CD4+CD25+ T cell population 
induced following IL-17 neutralization consisted of true Treg cells.  Additionally, patients 
with Lyme arthritis who fail to achieve resolution of disease following antibiotic treatment 
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were found to have fewer numbers of CD4+CD25+Foxp3+ Treg cells in the synovial 
fluid than those whose arthritis resolved (Shen et al. 2010).  No differences were seen 
in the suppressive capacity of Treg cells between groups, nor were differences in the 
percentages of Th1 or Th17 cells observed (Shen et al. 2010).  However, lower 
frequencies of Treg cells in the synovial fluid led to increased effector T cell proliferation 
and inflammatory cytokine production, which contribute to more severe arthritis in 
patients with antibiotic-refractory Lyme arthritis (Vudattu et al. 2013).  Together, these 
finding demonstrate the importance of Treg cells in the ability to prevent pathology or 
resolve inflammation in Lyme arthritis.  
 
Although research suggests that Treg cells may prevent pathology, downregulation of 
the immune response by these cells may also lead to advanced bacterial dissemination.  
In T. pallidum infection, increased IL-10 mRNA expression occurs in the skin at the site 
of infection and contributes to ineffective spirochete clearance (Wicher et al. 1998).  
Additionally, increased IL-10 production is associated with increased disease severity 
(Lusiak & Podwinska 2001).  The TpF1 antigen of Treponema causes monocytes to 
release IL-10 and TGF-β, which promote Treg cell differentiation (Babolin et al. 2011).  
Accordingly, increased expression of TpF1 leads to increased numbers of Treg cells 
and enhanced Treg cell-associated cytokine production (Li et al. 2013, Babolin et al. 
2011).  T cells with suppressive functions induced by T. palladium infection are known 
to inhibit phagocytosis of spirochetes by macrophages (Tabor et al. 1984, Tabor et al. 
1987), which may result in increased bacterial survival and dissemination. Specifically, 
patients with neurosyphilis have a greater number of Treg cells in the cerebrospinal fluid 
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than patients without neurological involvement (Li et al. 2013). Therefore, an enhanced 
Treg cell response during spirochete infection may promote survival of the organism 
and allow for its increased dissemination, leading to a longer or more severe course of 
disease. 
 
In conclusion, spirochetes, including B. burgdorferi, induce an inflammatory response 
that assists in clearing the infection, but the inflammatory response can also result in 
pathology.  Treg cells may regulate the immune response to spirochetal infection and 
limit pathology.  However, the presence of Treg cells can inhibit the inflammatory 
response, resulting in increased bacterial persistence and dissemination.  Current 
research suggests that a delicate balance between the pro-inflammatory response and 
anti-inflammatory response is vital to efficient bacterial clearance without leading to 
tissue damage.  Further discoveries regarding the timing and degree of the Treg cell 
response will lead to a more complete understanding of the role of Treg cells during B. 
burgdorferi infection.   
 
Hypothesis and Specific Aims 
Arthritis is a common clinical symptom of Lyme disease. It is known that an 
inflammatory response is initiated by B. burgdorferi infection, and that inflammatory T 
cells contribute to the development of Lyme arthritis.  However, the anti-inflammatory 
mechanisms that regulate the pathogenic T cell response are poorly understood.  The 
overall objective of this dissertation is to identify novel regulatory mechanisms of the 
immune response to B. burgdorferi, which will provide the foundation for the 
development of effective therapeutic strategies for Lyme arthritis. The hypothesis of this 
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dissertation is: a dysregulated immune response results in an excessive inflammatory 
response and in the development of arthritis following B. burgdorferi infection.  The 
hypothesis will be tested by addressing the following specific aims:  
1. Determine the effect of IL-10 in B. burgdorferi-induced arthritis.  The working 
hypothesis of this aim is: IL-10 regulates the inflammatory immune response in Lyme 
arthritis through inhibition of IL-17.   
2. Determine the effect of IL-10 in a T cell-driven model of Lyme arthritis. The 
working hypothesis of this aim is: IL-10 reduces CD4+ cell-derived IL-17 production and 
attenuates Lyme arthritis.   
3. Determine the contribution of existing Treg cells on the induction of arthritis 
following B. burgdorferi infection.  The working hypothesis of this aim is: Treg cells 
prevent the onset of arthritis following infection with B. burgdorferi.  
4. Determine the role of Treg cells on arthritis development during B. burgdorferi 
infection.  The working hypothesis of this aim is: Treg cells present following B. 
burgdorferi infection reduce arthritis severity.  
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Abstract 
Previous studies have shown that cells and cytokines associated with interleukin-17 (IL-
17)-driven inflammation are involved in the arthritic response to Borrelia burgdorferi 
infection. Here, we report that IL-17 is a contributing factor in the development of Lyme 
arthritis by showing that its production and histopathological effects are regulated by 
interleukin-10 (IL-10). Spleen cells obtained from B. burgdorferi-infected, “arthritis-
resistant” wild-type C57BL/6 mice produced low levels of IL-17 following stimulation with 
the spirochete. By contrast, spleen cells obtained from infected, IL-10-deficient C57BL/6 
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mice produced a significant amount of IL-17 following stimulation with B. burgdorferi. 
These mice developed significant arthritis, including erosion of the bones in the ankle 
joints. We further show that treatment with antibody to IL-17 partially inhibited the 
significant hind paw swelling and histopathological changes observed in B. burgdorferi-
infected, IL-10-deficient mice. Taken together, these findings provide additional 
evidence of a role for IL-17 in Lyme arthritis and reveal an additional regulatory target of 
IL-10 following borrelial infection. 
 
Introduction 
Borrelia burgdorferi, the causative agent of Lyme borreliosis, stimulates a complex 
series of inflammatory events that functions to eliminate the spirochete following 
infection but which also frequently leads to arthritis in humans (Steere et al. 2004). In 
addition, B. burgdorferi induces production of the anti-inflammatory cytokine interleukin-
10 (IL-10) early after stimulation of host cells (Giambartolomei et al. 1998, Brown et al. 
1999, Ganapamo et al. 2000), suggesting a possible mechanism of facilitating infection 
in the host. IL-10 also plays a central role in regulating the immune response during 
sustained infection with B. burgdorferi. Notably, a deficiency of IL-10 in otherwise 
“arthritis-resistant” C57BL/6 mice predisposes these animals to developing remarkable 
joint pathology following B. burgdorferi-infection (Brown et al. 1999). Despite exhibiting 
more severe arthritis, these B. burgdorferi-infected IL-10-deficient mice are more 
effective in eliminating the pathogen than are wild-type counterparts (Brown et al. 1999). 
Therefore, the dual outcomes associated with the inflammatory response to borrelial 
infection–robust anti-pathogen and arthritic responses–are inexorably linked to IL-10. As 
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additional immune mechanisms against B. burgdorferi continue to be identified, the 
extent to which IL-10 participates in these responses must be defined further. 
Accumulating evidence supports the contribution of such novel mechanisms in the 
development of Lyme arthritis. The pathology of disease in humans is driven, in large 
part, by Th1 cells and their prototypical inflammatory cytokine, interferon-gamma (IFN-γ) 
(Yssel et al. 1991, Gross et al. 1998, Strle et al. 2012, Shen et al. 2010). However, 
studies in multiple animal models have shown that a Th1 response is not absolutely 
necessary for the development of arthritis after B. burgdorferi infection (Brown & Reiner 
1999, Christopherson et al. 2003, Munson et al. 2004), while the inflammatory cytokine 
interleukin-17 (IL-17) contributes to disease (Burchill et al. 2003, Nardelli et al. 2004, 
Amlong et al. 2006, Nardelli et al. 2008b). Specifically, blocking IL-17 and various Th17-
associated cytokines in vivo reduced the severity of arthritis observed in models of 
Borrelia-associated arthritis in the presence (Nardelli et al. 2008b, Nardelli et al. 2010- 
Kotloski et al. 2008) or absence (Burchill et al. 2003, Nardelli et al. 2004, Amlong et al. 
2006) of IFN-γ. Importantly, Infante-Duarte, et al. described the capacity of synovial 
cells of human Lyme arthritis patients to produce IL-17 when stimulated with B. 
burgdorferi microbes or lipoproteins (Infante-Duarte et al. 2000). Specifically, the 
borrelial antigen neutrophil activating protein A (NapA) stimulates innate immune cells 
to provide a cytokine environment conducive to the development of Th17 cells within the 
joint (Codolo et al. 2008). In addition, NapA is retained in the synovia of humans with 
Lyme arthritis and maintains this Th17 response through its chemoattractant activity on 
various inflammatory cell types, including T cells that produce both IL-17 and IFN-γ 
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(Codolo et al. 2013). Therefore, IL-17 is a likely contributor to the pathogenesis of Lyme 
arthritis. Since IL-10 is a known modulator of the IL-17 response (Huber et al. 2011), it 
is necessary to determine the relationship of these cytokines during B. burgdorferi 
infection. 
In this study, we show that IL-10 inhibits the production of IL-17 from B. burgdorferi-
stimulated cells. In addition, we demonstrate that multiple cell types are likely involved 
in the IL-17 response following borrelial infection, and that the arthritis observed in 
infected IL-10-deficient mice develops, in part, due to the actions of IL-17. Collectively, 
these findings provide additional evidence that IL-17 contributes to the arthritis induced 
by B. burgdorferi and reveal an additional target of regulation by IL-10 in the context of 
borrelial infection.  
 
Materials and Methods 
Mice  
Six-to-12-week old, wild-type and IL-10-deficient mice on the C57BL/6 background 
(originally obtained from Jackson Laboratories) were provided by J.-A. Lyons (University 
of Wisconsin-Milwaukee)and were housed at the University of Wisconsin-Milwaukee 
animal facility. The mice weighed 20-30 g each and were housed in a humidity-
controlled environment at an ambient temperature of 21°C under a light-and-dark cycle 
of 12 h. Food and acidified water were provided ad libitum. Experimental protocols were 
reviewed and approved by the Institutional Animal Care and Use Committee for the 
University of Wisconsin-Milwaukee. 
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Organisms and Preparation  
Virulent B. burgdorferi 297 organisms (isolated from human spinal fluid) in modified 
Barbour-Stoenner-Kelly (BSK) medium supplemented with 10% glycerol were provided 
by S. M. Callister (Gundersen Lutheran Medical Center, La Crosse, WI). Low-passage 
(<10) organisms were grown at 32°C until they reached a concentration of 107 
microbes/ml, dispensed into 1.5-ml screw-cap tubes (Sarstedt, Newton, NC), and stored 
at -80°C. Prior to infection of mice, a 1-ml frozen suspension of spirochetes was 
thawed, added to 4 ml of BSK medium (Sigma-Aldrich, St. Louis, MO), and incubated at 
34°C for 6 days. On the day of infection, microbes were visualized by dark-field 
microscopy for motility and enumerated using a Petroff-Hausser counting chamber. 
 
Infection of mice  
Naïve mice were anaesthetized with isoflurane in a nose-and-mouth cup and then 
injected subcutaneously in each hind paw with 106 viable B. burgdorferi strain 297 
organisms in a volume of 50 µl BSK medium. Control groups consisted of naïve mice 
that were injected with BSK medium alone. Experimental and control groups with or 
without infection with B. burgdorferi contained 4 or 5 mice each.  
 
Administration of anti-IL-17 antibody 
Neutralizing anti-mouse IL-17A purified antibody (clone eBioMM17F3; IgG1) and mouse 
IgG1 purified isotype control antibody were purchased from eBioscience (San Diego, 
CA). The antibodies were resuspended in filter-sterilized (0.22 µm-pore-sized filter; 
Fisher Scientific, Waltham, MA) phosphate buffered saline (PBS) to achieve 
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concentrations of 50 µg/ml. Groups of B. burgdorferi-infected mice were injected within 
3 hours after infection with 2.5 µg (50 µl) of anti-IL-17 antibody subcutaneously in each 
hind paw while anesthetized with isoflurane contained in a nose-and-mouth cup. Mice 
were then injected daily thereafter with anti-IL-17 antibody for 6 days. Groups of B. 
burgdorferi-infected control mice were injected with isotype control antibody in a similar 
manner. 
 
Assessment of swelling  
Edematous changes of the hind paws of mice were evaluated in order to provide a 
measure of inflammation following infection with B. burgdorferi. A digital caliper 
(Marathon, Richmond Hill, Ontario) with a sensitivity of 0.01 mm was used to measure 
the width and thickness of each tibiotarsal joint. The width and thickness measurements 
were averaged to provide the mean caliper value. Baseline swelling levels of each 
group were measured prior to infection, and the changes in swelling from these baseline 
levels were determined at 3, 6, and 8 days after infection.  
 
Cell culture and ELISA  
Spleens were harvested from 4 or 5 mice per group on days 1 or 8 after infection. 
Single-cell, whole-spleen suspensions of each group were generated by gently passing 
cells through a nylon mesh screen (BD Falcon, BD Biosciences, San Jose, CA) into 
cold RPMI 1640 medium supplemented with L-glutamine and 25 mM HEPES (Cellgro, 
Corning, Manassas, VA). 1 × 106 whole spleen cells were incubated at 37°C in 5% CO2 
with or without 1 × 105 viable B. burgdorferi organisms in BSK medium and with or 
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without 5 µg anti-mouse CD4 antibody (clone GK1.5; eBioscience) in PBS. 
Supernatants were collected after 6 and 24 hours of incubation. Controls consisted of 
cells incubated with PBS but without antibodies, or with BSK medium but without 
organisms. 
 
Levels of IL-17 present in the supernatants of cell cultures were assessed using the IL-
17A ELISA Ready-Set-Go! Kit (eBioscience, San Diego, CA) and detected according to 
the manufacturer’s directions. The plates were read at 450 nm and values were 
expressed as optical densities. Standard curves were created and used to calculate pg 
IL-17A/ml of each sample. 
 
Borreliacidal Antibody Assay  
Blood was obtained by intracardiac puncture 8 days after infection, and sera were used 
to determine titers of borreliacidal antibodies. Samples of equal volume were pooled 
within a group of 4 or 5 mice. Each pooled sample was diluted 1:20 in PBS, passed 
through a 0.22 µm filter, and then further diluted serially, 1:40 to 1:10,240, with PBS. 
The diluted specimens were heated at 56°C for 30 minutes to inactivate complement 
and then cooled to 35°C. The complement-inactivated specimens were incubated with 
104 viable B. burgdorferi strain 297 organisms and 20 µL of sterile guinea pig 
complement serum (Sigma-Alrich, St. Louis, MO; 50% hemolytic component ≥ 200 
U/ml) in PBS for 24 hours. The presence of viable microbes was then observed in 20 
fields using dark-field microscopy. The titer of borreliacidal antibody was considered the 
reciprocal of the final dilution in which motile B. burgdorferi were observed. Control 
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samples contained B. burgdorferi and complement alone; B. burgdorferi and PBS alone; 
and B. burgdorferi and PBS added to naïve, non-immune serum. 
 
Preparation of tissues for histological examination 
At eight days after infection, the different groups of 4 or 5 mice each were euthanized, 
and their hind paws were amputated above the knee joint. The paws were cryptically 
coded, fixed in 10% buffered zinc formalin, and then decalcified. Following 
decalcification, the paws were placed in tissue-embedding cassettes, embedded in 
paraffin, and cut into 6-µm sections. The sections were placed on glass slides and 
stained with hematoxylin and eosin. An unbiased examination was performed by a 
board-certified pathologist (T. F. W.). The following scale was used to quantify the 
degree of histopathologic changes: 0, no change; 1, mild leukocytic infiltration of the 
subsynovial tissues; 2, moderate infiltration of the subsynovial tissues, synovium, and 
synovial space; 3, profuse leukocytic infiltration of subsynovial tissues, synovium, and 
synovial space; 4; profuse leukocytic infiltration of tissues with accompanying 
destruction of bone or cartilage. 
 
Statistics  
Data were analyzed by ANOVA, with the Tukey-Kramer post-hoc test used to examine 
pairs of means when a significant F ratio indicated reliable mean differences between 
the control and test groups. Paired data were analyzed using a two-tailed Student’s t-
Test. The alpha level was set at 0.05 prior to initiating the experiments. Data are 
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expressed as the means ± standard error of the mean. Figures indicate a single 
experiment. Replicate experiments showed similar relationships. 
 
Results 
B. burgdorferi-induced IL-17 production is increased eight days after infection in the 
absence of IL-10  
We measured the in vitro production of IL-17 by cells of wild-type and IL-10-deficient 
mice that were uninfected or infected with B. burgdorferi for eight days. Cells from wild-
type mice, regardless of whether the mice were previously infected, produced negligible 
amounts of IL-17 after 6 hours of incubation with B. burgdorferi (less than 4 pg/ml; Fig. 
1A). Production of IL-17 by these stimulated cells did not differ from that of unstimulated 
counterparts. In addition, stimulated cells from B. burgdorferi-infected wild-type mice 
produced slightly more IL-17 than stimulated cells from uninfected wild-type mice, but 
this increase was not significant. By contrast, B. burgdorferi-stimulated cells from 
uninfected and infected IL-10-deficient mice produced significantly more IL-17 than 
stimulated wild-type counterparts (P ≤ 0.05; Fig. 1A). Production of IL-17 by stimulated 
IL-10-deficient cells also was significantly greater than that of unstimulated IL-10-
deficient cells (P ≤ 0.05; Fig. 1A). These increases in IL-17 production following in vitro 
stimulation were observed among cells of both uninfected and B. burgdorferi-infected 
IL-10-deficient mice. Additionally, stimulated cells from infected IL-10-deficient mice 
produced significantly more IL-17 than stimulated cells from uninfected IL-10-deficient 
mice (P ≤ 0.05; Fig. 1A). 
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After 24 hours of in vitro stimulation with B. burgdorferi, cells from uninfected and 
infected wild-type mice produced low levels of IL-17 (less than 10 pg/ml; Fig. 1B). 
Production of IL-17 by wild-type cells stimulated in vitro was slightly, but not 
significantly, greater than that of unstimulated wild-type cells. In addition, the production 
of IL-17 by cells of infected wild-type mice did not differ from the production of IL-17 by 
cells of uninfected wild-type mice. In contrast, B. burgdorferi-stimulated cells of 
uninfected and infected IL-10-deficient mice produced more IL-17 than did stimulated 
wild-type counterparts (over 100 pg/ml and 600 pg/ml, respectively; Fig. 1B); however, 
only the latter cells exhibited a statistically significant increase (P ≤ 0.05). Unstimulated 
cells from infected IL-10-deficient mice also produced significantly more IL-17 than their 
unstimulated counterparts from infected wild-type mice (P ≤ 0.05; Figure 1B). In 
addition, stimulation of cells from infected IL-10-deficient mice caused a significant 
increase in IL-17 production compared to unstimulated conditions (P ≤ 0.05; Figure 1B). 
Moreover, cells from infected IL-10-deficient mice produced significantly more IL-17 
than cells from uninfected IL-10-deficient mice, regardless of whether the cells were 
stimulated in vitro (P ≤ 0.05; Figure 1B). 
 
Effects of early borrelial exposure on IL-17 production 
Splenic cells obtained from wild-type mice infected with B. burgdorferi for one day 
produced a negligible amount of IL-17 (less than 4 pg/ml) when cultured with or without 
B. burgdorferi for six hours (Fig. 2A). By contrast, cells from uninfected wild-type mice 
produced significantly more IL-17 than their counterparts from infected wild-type 
animals, regardless of whether the cells were stimulated in vitro with the spirochete (P ≤ 
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0.05; Figure 2A). Also, stimulated cells from uninfected wild-type mice produced 
significantly more IL-17 than stimulated cells from uninfected IL-10-deficient mice (P ≤ 
0.05; Figure 2A). In vitro stimulation did not cause a significant change in IL-17 
production among cells of either uninfected or B. burgdorferi-infected wild-type mice. By 
contrast, in vitro exposure to B. burgdorferi for six hours caused a significant decrease 
in the production of IL-17 by cells of both uninfected and infected IL-10-deficient mice (P 
≤ 0.05; Figure 2A).  
 
After 24 hours of incubation with or without B. burgdorferi, cells from uninfected wild-
type mice produced significantly more IL-17 than did cells from wild-type mice that were 
infected with the spirochete for one day (P ≤ 0.05; Figure 2B). Cells from uninfected 
wild-type mice also produced a significantly greater amount of IL-17 than cells from 
uninfected IL-10-deficient mice, regardless of in vitro stimulation (P ≤ 0.05; Figure 2B). 
Exposure to B. burgdorferi in vitro for 24 hours caused a significant decrease in IL-17 
production by cells of infected wild-type mice (P ≤ 0.05; Figure 2B) but did not 
significantly affect cells from uninfected counterparts. In addition, stimulation with the 
spirochete for 24 hours did not affect IL-17 production by cells of uninfected or B. 
burgdorferi-infected IL-10-deficient mice. 
 
IL-17 production following blockage of CD4 in vitro 
Suspensions of splenic cells derived from wild-type and IL-10-deficient mice, either 
uninfected or infected with B. burgdorferi for eight days, were stimulated in vitro with 
spirochetes in the presence or absence of 5 µg/ml anti-CD4 antibody for 6 and 24 
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hours. After 6 hours of incubation, no differences in IL-17 production were observed due 
to the presence of anti-CD4 antibody (data not shown).  
 
After 24 hours of incubation, the presence of anti-CD4 antibody slightly enhanced the 
production of IL-17 by cells of uninfected wild-type mice (Fig. 3A). However, this 
increase in IL-17 production was not statistically significant. In contrast, treatment of 
cells from B. burgdorferi-infected wild-type mice with anti-CD4 antibody significantly 
reduced IL-17 production compared to untreated cells (P ≤ 0.05; Fig. 3A). Treatment of 
cells from uninfected or infected IL-10-deficient mice with anti-CD4 antibody caused a 
decrease in IL-17 production that was not statistically significant (Fig. 3B).  
 
Effects of anti-IL-17 antibody treatment on hind paw swelling 
Wild-type and IL-10-deficient mice were infected in the hind paws with viable B. 
burgdorferi strain 297 organisms. One group of mice from each strain was administered 
anti-IL-17 antibody on the day of infection and then daily for 7 days, while the remaining 
group of mice received an isotype control antibody. The hind paws of B. burgdorferi-
infected, untreated IL-10-deficient mice had increased swelling of the hind paws 
compared to those of infected, untreated wild-type mice up to 6 days after infection (P ≤ 
0.05; Fig. 4). The edematous changes in both groups decreased to levels below 
baseline measurements by day 8 after infection.  
 
Treatment of B. burgdorferi-infected mice with antibody to IL-17 ameliorated the 
swelling observed in untreated mice. Administration of anti-IL-17 antibody significantly 
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reduced the edematous changes in B. burgdorferi-infected IL-10-deficient mice at 3 and 
6 days after infection (P ≤ 0.05; Fig. 4). By day 8 after infection, there were no 
significant differences in hind paw swelling between these groups. Similarly, treatment 
of B. burgdorferi-infected wild-type mice with anti-IL-17 antibody reduced hind-paw 
swelling; however, the effects of the antibody in these mice were delayed and milder. A 
significant decrease in paw swelling was only observed at day 6 after infection (P ≤ 
0.05; Fig. 4). Mice that were injected with BSK medium and then injected daily with anti-
IL-17 or isotype control antibody did not show changes in hind paw swelling from 
baseline levels (data not shown). 
 
Effect of IL-17 antibody administration on histopathology 
Histopathological analysis of hind paws, including the tibiotarsal joints and knees, was 
performed on untreated or anti-IL-17 antibody-treated mice infected with B. burgdorferi 
in order to determine whether the presence of IL-10 regulates IL-17-mediated arthritis 
induced by the spirochete. B. burgdorferi-infected wild-type mice exhibited minimal 
histopathological changes on day 8 after infection, with only mild hyperplasia observed 
in some animals (Table 1). B. burgdorferi-infected wild-type mice that were administered 
anti-IL-17 antibody displayed no significant histopathological changes. The 
histopathological changes observed in untreated, infected wild-type mice were too mild 
to attribute the lack of pathology in treated animals to the anti-IL-17 antibody. 
 
By contrast, the severity of pathology among untreated IL-10-deficient mice, particularly 
in the knee and perisynovium of the tibiotarsal joints, was significantly greater than that 
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of untreated wild-type mice (P ≤ 0.05; Table 1). IL-10-deficient mice displayed moderate 
lymphocytic infiltration, as well as hyperplasia and hypertrophy, in the tibiotarsal tissues 
and knee 8 days after infection with B. burgdorferi (Table 1). In addition, these mice 
exhibited mild erosion of bones in the tibiotarsal joint. Treatment of B. burgdorferi-
infected, IL-10-deficient mice with antibodies to IL-17 slightly reduced, but did not 
abrogate, cellular infiltration, hyperplasia, and hypertrophy of the synovium and 
perisynovium of the tibiotarsal joint (Table 1). However, treatment of infected IL-10-
deficient mice with anti-IL-17 antibodies did significantly reduce the histopathological 
changes of the knee joints observed in infected, but untreated, IL-10-deficient mice (P ≤ 
0.05; Table 1).   
 
Borreliacidal antibody titers 
Borreliacidal antibody titers were obtained with sera from wild-type and IL-10-deficient 
mice that were uninfected or infected with B. burgdorferi for 8 days. The borreliacidal 
antibody titers were low (≤ 80; Fig. 5) in all groups. No significant differences were 
detected.  
 
Discussion 
In this report, we support and extend recent findings that IL-17 is a contributing factor in 
the development of Lyme arthritis by showing that its production and histopathological 
effects are regulated by IL-10. Spleen cells obtained from wild-type C57BL/6 mice, 
which are resistant to developing arthritis following infection with B. burgdorferi 
(Barthold et al. 1990), produced low levels of IL-17 following stimulation with the 
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spirochete. By contrast, spleen cells obtained from IL-10-deficient C57BL/6 mice, which 
develop moderate arthritis after borrelial infection (Brown et al. 1999), produced a 
significant amount of IL-17 at the time of arthritic manifestations following infection with 
B. burgdorferi. We further showed that the significant hind paw swelling and 
histopathological changes observed in B. burgdorferi-infected, IL-10-deficient mice were 
partially inhibited by administration of anti-IL-17 antibody. Collectively, these findings 
support our claims (Burchill et al. 2003, Nardelli et al. 2004, Amlong et al. 2006, Nardelli 
et al. 2008b, Nardelli et al. 2010, Kotloski et al. 2008, Nardelli et al. 2008a) and those of 
others (Codolo et al. 2008, Codolo et al. 2013) that IL-17 is involved in the development 
of arthritis following infection with B. burgdorferi. More importantly, they reveal a 
significant regulatory mechanism for an inflammatory pathway that is induced by 
borrelial infection (Infante-Duarte et al. 2000) and which is known to contribute to 
several other types of arthritis (Chabaud et al. 2000, Agarwal et al. 2008, Pinto et al.  
2010, Lubberts et al. 2004). 
 
The finding that IL-10 regulates the arthritic, IL-17-mediated response to B. burgdorferi 
adds to the known properties of the anti-inflammatory cytokine in controlling the immune 
response to, and pathological outcomes of, borrelial infection. Early investigations into 
the differences in pathology observed between C3H and C57BL/6 mice demonstrated 
that the effect of IL-10 is a key factor in determining disease outcome (Brown et al. 
1999, Ganapamo et al. 2000). Until now, much of the investigation pertaining to the 
inflammatory targets of IL-10 focused on the Th1/IFN-γ response, which has long been 
known as a major inflammatory pathway of later-stage Lyme arthritis (Yssel et al. 1991, 
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Gross et al. 1998).  For example, modulation of IL-10 in vitro reciprocally influenced 
IFN-γ production by stimulated synovial cells of Lyme arthritis patients (Yin et al. 1997). 
In addition, differences in IL-10-mediated regulation of IFN-γ accounted for the 
differences in arthritic severity exhibited by C3H and C57BL/6 mice (Brown et al. 1999, 
Ganapamo et al. 2000). In support of this, recent findings show that IL-10 plays a 
particularly important role in controlling the IFN-γ-driven arthritis caused, in large part, 
by CD4+ T cells in B. burgdorferi-infected mice (Sonderegger et al. 2012). Our current 
findings suggest that IL-10 additionally exerts its anti-inflammatory effects during B. 
burgdorferi infection by suppressing the production of IL-17, even in the presence of 
IFN-γ. 
 
These findings are important because they provide additional support that IL-17 is 
elicited in response to B. burgdorferi and, ultimately, contributes to the pathology of 
Lyme arthritis. Consideration of IL-17 as an inflammatory mediator of Lyme arthritis 
stems from the observation that, while Th1-mediated inflammation is a major cause of 
pathology (Yssel et al. 1991, Gross et al. 1998, Strle et al. 2012, Shen et al. 2010), 
arthritis also develops independently of IFN-γ (Brown & Reiner 1999, Christopherson et 
al. 2003, Munson et al. 2004). Infante-Duarte, et al. first determined that stimulated cells 
of Lyme arthritis patients produce IL-17 (Infante-Duarte et al. 2000). Following this 
observation, a series of studies showed that various Th17-associated cytokines were 
associated with pathology in murine models of Borrelia-induced arthritis (Burchill et al. 
2003, Nardelli et al. 2004, Amlong et al. 2006, Nardelli et al. 2008b, Nardelli et al. 2010, 
Kotloski et al. 2008), supporting claims of the arthritic potential of IL-17 in Lyme arthritis 
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(Nardelli et al. 2008a). Supporting this, NapA of B. burgdorferi stimulated innate cells to 
drive the development of Th17 cells that were present in the synovia of humans with 
Lyme arthritis (Codolo et al. 2008). NapA is a key antigen in the recruitment of 
inflammatory cells which, along with NapA itself, stimulate the production of IL-17 from 
different T cell populations (Codolo et al. 2013). However, Th17 cells were greatly 
outnumbered by Th1 cells in the synovia of humans with antibiotic-refractory or 
antibiotic-responsive Lyme arthritis, comprising approximately 5% of all CD4+ T cells 
(Shen et al. 2010). As a result, little, if any, contribution to disease was attributed to 
Th17 cells.  Although some studies have demonstrated the reciprocal nature of Th1 and 
Th17 cells (Yoshimura et al. 2006), others have shown that these inflammatory 
pathways can function simultaneously and, occasionally, even be expressed 
simultaneously by an individual cell (Codolo et al. 2013, Zielinski et al. 2012). Our 
current findings support the assertion that IL-17 contributes to the pathology of Lyme 
arthritis.  
 
Our findings also suggest that multiple cell types are responsible for the production of 
IL-17 in response to B. burgdorferi. Various cell types, including Th17 cells, produce the 
cytokine (Pappu et al. 2011). We showed that unseparated spleen cells from infected 
C57BL/6 wild-type mice, when incubated with B. burgdorferi and antibodies to CD4, 
produced significantly less IL-17 than did stimulated cells not additionally incubated with 
antibodies. However, the production of IL-17 by these latter cells was initially low. When 
we blocked CD4 in cultures of stimulated cells obtained from IL-10-deficient mice, we 
observed decreases in IL-17 production; however, these decreases were not 
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statistically significant. It is possible that the concentration of anti-CD4 antibody we used 
here was insufficient to counter the significant production of IL-17 by these IL-10-
deficient cells. However, it is also probable that CD4+ and non-CD4+ cell populations 
produced IL-17 in this system. We are currently assessing the production of IL-17 by 
these cells in the presence of multiple doses of anti-CD4 antibody, and are 
characterizing IL-17-producing cell phenotypes during infection.  
 
It is important also to note that the immune pathways associated with regulation of IL-17 
are complex. For example, in support of our findings, opposing functions of IL-10 and 
various IL-17-producing cell types have been reported in other disease models, 
including infections (Frodermann et al. 2011, Gonzalez-Lombana et al. 2013) and, 
importantly, arthritis (Yang et al. 2012, Heo et al. 2010). However, cells that produce 
both cytokines exist (Zielinkski et al. 2012, McGeachy et al. 2007), and IL-10-producing 
regulatory T (Treg) cells have also been shown to aid in the production of Th17 cells at 
certain periods of development (Chen et al. 2011). Moreover, the roles of Th17 cells 
and IL-17 in Lyme arthritis have been challenged by the finding that humans with a 
reduced capacity to bind the Th17 cell-survival cytokine interleukin-23 (IL-23) have 
reduced IL-17 production but do not exhibit reduced arthritis (Oosting et al. 2011). In 
addition, we showed that the Treg cell-associated cytokine interleukin-35 enhances, 
rather than inhibits, arthritis in a murine model of disease and only reduces IL-17 
production slightly (Kuo et al. 2011). Taken together, these findings demonstrate the 
complexity of inflammatory and regulatory pathways involved in Lyme arthritis and 
necessitate their further investigation. 
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Our findings suggest that IL-10 regulates B. burgdorferi-mediated pathology, in part, by 
limiting the arthritic potential of IL-17. The data we present here are reminiscent of our 
findings linking IL-17 and putative Treg cells in a model of Borrelia-induced arthritis 
(Nardelli et al. 2004, Nardelli et al. 2005, Nardelli et al. 2006). We showed that blocking 
IL-17 in IFN-γ-deficient, Borrelia-vaccinated and -infected mice prevented pathology and 
increased the production of CD25-expressing CD4+ cells (Nardelli et al. 2004). 
Concomitantly injecting these mice with antibody to CD25 reduced this cell population 
and resulted in massive erosion of the ankle joints (Nardelli et al. 2004). Adoptive 
transfer of CD4+CD25+ cells, enriched following anti-IL-17 antibody treatment, into 
infected recipients completely prevented the development of arthritis (Nardelli et al. 
2005). Importantly, we did not observe regulatory functions among CD4+CD25+ cells 
obtained from mice in which IL-17 was not blocked (Nardelli et al. 2006). Following 
these early experiments, Bettelli, et al. showed that Th17 cells and CD4+CD25+Foxp3+ 
Treg cells developed via inverse pathways from a common precursor cell (Bettelli et al. 
2006). In light of our findings from nearly a decade ago, it may not be surprising that we 
observed a significant IL-17 response in IL-10-deficient, B. burgdorferi-infected mice, as 
CD4+CD25+Foxp3+ Treg cells function, in large part, through their production of IL-10 
(Huber et al. 2011). In addition, it may not be surprising that anti-IL-17 antibody 
treatment did not completely abrogate arthritis in infected IL-10-deficient mice, since 
increased IL-17 production is likely just one of many effects of an absence of IL-10. In 
support of our hypothesis that Treg cells are key mediators of Lyme arthritis (Nardelli et 
al. 2004, Nardelli et al. 2008a, Nardelli et al. 2005, Nardelli et al. 2006), more recent 
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findings have shown that patients with persistent, antibiotic-refractory disease produce 
more Treg cells than those with disease that readily resolves with antimicrobial therapy 
(Shen et al. 2010). In addition, longer durations of antibiotic-refractory Lyme arthritis 
post-treatment are associated with lower frequencies of Treg cells (Shen et al. 2010, 
Vudattu et al. 2013). Collectively, these data imply that Lyme arthritis may be modulated 
by IL-10, which, in the context of borrelial infection, down-regulates inflammatory 
cytokines, including IL-17. 
 
What is the importance of this alternative response to B. burgdorferi? We show that 
wild-type or IL-10-deficient cells harvested one day after infection, when subsequently 
stimulated with the spirochete, produce an equal or reduced amount of IL-17. 
Additionally, cells from B. burgdorferi-infected wild-type mice produce less IL-17 than 
cells from uninfected mice. Collectively, these findings suggest a tendency toward an 
anti-inflammatory mechanism early after interaction with the spirochete. In support of 
this, early infection with B. burgdorferi results in an increase in IL-10 (Lazarus et al. 
2008), suggesting that the resulting suppression of the inflammatory response may 
allow a successful infection to occur. Our findings suggest that initial exposure with the 
spirochete may cause an early delay or decrease in IL-17 that may not only assist in 
successful infection, but which may occur independently of IL-10. Suppression of IL-17 
production following early exposure to B. burgdorferi may allow some of the initial 
infectious spirochetes to survive, possibly until the inflammatory response to borrelial 
antigens becomes more robust. Additional studies, particularly ones using skin samples 
of tick-infected mice, would be required to test this hypothesis. By contrast, the effects 
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of IL-10 on IL-17 production were more pronounced after one week of infection. 
Borrelial infection in the presence or absence of IL-10 may be associated with an 
inverse response of various inflammatory cytokines, including not only tumor necrosis 
factor-alpha and IFN-γ (Brown et al. 1999, Ganapamo et al. 2000, Ganapamo et al.  
2000, Yin et al. 1997, Sonderegger et al. 2012, Lazarus et al. 2008, Murthy et al. 2000, 
Diterich et al. 2001, Crandall et al. 2006, Lazarus et al. 2006, Gautam et al. 2011), but, 
also, IL-17. If a certain threshold of immune suppression by IL-10 is not achieved, a 
significant, multi-faceted inflammatory response may ensue.  
 
Our histopathological findings support the claim of multiple inflammatory pathways 
contributing to the development of Lyme arthritis. As expected, B. burgdorferi-infected, 
C57BL/6 wild-type mice exhibited mild paw swelling and minimal histopathological 
changes by day 8 after infection. Despite the mild hind paw swelling of these mice, 
administration of anti-IL-17 antibody significantly decreased the levels of edema by day 
six after infection. By contrast, B. burgdorferi-infected IL-10-deficient mice exhibited 
moderate swelling and histopathological changes of the hind paws. Treatment with 
antibody to IL-17 resulted in a significant reduction of swelling that was observed sooner 
and which was sustained for the duration of the experiment. Importantly, the overall 
histopathology of these treated mice was decreased, particularly in the knee and 
perisynovium of the tibiotarsal joint. However, some mice were free of pathology, while 
others still exhibited a degree of pathology. This supports the idea that IL-17 is a partial 
contributor to arthritis and, therefore, blocking only this cytokine would likely not be a 
panacea.  
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Finally, we found that after eight days of infection, IL-10 failed to significantly affect the 
levels of borreliacidal antibodies in the serum of B. burgdorferi-infected mice. A 
deficiency in IL-10 has been linked to reduced microbial loads and increased levels of 
B. burgdorferi-specific antibodies (Brown et al. 1999, Lazarus et al. 2006); however, 
these findings were observed after at least two weeks after infection. In addition, a 
robust innate immune response, rather than the borreliacidal antibody response, was 
implicated in the reduced levels of B. burgdorferi in the tissues of IL-10-deficient mice 
(Lazarus et al. 2006). Therefore, the lack of significant borreliacidal antibody activity in 
our IL-10 deficient mice may not be surprising. The apparent lack of an influence of IL-
17 on borreliacidal antibody production in these mice may also not be surprising, 
considering our previous finding that blocking IL-17 in a model of B. burgdorferi-
mediated arthritis failed to affect these titers (Amlong et al. 2006), and the recent finding 
that antibody production overall may not be affected directly by IL-17 (Shibui et al. 
2012). We are further investigating the role of IL-17 in the early antibody response to B. 
burgdorferi. 
 
In summary, we showed that IL-10 regulates an arthritic IL-17 response following 
infection with B. burgdorferi. These findings add to the known immunomodulatory 
functions of IL-10 in the context of borrelial infection, as well as support the growing 
evidence that IL-17 contributes to disease. These findings were observed using infected 
IL-10-deficient C57BL/6 mice, which has been described recently as a viable model to 
investigate elements of adaptive immunity not readily observed in traditional disease 
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models (Sonderegger et al. 2012). This sentiment echoes our previous claims that the 
use of models that exhibit the full array of immune events (including T cells) involved in 
the development of arthritis in humans is vital for a more complete understanding of the 
inflammatory events associated with Lyme arthritis in humans (Nardelli et al. 2010, 
Kotloski et al. 2008, Nardelli et al. 2008a). Here, we showed that this model also allows 
for investigating the role of IL-17 in Borrelia-mediated arthritis, which while shown to 
potentially contribute to human disease (Codolo et al. 2008, Colodo et al. 2013), has not 
been demonstrated in traditional animal models (Nardelli et al. 2010). More importantly, 
we provide additional evidence for considering an inflammatory pathway that may be 
targeted for the treatment of Lyme arthritis. 
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Figure 1. 
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Figure 1. IL-17 production is increased in the absence of IL-10 eight days after 
infection with B. burgdorferi. Splenic cells obtained from wild-type (black bars) and 
IL-10-deficient (white bars) mice eight days after injection of B. burgdorferi or BSK 
medium were cultured in the presence or absence of the spirochete for 6 (A) and 24 (B) 
hours.  (A) After 6 hours of incubation, cells from infected or uninfected wild-type mice 
produced minimal IL-17, regardless of in vitro stimulation. By contrast, stimulated cells 
from uninfected and B. burgdorferi-infected IL-10-deficient mice produced significant 
amounts of IL-17. The IL-17 production by these stimulated IL-10-deficient cells was 
significantly greater than that of stimulated wild-type counterparts, as well as that of 
unstimulated IL-10-deficient counterparts. Additionally, stimulated cells from infected IL-
10-deficient mice produced significantly more IL-17 than stimulated cells from 
uninfected IL-10-deficient mice. (B) Production of IL-17 by wild-type cells remained low 
after 24 hours of incubation with or without the spirochete. By contrast, stimulated cells 
from B. burgdorferi-infected IL-10-deficient mice produced a large amount of IL-17. The 
production of IL-17 by these cells was significantly greater than that of stimulated cells 
from infected wild-type mice, stimulated cells from uninfected IL-10-deficient mice, and 
unstimulated cells from infected IL-10-deficient mice. Additionally, unstimulated cells 
from infected IL-10-deficient mice produced significantly more IL-17 than did 
unstimulated cells from infected wild-type mice and uninfected IL-10-deficient mice. 
Data are mean levels of IL-17/ml culture supernatant ± SEM. *P ≤ 0.05. ND, not 
detected. 
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Figure 2. 
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Figure 2. Effects of early B. burgdorferi exposure on production of IL-17. Splenic 
cells obtained from wild-type (black bars) and IL-10-deficient (white bars) mice one day 
after injection of B. burgdorferi or BSK medium were cultured in the presence or 
absence of the spirochete for 6 (A) and 24 (B) hours. (A) After 6 hours of incubation, 
cells from uninfected wild-type mice produced significantly more IL-17 than did cells 
from infected wild-type mice, regardless of stimulation in vitro. Stimulated cells from 
uninfected wild-type mice also produced significantly more IL-17 than stimulated cells 
from uninfected IL-10-deficient mice. In addition, in vitro stimulation with B. burgdorferi 
for 6 hours caused a significant decrease in IL-17 production by cells from IL-10-
deficient, but not wild-type, mice, regardless of whether the mice were previously 
infected. (B) After 24 hours of incubation, cells from uninfected wild-type mice produced 
significantly more IL-17 than did cells from infected wild-type mice, regardless of 
stimulation in vitro. Similarly, these cells produced significantly more IL-17 than those of 
uninfected IL-10-deficient counterparts. In addition, in vitro stimulation with B. 
burgdorferi for 24 hours caused a significant decrease in IL-17 production by cells from 
infected wild-type mice, but not by those of uninfected wild-type mice, uninfected 
interleukin-10-deficient mice, or B. burgdorferi-infected interleukin-10-deficient mice. 
Data are mean levels of IL-17/ml culture supernatant ± SEM. *P ≤ 0.05.  
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Figure 3. 
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Figure 3. Partial inhibition of IL-17 production by blocking CD4 in vitro. Wild-type 
(A) and IL-10-deficient (B) splenic cells obtained from uninfected mice and mice infected 
with B. burgdorferi for 8 days were stimulated with the spirochete in the presence or 
absence of 5 µg/ml anti-CD4 antibody for 24 hours. (A) Addition of anti-CD4 antibody to 
cells of uninfected, wild-type mice did not significantly affect IL-17 production. In 
contrast, anti-CD4 antibody treatment of cells from B. burgdorferi-infected wild-type 
mice caused a significant reduction in IL-17 production. (B) Anti-CD4 antibody treatment 
of cells from uninfected or B. burgdorferi-infected IL-10-deficient mice reduced the 
production of IL-17. However, these reductions were not statistically significant. Data 
are mean levels of IL-17/ml culture supernatant ± SEM. * P ≤ 0.05.  
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Figure 4. 
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Figure 4. Treatment of B. burgdorferi-infected IL-10-deficient mice with anti-IL-17 
antibody significantly reduces hind paw swelling. Wild-type (black squares) and IL-
10-deficient (white squares) mice were infected with B. burgdorferi and administered 
anti-IL-17 antibody (dashed lines) or isotype control antibody (solid lines) within 3 hours 
of infection and daily thereafter for 7 days. Hind paw swelling of infected, but untreated, 
IL-10-deficient mice was greater than that of infected, but untreated, wild-type mice. 
Anti-IL-17 antibody treatment of infected wild-type mice caused a significant reduction in 
hind paw swelling that was evident on day 6 after infection. Treatment of B. burgdorferi-
infected IL-10-deficient mice with anti-IL-17 antibody caused a substantial reduction in 
hind paw swelling that was evident on day 3 after infection and which lasted through 
day 6 after infection. Data are mean changes in paw swelling relative to baseline ± 
SEM. * P ≤ 0.05.  
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Table 1. 
 
 
 Synovium 
(Tibiotarsal) 
Perisynovium 
(Tibiotarsal) 
Tibiotarsal 
Bone Erosion 
Knee 
Wild-type + isotype 
antibody 
0.50 0.00 0.00 0.50 
Wild-type + anti-IL-
17 antibody 
0.50 0.00 0.00 0.25 
IL-10-deficient + 
isotype antibody 
1.75 1.75* 0.75 2.50* 
IL-10-deficient + 
anti-IL-17 antibody 
1.50 1.00* 0.75 1.00** 
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Table 1. Treatment of B. burgdorferi-infected IL-10-deficient mice with anti-IL-17 
antibody reduces the severity of histopathology. B. burgdorferi-infected wild-type 
mice that were administered anti-IL-17 antibody or an isotype control antibody exhibited 
minimal histopathological changes of the ankle joint 8 days after infection. B. 
burgdorferi-infected IL-10-deficient mice exhibited arthritic changes of the hind paws, 
including bone erosion of the ankle joint and cellular infiltration and hyperplasia of the 
perisynovial tissues and knee, 8 days after infection. Treatment of these mice with anti-
IL-17 antibody caused a significant reduction in the severity of pathology observed in 
the perisynovium of the tibiotarsal joint and knee. *Significantly greater (P ≤ 0.05) than 
wild-type counterpart. **Significantly (P ≤ 0.05) less than isotype antibody-treated 
counterpart. 
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Figure 5. 
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Figure 5. IL-10 deficiency does not affect borreliacidal antibody titers eight days 
after infection. Sera from uninfected and B. burgdorferi-infected wild-type (black bars) 
and IL-10-deficient (white bars) mice were collected on day 8 after infection. 
Borreliacidal antibody titers of all groups were low (≤ 80). No significant differences in 
titers between groups were detected. 
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Abstract 
Lyme borreliosis, which is caused in the United States by the spirochete Borrelia 
burgdorferi, may manifest as different arrays of signs, symptoms, and severities 
between infected individuals. Recent studies have indicated that particularly severe 
forms of Lyme borreliosis in humans are associated with an increased Th17 response. 
Here, we hypothesized that a murine model combining the dysregulated immune 
response of an environment lacking interleukin-10 (IL-10) with a robust T cell-driven 
inflammatory response would reflect arthritis associated with the production of 
interleukin-17 (IL-17) by CD4+ cells. We demonstrate that IL-10 regulates the 
production of IL-17 by Borrelia-primed CD4+ cells early after interaction with Lyme 
spirochetes in vitro and that infection of Borrelia-primed mice with B. burgdorferi leads 
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to significant production of IL-17 that contributes to the development of severe arthritis. 
These results extend our previous findings by demonstrating that a dysregulated 
adaptive immune response to Lyme spirochetes can contribute to severe, Th17-
associated arthritis.  These findings may lead to therapeutic measures for individuals 
with particularly severe symptoms of Lyme borreliosis. 
 
Introduction 
The causative agent of Lyme borreliosis in the United States, Borrelia burgdorferi, may 
induce a potent immune response, which can result in multi-system pathology in 
untreated individuals. The signs and symptoms of Lyme borreliosis are determined, in 
part, by the degree to which inflammatory mediators of innate and adaptive immunity 
are activated and regulated throughout infection. That Lyme borreliosis within a 
population is manifested as different arrays of signs and symptoms, each with varying 
degrees of severity, indicates that inflammatory responses to the spirochete differ in 
robustness and mechanism. This assertion is supported by recent findings that different 
immune pathways exist for the development of Lyme arthritis in experimental animals 
(Sonderegger et al. 2012, Hansen et al. 2013) and humans (Crandall et al. 2006, Strle 
et al. 2014). As a result, no one animal model of B. burgdorferi infection is sufficient to 
reflect the complex immune responses and varying clinical outcomes exhibited by 
humans. 
 
The differences in pathology between genotypes of experimental animals have been 
partially linked to the anti-inflammatory cytokine interleukin-10 (IL-10). IL-10 is produced 
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following exposure to borrelial antigens (Giambartolomei et al. 1998; Brown J et al. 
1999; Lazarus et al. 2008), possibly aiding infection by suppressing various effectors of 
the innate immune response (Yin et al. 1997; Brown J et al.1999; Lazarus et al. 2006; 
Gautam et al. 2011). However, the early production of IL-10 following B. burgdorferi 
infection also affects the adaptive immune response. For example, IL-10 produced by 
macrophages plays a significant role in inhibiting an interferon-gamma (IFN-γ)-driven 
arthropathy in mice (Sonderegger et al. 2012). Also, B. burgdorferi-induced IL-10 
inhibits events involved in the activation of adaptive immunity, including phagocytosis 
and expression of MHC class II and various co-stimulatory molecules (Chung et al. 
2013). Additionally, we showed that the anti-inflammatory effects of IL-10 in the days 
following infection with B. burgdorferi extend to preventing an interleukin-17 (IL-17)-
dependent arthropathy (Hansen et al. 2013).  
 
We first identified a role for an arthritic IL-17 response to B. burgdorferi using a model 
exhibiting a particularly robust T cell response to Lyme spirochetes (Lim et al. 1995a, 
1995b). Specifically, we showed that wild-type and IFN-γ-deficient C57BL/6 mice that 
are primed and subsequently infected with heterologous Lyme spirochetes develop 
arthritis that is dependent, in part, on various Th17-associated cytokines (Burchill et al. 
2003; Nardelli et al. 2004; Nardelli et al. 2005; Amlong et al. 2006; Kotloski et al. 2008; 
Nardelli et al. 2008b; Kuo et al. 2011). Importantly, the presence of Th17 cells or their 
associated cytokines in humans with Lyme arthritis has been demonstrated in several 
studies. For example, IL-17-producing T cells have been isolated from the joints of 
humans with Lyme arthritis (Infante-Duarte et al. 2000; Codolo et al. 2008; Codolo et al. 
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2013). In addition, while Th1 cells have long been observed in patients with Lyme 
arthritis (Yssel et al. 1991; Gross et al. 1998; Shen et al. 2010; Strle et al. 2012), a 
substantial proportion of Th17 cells has been shown to be present among individuals 
with the disease (Shen et al. 2010). Also, the Th17 cell-supporting cytokine IL-23, 
which, like IL-17, is induced by B. burgdorferi (Knauer et al. 2007), has been shown to 
be elevated in certain patients with severe, persisting symptoms after treatment for 
Lyme borreliosis (Strle et al. 2014).  
 
It has been hypothesized that the severe symptoms of Lyme arthritis may be due 
partially to a dysregulated immune response (Nardelli et al. 2004; Steere and Glickstein 
2004; Nardelli et al. 2008a). In this report, we used a model combining the dysregulation 
of an environment devoid of IL-10 (Sondergger et al. 2012) with the potency of a robust 
T cell-driven inflammatory response (Lim et al. 1995a, 1995b) to characterize factors 
that may influence the severe disease, which occurs in some patients. We show that 
Borrelia-primed CD4+ cells produce IL-17 in an IL-10-regulated manner soon after 
interaction with Lyme spirochetes in vitro. In addition, infection of Borrelia-primed, IL-10-
deficient mice induces a substantial increase in IL-17 production that may contribute to 
the development of severe arthritis. These results extend our previous findings by 
demonstrating that a dysregulated adaptive immune response to Lyme spirochetes can 
lead to Th17-associated inflammation.  These findings may lead to therapeutic 
measures for individuals with particularly severe symptoms of Lyme borreliosis that are 
associated with an increased Th17 response. 
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Materials and Methods 
Mice 
Male and female, six- to twelve-week old, IL-10-deficient and wild-type mice on the 
C57BL/6 background, originally obtained from Jackson Laboratories, were provided by 
J.-A. Lyons (University of Wisconsin-Milwaukee).  Mice were housed at the University of 
Wisconsin-Milwaukee animal facility at an ambient temperature in a humidity-controlled 
environment under a 12-hour light/dark schedule.  Food and water were provided ad 
libitum.  All experiments were reviewed and approved by the University of Wisconsin-
Milwaukee Institutional Animal Care and Use Committee.  
 
Priming of mice 
It has been shown that injection of experimental animals with inactivated, whole Lyme 
spirochetes in adjuvant primes the animals for a robust, arthritic T cell response (Lim et 
al. 1995a, 1995b) that is activated following infection with heterologous spirochetes. A 
homologous infection strain also was used to induce arthritis after priming of hamsters. 
This depended on infection occurring prior to the development of protective antibodies 
produced in response to priming (Lim et al. 1994); however, this has yielded 
inconsistent results in mice.  We used this heterologous priming/infection model in mice 
to identify a role for IL-17 in the development of Borrelia-induced arthritis (Burchill et al. 
2003; Nardelli et al. 2008b), which has been reported in some humans (Codolo et al. 
2008, 2013) but which is not evident upon infection of disease-susceptible C3H mice 
(Nardelli et al. 2010; Lasky et al. 2015).   
 
  93 
Borrelia bissettii organisms (provided by S. M. Callister, Gundersen Health System, La 
Crosse, WI) were maintained as 1.0 mL frozen stocks at -80°C.  Aliquots were thawed 
and inactivated by incubating in a 56°C water bath for 30 minutes.  Inactivation of the 
organisms was determined by lack of motility when viewed under dark-field microscopy 
and lack of growth after culture in Barbour-Stoenner-Kelly (BSK) medium for seven 
days.  Heat-inactivated bacteria were washed four times by centrifuging (10,000 x g) 
with phosphate buffered saline (PBS) for 10 minutes, resuspended in PBS, and 
enumerated using a Petroff-Hausser counting chamber.  After washing, inactivated 
bacteria were mixed with the adjuvant (1% aluminum hydroxide; General Chemical 
Performance Products, Berkeley Heights, NJ) to obtain a final concentration of 4 x 106 
organisms mL-1 in the preparation.  Mice were injected with 0.25 mL of the antigen 
suspension subcutaneously in each inguinal region while under anesthesia with 
isoflurane in a nose-and-mouth cup. Control groups consisted of mice injected with 
aluminum hydroxide without B. bissettii. 
 
Infection of mice 
Borrelia burgdorferi 297 organisms (provided by S. M. Callister) were maintained as 1.0 
mL frozen stocks at -80°C.  Aliquots were grown at 34°C for three to six days in BSK 
medium prior to infection. Twenty-one days after priming, groups of four to six mice 
were injected with 106 viable B. burgdorferi 297 organisms in 50 µl BSK medium 
subcutaneously in each hind paw while anesthetized with isoflurane in a nose-and-
mouth cup. Control groups consisted of primed mice injected with BSK medium alone.   
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Administration of anti-IL-17 antibody 
Monoclonal antibodies specific for mouse IL-17A (clone eBioMM17F3; IgG1) and 
mouse IgG1 isotype control antibodies were purchased from eBioscience (San Diego, 
CA). Antibodies were reconstituted with filter-sterilized PBS to create a final 
concentration of 50 µg mL-1. Three hours after infection, mice were injected with 50 uL 
(2.5 µg) of anti-IL-17 antibodies subcutaneously in each hind paw while anesthetized 
with isoflurane in a nose-and-mouth cup. Antibody treatment was conducted daily for 
seven days.  Control mice were injected in the same manner with IgG isotype control 
antibody (eBioscience).   
 
Assessment of swelling 
The width and thickness of the tibiotarsal joints were measured using a digital caliper 
(Marathon; Richmond Hill, Ontario, Canada) with a sensitivity of 0.01 mm. 
Measurements were conducted immediately prior to, and throughout, infection with B. 
burgdorferi. The paws of antibody-injected mice were measured before injection.    
 
Spleen cell culture 
Spleen cells were harvested from mice one or eight days after infection (or 22 or 29 
days after priming, in uninfected animals). Single-cell suspensions of whole spleen cells 
were created by passing the tissue gently through a nylon mesh screen (BD Falcon; BD 
Biosciences, San Jose, CA) into cold RPMI 1640 medium (Cellgro; Corning, Manasas, 
VA) supplemented with L-glutamine and 25 mM HEPES.  1 x 106 spleen cells were 
incubated with or without 1 x 105 viable B. burgdorferi strain 297 organisms and with or 
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without 5 µg anti-mouse CD4 antibodies (clone G1.5; eBioscience) or isotype control 
antibodies (eBioscience). Cell culture supernatants were collected after six or 24 hours 
of incubation at 37°C in an atmosphere of 5% CO2. 
 
ELISA 
IL-17 levels in cell culture supernatants were determined using IL-17A ELISA Ready-
Set-Go! Kits (eBioscience; San Diego, CA) according to the manufacturer’s instructions.  
The plates were read at an absorbance of 450 nm to generate optical density values. 
Standard curves were then created to calculate the amount of IL-17 in each sample as 
pg mL-1.   
 
Histological examination 
Histological examination was conducted by a board-certified pathologist (Thomas F. 
Warner, University of Wisconsin-Madison) as described previously (Hansen et al. 2013). 
Briefly, paws were dissected eight days after infection, fixed in formalin, decalcified, 
sectioned, and stained with hematoxylin & eosin. The histopathological changes were 
scored according to the following scale: 0, no change; 1, mild leukocytic infiltration of 
subsynovial tissue; 2, moderate infiltration of subsynovial tissue, synovium, and synovial 
space; 3, profuse leukocytic infiltration of subsynovial tissue, synovium and synovial 
space; and 4, profuse leukocytic infiltration of tissues with destruction of bone or 
cartilage present.   
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Statistics 
Data were analyzed using ANOVA followed by the Tukey-Kramer post hoc test when a 
significant F value indicated reliable mean differences. Paired data were analyzed using 
two-tailed Student’s t test. Data were analyzed using Prism and SigmaPlot.  The alpha 
level was set at 0.05 prior to initiation of experiments.  Data are expressed as mean ± 
standard error of the mean (SEM) and reflect the results of two experiments, unless 
otherwise stated. 
 
Results 
Production of IL-17 eight days after infection of primed mice 
Spleen cells from B. bissettii-primed, but uninfected, wild-type C57BL/6 mice produced 
low amounts of IL-17 (5 pg mL-1 supernatant) after six hours of incubation in media 
(Figure 1A). When B. bissettii-primed wild-type cells were stimulated in vitro for six 
hours with a viable heterologous spirochete, B. burgdorferi strain 297, no IL-17 was 
detected. In addition, spleen cells from B. bissettii-primed, IL-10-deficient mice 
produced amounts of IL-17 that were below the level of detection of the assay following 
incubation in media for six hours (Figure 1A). However, incubation of B. bissettii-primed, 
IL-10-deficient cells with a heterologous Borrelia strain significantly increased the 
production of IL-17 (19 pg mL-1; P ≤ 0.05). The production of IL-17 by these primed, 
stimulated IL-10-deficient cells also was significantly greater (P ≤ 0.05) than that of their 
wild-type counterparts. After 24 hours of stimulation with B. burgdorferi strain 297, cells 
from Borrelia-primed, but uninfected, wild-type mice produced more IL-17 than their 
unstimulated counterparts (Figure 1C). However, this increase was not statistically 
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significant. By contrast, primed cells from IL-10-deficient mice produced a large amount 
of IL-17 (approximately 500 pg mL-1) following exposure in vitro to the heterologous 
strain, which was significantly greater (P ≤ 0.05) than that of primed, but unstimulated, 
IL-10-deficient cells (74 pg mL-1) and primed, stimulated wild-type cells. 
 
Similar findings were observed among cells that were obtained from B. bissettii-primed 
mice that were subsequently infected with B. burgdorferi strain 297 for eight days. 
Spleen cells from primed, infected wild-type mice exhibited no differences in IL-17 
production when incubated for six hours with the infection strain (Figure 1B). By 
contrast, incubation of cells from IL-10-deficient, primed and infected mice for six hours 
with the challenge strain significantly increased the production of IL-17, from 9 pg mL-1 
supernatant to 43 pg mL-1 supernatant (P ≤ 0.05; Figure 1B). In addition, in vitro 
stimulation of spleen cells from Borrelia-primed and -infected mice resulted in a 
significant increase in IL-17 production in the absence of IL-10 compared to wild-type 
cells. Moreover, spleen cells from primed, infected wild-type mice exhibited increased, 
but not statistically significant, IL-17 production when incubated for 24 hours with the 
infection strain (Figure 1D). Spleen cells from IL-10-deficient, Borrelia-primed and -
infected mice that were stimulated with the infection strain in vitro produced significantly 
more (P ≤ 0.05) IL-17 (186 pg mL-1) than unstimulated IL-10-deficient cells (5 pg mL-1) 
and stimulated wild-type cells.  
 
Overall, these findings show that in the absence of IL-10, stimulation of primed 
splenocytes induced production of IL-17, which increased dramatically with duration of 
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exposure to the spirochete. In addition, the magnitude of increased IL-17 production by 
primed, stimulated IL-10-deficient cells was much greater when the primed mice were 
additionally infected. 
 
Effects of CD4 blockage among cells of primed mice infected for eight days 
Spleen cells obtained from B. bissettii-primed mice that were uninfected or infected with 
B. burgdorferi strain 297 for eight days, described above, also were stimulated in vitro 
with the challenge isolate in the presence of anti-CD4 antibodies. The presence of anti-
CD4 antibodies for six or 24 hours did not affect the production of IL-17 from stimulated 
cells of Borrelia-primed, uninfected wild-type mice (Figures 2A and 2C). While we did 
observe that anti-CD4 antibodies caused a 31% reduction in IL-17 production among 
primed wild-type cells that were stimulated for 24 hours, this decrease was not 
statistically significant. Blockage of CD4 also had no effect on IL-17 production by 
primed and stimulated IL-10-deficient cells (Figures 2A and 2C). The production of IL-17 
by these cells was still significantly greater than that of wild-type counterparts, even with 
the addition of anti-CD4 antibodies.  
 
Similarly, addition of anti-CD4 antibodies had no statistically significant effects on IL-17 
production by stimulated cells that were obtained from mice that were primed and then 
infected for eight days with B. burgdorferi strain 297 (Figures 2B and 2D). However, 
some trends were evident. Stimulated cells obtained from primed and infected wild-type 
mice, when incubated in the presence of anti-CD4 antibodies, exhibited 30% and 60% 
reductions in IL-17 production after six (Figure 2B) and 24 (Figure 2D) hours of 
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incubation, respectively. Additionally, stimulated cells obtained from primed and infected 
IL-10-deficient mice, when incubated with anti-CD4 antibodies, exhibited a 43% 
reduction in IL-17 production after six hours of incubation (Figure 2B). However, these 
decreases were not statistically significant.  
 
Collectively, these findings demonstrate that CD4+ cells obtained from the spleen eight 
days after infection of primed mice may not be a statistically significant source of IL-17, 
regardless of whether IL-10 is present. However, trends indicating a possible 
contribution of CD4+ cells to the production of IL-17 in this model led us to investigate 
these immune events at an earlier time point following infection.  
 
Production of IL-17 one day after infection of primed mice 
We investigated the role of IL-10 on IL-17 production on the day following infection of 
Borrelia-primed mice. Spleen cells obtained from B. bissettii-primed wild-type mice that 
were infected for one day with B. burgdorferi strain 297 produced approximately 32 pg 
mL-1 IL-17 after incubation in media for six hours. Stimulation of these cells in vitro with 
the infection strain caused a significant decrease in IL-17 production (24 pg mL-1; P ≤ 
0.05, Figure 3A). Similarly, stimulated cells from primed IL-10-deficient mice that were 
infected for one day produced significantly less IL-17 than did unstimulated cells (16.0 
pg mL-1 vs. 23.23 pg mL-1; P ≤ 0.05). Additionally, unstimulated and stimulated cells 
from these wild-type mice each produced significantly more IL-17 than did their IL-10-
deficient counterparts after six hours of incubation. 
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After 24 hours of incubation in media, cells from primed wild-type mice that were 
infected with B. burgdorferi strain 297 for one day produced minimal amounts of IL-17 (5 
pg mL-1), which were not affected by in vitro stimulation (Figure 3B). By contrast, 
stimulation of cells from primed, IL-10-deficient mice that were infected for one day 
increased IL-17 production. This increase was notable but did not achieve statistical 
significance (P = 0.07). Collectively, these findings show that splenocytes obtained 
following early infection of primed mice initially down-regulated their production of IL-17 
for a short time upon stimulation with viable spirochetes.    
 
Effects of CD4 blockage among cells of primed mice infected for one day 
Spleen cells obtained from B. bissettii-primed mice that were infected with B. burgdorferi 
strain 297 for one day, described above, were stimulated in vitro with the challenge 
isolate in the presence of anti-CD4 antibodies. Incubation of stimulated wild-type cells 
with anti-CD4 antibodies for six hours did not affect the production of IL-17 (Figure 4A). 
By contrast, incubation of stimulated, IL-10-deficient cells with anti-CD4 antibodies for 
six hours resulted in a greater than 50% reduction in the production of IL-17 compared 
to stimulated cells incubated with isotype control antibodies, a decrease which was 
statistically significant (P ≤ 0.05; Figure 4A). The amount of IL-17 produced by these 
stimulated IL-10-deficient cells following incubation with anti-CD4 antibodies was also 
significantly less than that of stimulated wild-type cells incubated with the antibodies. By 
contrast, after 24 hours of incubation, no effects on IL-17 production due to the 
presence of anti-CD4 antibodies were observed (Figure 4B). Collectively, these findings 
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suggest that in the absence of IL-10, production of IL-17 by primed CD4+ cells occurs 
early upon exposure to viable spirochetes.  
 
Effects of IL-10 on hind paw swelling and arthritis 
We measured the average changes in hind paw swelling, compared to baseline levels, 
following infection of B. bissettii-primed mice with B. burgdorferi strain 297. Primed wild-
type mice exhibited no swelling of the hind paws in the eight days following injection of 
BSK medium (Figure 5). By contrast, infection of primed wild-type mice caused an 
increase in hind paw swelling that was significantly greater (P ≤ 0.05) three and six days 
after infection. By day eight after infection, the paw swelling observed among primed, 
infected wild-type mice was still greater than that of uninfected controls. However, this 
increase was not statistically significant (P = 0.06). Similarly, Borrelia-primed, IL-10-
deficient mice did not display hind paw swelling after injection of BSK medium. 
However, infection of primed IL-10-deficient mice led to severe hind paw swelling that 
was significantly greater than that of uninfected counterparts throughout the study (P ≤ 
0.05). Moreover, Borrelia-primed, infected IL-10-deficient mice exhibited significantly 
greater hind paw swelling throughout the study compared to primed, infected wild-type 
mice (P ≤ 0.05). 
 
Mild cellular infiltration into the synovium of the tibiotarsal joint and into the knee was 
observed when Borrelia-primed wild-type mice were infected with B. burgdorferi strain 
297 for eight days. Minimal infiltration into the perisynovial tissues of the tibiotarsal joint 
also was observed in these mice. By contrast, primed IL-10-deficient mice exhibited 
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moderate infiltration of cells, mostly lymphocytes, into these tissues eight days after 
infection. In particular, the lymphocytic infiltration observed in the perisynovial tissues of 
the tibiotarsal joint in primed, infected IL-10-deficient mice was significantly greater than 
that of wild-type counterparts (P ≤ 0.05). In addition, Borrelia-primed mice that were not 
infected exhibited no histopathological changes of the tibiotarsal or knee joints (Table 
1). Collectively, these results demonstrate that the swelling and arthritis observed in this 
disease model is significantly regulated by IL-10. 
 
Effect of IL-10-regulated IL-17 on hind paw swelling and arthritis 
In a separate trial, B. bissettii-primed mice were infected with B. burgdorferi strain 297 
and then administered anti-IL-17 antibodies or isotype-control antibodies. Primed wild-
type mice exhibited moderate hind paw swelling following infection with B. burgdorferi 
strain 297, returning to baseline levels by day eight of infection (Figure 6). As we have 
shown previously, administration of anti-IL-17 antibodies to these mice inhibited the 
development of hind paw swelling and, here, also reduced the average paw size below 
baseline measurements. This reduction was statistically significant (P ≤ 0.05) 
throughout the experiment. In addition, B. bissettii-primed, IL-10-deficient mice infected 
with B. burgdorferi strain 297 exhibited pronounced hind paw swelling that was apparent 
by day three after infection and which also returned to baseline levels eight days after 
infection. These mice exhibited significantly greater paw swelling than wild-type 
counterparts (P ≤ 0.05) at days three and six after infection. Administration of anti-IL-17 
antibodies to primed and infected IL-10-deficient mice delayed the onset of paw 
swelling, significantly reducing it at day three after infection (P ≤ 0.05; Figure 6). 
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Additionally, even after treatment with anti-IL-17 antibodies, primed and infected IL-10-
deficient mice displayed greater paw swelling than anti-IL-17 antibody-treated, primed 
and infected wild-type mice. This difference was not statistically significant three days 
after infection (P = 0.057) but was significant thereafter (P ≤ 0.05).  
 
B. bissettii-primed IL-10-deficient mice that were infected with B. burgdorferi strain 297 
for eight days exhibited severe and moderate infiltration of lymphocytes into the synovial 
and perisynovial tissues, respectively, of the tibiotarsal joints (Table 2). Treatment of 
primed, infected IL-10-deficient mice with anti-IL-17 antibodies reduced the degree of 
pathology in these tissues; however, these changes were not statistically significant. 
Additionally, no histopathological changes to the knee joints were observed. 
Collectively, these results demonstrate that IL-17 significantly contributes to the edema 
and may potentially contribute to the pathology in this dysregulated disease model. 
 
Discussion 
It is well documented that adaptive immunity is not absolutely required for the 
development of Lyme arthritis in C3H mice (Barthold et al. 1993; Brown & Reiner 1999). 
However, CD4+ T cells have been shown to contribute to disease in other animal 
models (Lim et al. 1995a, 1995b; McKisic et al. 2000; Wang et al. 2008). This is an 
important consideration, as inflammatory T cell responses are observed in individuals 
with Lyme arthritis, including antibiotic-refractory disease (Strle et al. 2012). Th1 
(Sonderegger et al. 2012) and IL-17-associated (Hansen et al. 2013) responses also 
have been reported in B. burgdorferi-infected IL-10-deficient C57BL/6 mice. These mice 
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allow for examination of a dysregulated immune response (Sonderegger et al. 2012) 
involving inflammatory T cells, which contribute to the symptoms of severe Lyme 
arthritis. 
 
The variable incidence and severity of symptoms that may result among individuals 
infected with B. burgdorferi suggest that different immune mechanisms, and various 
intensities thereof, may be elicited in response to the spirochete. Conflicting findings of 
the involvement of IL-17 in experimental animals highlight the likelihood that a Th17 
response to the spirochete varies by genetic makeup and model of disease induction. 
For example, various groups have shown that murine cells produce Th17-associated 
cytokines in response to B. burgdorferi (Infante-Duarte et al. 2000; Knauer et al. 2007; 
Oosting et al. 2011). Additionally, we showed that priming of otherwise arthritis-resistant 
C57BL/6 mice prior to heterologous infection induces arthritis dependent on these 
Th17-associated cytokines (Burchill et al. 2003; Nardelli et al. 2004; Nardelli et al. 2005; 
Amlong et al. 2006; Kotloski et al. 2008; Nardelli et al. 2008b; Kuo et al. 2011), 
particularly in the absence of IFN-γ (Burchill et al. 2003; Nardelli et al. 2004; Amlong et 
al. 2006). Also, we recently showed that infected C57BL/6 mice lacking IL-10 developed 
destructive pathology that was prevented by administration of anti-IL-17 antibodies 
(Hansen et al. 2013). However, we also observed that infected C3H mice, with or 
without prior priming, produced little serum IL-17, and that administration of anti-IL-17 
antibodies to these mice actually increased some aspects of disease (Nardelli et al. 
2010). In addition, Lasky et al. (2015) provided convincing evidence that mice deficient 
in the IL-17A receptor displayed similar degrees of paw swelling and histopathology as 
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did infected wild-type controls. Therefore, the contribution of IL-17 to experimental Lyme 
arthritis likely depends on a variety of factors, including genetic makeup, method of 
disease induction, and the presence of functional immunoregulatory mechanisms.  
 
Studies using human samples also have demonstrated conflicting findings pertaining to 
the role of IL-17 in Lyme arthritis. Synovial fluid T cells from Lyme arthritis patients 
produce IL-17 in response to borrelial lipoproteins (Infante-Duarte et al. 2000), including 
neutrophil activating protein A (NapA) (Codolo et al. 2008, 2013). Additionally, NapA 
induces the production of IL-23 from various innate cells (Codolo et al. 2008). By 
contrast, Bachmann et al. (2010) showed that stimulation of human peripheral blood 
mononuclear cells with various Lyme spirochetes failed to induce production of IL-17. 
Additionally, while Oosting, et al. (2011) showed that B. burgdorferi stimulated IL-17 and 
IL-23 from human peripheral blood mononuclear cells, and that a single nucleotide 
polymorphism in the IL-23 receptor gene resulted in less IL-17 production, this 
polymorphism did not affect the incidence of disease. Collectively, these conflicting 
findings in humans demonstrate that the robustness of the Th17 response to B. 
burgdorferi may be as varied as the individuals from which the samples were obtained. 
 
However, several reports describe an interesting association between Th17 responses 
and particularly severe or prolonged disease following infection with B. burgdorferi, 
including cases of antibiotic-refractory disease. Codolo et al. (2008) showed that 
patients with antibodies to the IL-17-inducing protein NapA tended to have a prolonged 
resolution of arthritis following treatment, and they more frequently exhibited antibiotic-
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refractory disease, than Lyme arthritis patients who did not have detectible levels of the 
antibodies. In addition, Shen et al. (2010) showed that among patients with responsive 
or refractory Lyme arthritis, the percentage of Th17 cells among total CD4+ T cells was, 
overall, relatively low (about 5%). However, Th17 cells comprised over 10% of the 
synovial fluid CD4+ T cells in two of six patients with antibiotic-responsive disease. 
Among 12 patients with antibiotic-refractory disease, this percentage approached 10% 
in multiple patients, including one in whom approximately 25% of the synovial CD4+ T 
cells were Th17 cells (Shen et al. 2010). Furthermore, the results of a study by Strle et 
al. (2014) demonstrated that higher levels of IL-23 were associated with more 
symptomatic infection prior to treatment. Also, IL-23 levels were higher in a group that 
eventually exhibited post-Lyme symptoms than a group in whom disease resolved. In 
addition, nearly two-thirds of patients with detectable IL-23 had symptoms after 
treatment, and all patients with exceedingly high levels of IL-23 had these symptoms 
(Strle et al. 2014). Collectively, these findings support our observations of IL-17 
responses in the dysregulated, Borrelia-induced, T cell-associated arthropathy that we 
describe here. However, the compelling findings of Lasky et al. (2015) and Oosting et 
al. (2011) that an IL-17 response is not involved in the development of Lyme arthritis are 
also supported by the fact that not all patients with Lyme arthritis produce detectable IL-
17. It is possible that those with severe, prolonged disease are predisposed to exhibiting 
particularly dysregulated inflammation indicative of a Th17 cell response. This 
hypothesis is supported by our current findings and by our previous work showing that 
depletion of putative regulatory T cells leads to severe, IL-17-dependent arthritis using 
the priming/infection model (Nardelli et al. 2004, 2005, 2006). Therefore, it is possible 
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that an inability to properly regulate the adaptive immune response may result in severe 
or persistent Lyme arthritis, and that a Th17 response may be involved. 
 
Here, we extend our previous findings by showing that IL-10 controls an inflammatory, 
CD4+ cell-mediated IL-17 response in an immune-dysregulated system characterized 
by repeated exposure to Borrelia antigens. Splenocytes from Borrelia-primed mice 
infected with B. burgdorferi for one day responded to in vitro stimulation with an initial 
decrease in IL-17 production (Figure 3A), supporting our previous findings in a different 
disease model (Hansen et al. 2013). However, in the absence of IL-10, a significant 
source of this early IL-17 was CD4+ cells (Figure 4A). As infection progressed in these 
primed, IL-10-deficient mice, their splenocytes responded to in vitro stimulation with a 
vigorous IL-17 response (Figure 1D). These primed, IL-10-deficient mice infected with 
B. burgdorferi eventually developed massive hind paw swelling that was significantly 
reduced by administration of IL-17 antibodies (Figure 6). Our findings support our 
previous report of an additional regulatory role for IL-10 in Lyme arthritis (Hansen et al. 
2013) and extend it by providing evidence that Borrelia-primed, IL-17-producing CD4+ 
cells may contribute to the histopathologic effects of a dysregulated response to the 
spirochete. It is necessary to state that while administration of anti-IL-17 antibodies to 
Borrelia-primed, infected IL-10-deficient mice significantly reduced hind paw swelling, 
the corresponding decrease in histopathological score was not statistically significant. 
This was surprising, as blockage of IL-17 has significantly reduced pathology 
consistently in Borrelia-primed and -infected C57BL/6 mice, regardless of whether the 
mice were wild-type (Nardelli et al. 2008b) or IFN-γ-deficient (Burchill et al. 2003; 
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Nardelli et al. 2004). This may have been due to a single mouse in which pathology was 
notable despite receiving anti-IL-17 antibodies; all others displayed no histopathological 
changes. However, we previously showed that administration of anti-IL-17 antibodies 
did not completely prevent the pathology of the tibiotarsal joint following infection of 
unprimed, IL-10-deficient mice (Hansen et al. 2013); therefore, it perhaps is not 
surprising that blocking IL-17 failed to completely abrogate pathology in this 
dysregulated system. It would be interesting to determine the mechanisms by which this 
dysregulated immunity contributed to cellular effects in the spleen early after infection of 
the footpad. As later-stage Lyme arthritis in humans, including antibiotic-refractory 
disease, is associated with heightened T cell responses, it is important to consider the 
contribution that Th17 cells may play to the development of pathology.  
 
While our findings support our previous report (Hansen et al. 2013), the use of Borrelia-
primed mice here yielded unique information. For example, the significant increase in 
IL-17 production we observed among primed cells of uninfected, IL-10-deficient mice 
after six hours of stimulation (Figure 1A) was maintained after 24 hours (Figure 1B). By 
contrast, we previously showed that stimulation of cells from non-primed, uninfected IL-
10-deficient mice caused a significant increase in IL-17 production that, while still 
elevated by 24 hours, was not statistically different from unstimulated cells at this later 
time point (Hansen et al. 2013). Therefore, previous exposure to borrelial antigens in 
the absence of IL-10 primed mice for a significantly sustained IL-17 response. When 
these primed, stimulated IL-10-deficient cells were additionally incubated with anti-CD4 
antibodies, we observed no decrease in IL-17 production (Figures 2A and 2C). This 
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result was unexpected. It is possible that a reduction would have been apparent if we 
had used a higher concentration of anti-CD4 antibodies. Alternatively, it is possible that 
primed mice may require active infection to generate IL-17-producing CD4+ cells more 
efficiently, or, possibly, that CD4+ cells are not a major source of IL-17 in these primed, 
uninfected mice. Nonetheless, these results show that priming alone, without 
subsequent infection, is sufficient to induce an IL-17 response upon encountering viable 
spirochetes in vitro, and that IL-10 plays a significant role in preventing a robust IL-17 
response. 
 
In addition, the use of this priming/infection model shows that in the context of 
dysregulated immunity, repeated exposure to viable Borrelia organisms leads to the 
potential for a massive IL-17 response. While stimulation of cells from primed, 
uninfected IL-10-deficient mice caused a 7-fold increase in IL-17 production (Figure 1C), 
stimulation of cells from primed IL-10-deficient mice infected for eight days caused a 33-
fold increase in IL-17 production (Figure 1D). Blocking CD4 among these cells for six 
hours reduced IL-17 production by 43% (Figure 2B). Although this decrease was not 
statistically significant, it was greater than the decrease we observed among wild-type 
counterparts. Nonetheless, the lack of a statistically significant decrease also was 
surprising. Perhaps a higher concentration of CD4-neutralizing antibodies would have 
exerted greater effects on this significant production of IL-17. Alternatively, it is possible 
that by eight days after infection in this system, the capacity of CD4+ cells to mount an 
IL-17 response has waned. In support of this hypothesis, CD4+ cells were a significant 
source of IL-17 as soon as one day after infection of primed IL-10-deficient mice, which 
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eventually developed moderate-to-severe arthritis. It is possible that in a system of 
dysregulated immunity, Th17-associated arthritic responses are established early 
following activation of lymphocytes by B. burgdorferi. This may account for the 
occurrence of potent Th17 responses in subsets of patients with particularly severe or 
prolonged Lyme arthritis. 
 
In conclusion, we support and extend our previous findings by showing that in the 
context of dysregulated immunity, Borrelia-experienced CD4+ cells subsequently 
exposed to B. burgdorferi have the potential to contribute to IL-17-mediated edema and 
pathology. This response occurs soon after restimulation and may increase 
substantially with the duration of infection. Importantly, our previous and current 
assertions that Th17-related pathology contributes to Lyme arthritis have been 
supported by recent reports linking these responses to persistent Lyme arthritis and 
post-Lyme disease sequelae in humans. Consideration of Th17-mediated pathology 
may be important for those symptomatic patients with prolonged, untreated infection 
with B. burgdorferi. This consideration may also be important for patients who exhibit 
symptoms following antimicrobial treatment for confirmed infection, particularly in a 
potential scenario in which inflammation might be prolonged due to repeated responses 
to borrelial antigens released from host tissues (Wormser et al., 2012). Further 
characterization of a dysregulated IL-17 response in the development of Lyme 
borreliosis could lead to novel therapeutic and preventative measures against the 
disease, particularly in subsets of patients with especially severe or prolonged 
symptoms. 
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Figure 1. 
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Figure 1. Levels of IL-17 in supernatants of spleen cells that were stimulated or 
not stimulated with B. burgdorferi strain 297 for 6 (A and B) or 24 (C and D) hours. 
Spleen cells were obtained from Borrelia-primed wild-type (black bars) or IL-10-deficient 
(white bars) mice that were not infected (A & C) or infected (B & D) with B. burgdorferi 
strain 297 for 8 days. *, P ≤ 0.05. Bars indicate ±SEM. 
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Figure 2. 
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Figure 2. Levels of IL-17 in supernatants of spleen cells that were stimulated with 
B. burgdorferi strain 297 and treated with either anti-CD4 antibodies or isotype 
control antibodies for 6 (A and B) or 24 (C and D) hours. Spleen cells were obtained 
from Borrelia-primed wild-type (black bars) or IL-10-deficient (white bars) mice that were 
not infected (A & C) or infected (B & D) with B. burgdorferi strain 297 for 8 days. *, P ≤ 
0.05. Bars indicate ±SEM. 
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Figure 3. 
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Figure 3. Levels of IL-17 in supernatants of spleen cells that were stimulated or 
not stimulated with B. burgdorferi strain 297 for 6 (A) or 24 (B) hours. Spleen cells 
were obtained from Borrelia-primed wild-type (black bars) or IL-10-deficient (white bars) 
mice that were infected with B. burgdorferi strain 297 for 1 day. *, P ≤ 0.05. Bars 
indicate ±SEM. 
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Figure 4. 
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Figure 4. Levels of IL-17 in supernatants of spleen cells that were stimulated with 
B. burgdorferi strain 297 and treated with either anti-CD4 antibodies or isotype 
control antibodies for 6 (A) or 24 (B) hours. Spleen cells were obtained from 
Borrelia-primed wild-type (black bars) or IL-10-deficient (white bars) mice that were 
infected with B. burgdorferi strain 297 for 1 day. *, P ≤ 0.05. Bars indicate ±SEM. 
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Figure 5. 
 
  
  121 
Figure 5. Average change in hind paw swelling among Borrelia-primed wild-type 
(filled squares) and IL-10-deficient (open squares) mice that were subsequently 
infected with B. burgdorferi strain 297 (solid lines) or injected with BSK medium 
(dashed lines). *, significant (P ≤ 0.05) difference in degree of hind paw swelling due to 
genotype. +, significant (P ≤ 0.05) difference in degree of hind paw swelling due to 
infection. Bars indicate ±SEM. 
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Figure 6. 
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Figure 6. Average change in hind paw swelling among Borrelia-primed wild-type 
(filled squares) and IL-10-deficient (open squares) mice that were subsequently 
infected with B. burgdorferi strain 297 and injected with anti-IL-17 antibodies 
(dashed lines) or isotype control antibodies (solid lines). *, significant (P ≤ 0.05) 
difference in degree of hind paw swelling due to genotype. +, significant (P ≤ 0.05) 
difference in degree of hind paw swelling due to antibody treatment. Bars indicate 
±SEM. 
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Table 1. 
 
 Synovium 
(Tibiotarsal) 
Perisynovium 
(Tibiotarsal) 
Knee 
Primed wild-
type mice 
0 0 0 
Primed, 
infected wild-
type mice 
0.88 ± 0.64 0.38 ± 0.26 0.94 ± 0.49 
Primed IL-10-
deficient mice 
0 0 0 
Primed, 
infected IL-10-
deficient mice 
2.17 ± 0.48 2.0 ± 0.37* 2.0 ± 0.52 
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Table 1. Effects of IL-10 deficiency on development of histopathology following 
infection of Borrelia-primed mice with B. burgdorferi strain 297. Primed wild-type 
mice exhibited mild infiltration of inflammatory cells into the synovium of the tibiotarsal 
joint and into the knee eight days after infection with viable spirochetes. These mice 
also exhibited minimal infiltrates into the perisynovial tissues of the tibiotarsal joints. By 
contrast, primed IL-10-deficient mice exhibited moderate cellular infiltration into all of 
these tissues eight days after infection, with a significant (P ≤ 0.05) increase manifested 
in the perisynovial tissues of the tibiotarsal joint. No histopathological changes were 
observed in primed, uninfected mice. Histopathology was graded on a scale of 0-4, as 
described in Materials and Methods. Data ± SEM; n = 4-6 mice per group. 
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Table 2. 
 
 Synovium 
(Tibiotarsal) 
Perisynovium 
(Tibiotarsal) 
Primed, 
infected IL-10 
deficient-mice + 
isotype control 
antibody 
3.0 ± 1.78 1.75 ± 0.75 
Primed, 
infected IL-10-
deficient mice + 
anti-IL-17 Ab 
1.5 ± 1.5 0.5 ± 0.5 
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Table 2. Effects of anti-IL-17 antibody treatment on development of 
histopathology following infection of Borrelia-primed, IL-10-deficient mice with B. 
burgdorferi strain 297. Primed, IL-10-deficient mice that received isotype control 
antibodies exhibited severe and moderate cellular infiltration into the synovial and 
perisynovial tissues, respectively, of the tibiotarsal joint eight days after infection. 
Treatment of primed, infected IL-10-deficient mice with anti-IL-17 antibodies reduced 
the degree of pathology in these tissues; however, these changes were not statistically 
significant. No changes to the knee were noted. Histopathology was graded on a scale 
of 0-4, as described in Materials and Methods. Data ± SEM; n = 4 mice per group. 
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CHAPTER 4:  SPECIFIC AIM 3 
 
 
The Role of Existing Regulatory T Cells on Induction of Borrelia 
 
burgdorferi-Induced Arthritis 
 
 
Abstract 
 
The anti-inflammatory mechanisms that regulate the pathogenic T cell response to 
Borrelia burgdorferi are poorly understood. Previous studies have suggested a role for 
interleukin-10 (IL-10) and regulatory immune cells in the modulation of Lyme arthritis.  
Here, we utilized the “depletion of regulatory T cell” (DEREG) mouse model, which 
allows for the selective depletion of CD4+CD25+Foxp3+ regulatory T (Treg) cells, to 
directly examine the effects of Treg cells on the development of arthritis following B. 
burgdorferi infection.  We demonstrate that Treg cell depletion prior to infection results 
in greater hind paw swelling and the development of arthritis, along with an increased B. 
burgdorferi-specific antibody response. However, we observed limited effects on the 
production of certain inflammatory cytokines.  Additionally, we found that Treg cells 
have no effect on the levels of Borrelia DNA in the joint tissue.  These findings add to 
accumulating knowledge regarding the immunomodulatory function of Treg cells in B. 
burgdorferi-induced arthritis, as well as provide additional considerations for the impact 
of Treg cells on the inhibition of the antibody response during infection with B. 
burgdorferi.  
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Introduction 
 
Infection with Borrelia burgdorferi results in a variety of symptoms, including 
inflammation of the joint tissue, which may progress to a more severe condition known 
as Lyme arthritis. CD4+CD25+Foxp3+ regulatory T (Treg) cells are important regulators 
of the inflammatory response, in part, through production of interleukin-10 (IL-10) 
(Rubtsov et al. 2008). B. burgdorferi induces production of IL-10 early after stimulation 
of host cells (Giambartolomei et al. 1998).  We recently showed that IL-10 regulates the 
production of interleukin-17 (IL-17) from CD4+ T cells and moderates the development 
of pathology in two different murine models of B. burgdorferi-induced arthritis (Hansen 
et al. 2013, Hansen et al. 2016). Although the source of IL-10 was not determined in 
these studies, accumulating evidence suggests that Treg cells, a notable source of IL-
10, may inhibit the inflammatory response induced by B. burgdorferi infection.  
 
Specifically, evidence supports a role for Treg cells in reducing inflammation in Lyme 
arthritis.  Inhibition of IL-17 in an interferon-γ (IFN-γ)-deficient mouse model of Lyme 
arthritis results in an increased number of CD4+CD25+ T cells and prevents the 
development of arthritis (Nardelli et al. 2004). Depletion of CD25-expressing cells in 
these mice resulted in destructive arthritis (Nardelli et al. 2004). In addition, 
CD4+CD25+ T cells isolated from these infected mice treated with anti-IL-17 antibodies 
inhibited arthritis when adoptively transferred into infected mice (Nardelli et al. 2005). By 
contrast, depletion of CD25+ cells in Borrelia-infected mice in which IL-17 was not 
neutralized did not affect the development of arthritis (Nardelli et al. 2006).  These 
findings suggest that in the absence of IL-17, a specific population of CD4+CD25+ T 
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cells developed in this system.  Notably, Th17 and CD4+CD25+Foxp3+ Treg cells 
develop from a common precursor, which suggests that the CD4+CD25+ cell population 
induced in the absence of IL-17 were Foxp3+ Treg cells (Bettelli et al. 2006).  
Additionally, patients with antibiotic-refractory Lyme arthritis who experience a longer 
duration of joint inflammation have fewer numbers of Treg cells in the synovial fluid than 
patients whose arthritis resolved following antibiotic therapy (Shen et al. 2010). Also, 
Treg cells isolated from the synovial fluid of patients with antibiotic-refractory Lyme 
arthritis had a decreased ability to suppress effector T cell proliferation, resulting in 
greater inflammatory cytokine production (Vudattu et al. 2013). Therefore, Treg cells 
may inhibit B. burgdorferi-induced joint inflammation; however, the direct role of Treg 
cells in Lyme arthritis has not been investigated.   
 
In order to characterize the effects of Treg cells on the early inflammatory events of 
Lyme arthritis, we utilized “depletion of regulatory T cell” (DEREG) mice. DEREG mice 
express a diphtheria toxin (DTx) receptor linked to the Treg cell-specific Foxp3 
promoter, which allows for the selective elimination of Foxp3+ Treg cells following 
administration of DTx at the desired time point (Lahl & Sparwasser 2011). We utilized 
DEREG mice on the C57BL/6 background, a strain that is naturally resistant to the 
development of Lyme arthritis, in order to determine the effect of Treg cells on the 
inflammatory response to B. burgdorferi.  We hypothesized that Treg cells prevent the 
onset of arthritis following infection with B. burgdorferi.  We found that depletion of Treg 
cells prior to infection with B. burgdorferi results in decreased IL-10 production in early 
infection.  Additionally, depletion of Treg cells leads to increased paw swelling and 
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pathology associated with arthritis, but does not affect spirochete load in the joint tissue. 
Moreover, depletion of Treg cells leads to increased Borrelia-specific antibody 
production. These results demonstrate that Treg cells are important mediators of the 
immune response to B. burgdorferi.  
 
Materials and Methods 
Mice 
 
Six-to-12 week old, male and female C57BL/6 DEREG mice (The Jackson Laboratory) 
were housed at the University of Wisconsin-Milwaukee animal research facility in a 
humidity-controlled environment at 21°C under a 12-hour light-and-dark cycle.  Mice 
had access to food and acidified water ad libitum.  The Institutional Animal Care and 
Use Committee at the University of Wisconsin-Milwaukee approved all experimental 
procedures. 
 
Depletion of Treg cells 
Diphtheria toxin (Calbiochem, San Diego, CA) was reconstituted in filter-sterilized PBS.  
Mice were injected with 1 µg diphtheria toxin in 100 µl of PBS intraperitoneally (i.p.) on 
the two consecutive days prior to infection with B. burgdorferi.  Control groups included 
DEREG mice injected with PBS prior to infection and DEREG mice administered 
diphtheria toxin injected that were not infected.  Groups consisted of 3-4 mice each.   
 
 
 
  139 
Preparation of bacteria 
B. burgdorferi strain B31-A3 organisms were provided by J. Coburn (Medical College of 
Wisconsin, Milwaukee, WI).  Low passage organisms were grown at 32°C in modified 
Barbour-Stoenner-Kelly (BSK) medium until they reached a concentration of 106 
microbes/ml before being aliquoted into 1.5-ml screw-cap tubes (Sarstedt, Newton, NC) 
and stored at -80°C.  On the day of infection, 1 mL frozen suspensions of spirochetes 
were thawed, washed, and resuspended in PBS supplemented with 0.2% non-immune 
serum, as described by Ristow et al. (2012). Dark-field microscopy was used to 
determine motility and enumerate microbes using a Petroff-Hausser counting chamber. 
  
Infection of mice  
Naïve mice were anaesthetized with isoflurane in a nose-and-mouth cup and infected 
by subcutaneous injection between the scapulae with 2x104 viable B. burgdorferi strain 
B31-A3 organisms in a volume of 0.05 mL of PBS supplemented with 0.2% non-
immune mouse serum. Control groups consisted of naïve DEREG mice injected with 
PBS supplemented with non-immune serum.  
 
 
Assessment of swelling  
 
Swelling of each hind paw was assessed every other day in order to determine changes 
in edema of the tibiotarsal joint following B. burgdorferi infection using a digital caliper 
(Marathon, Richmond Hill, Ontario) with a sensitivity of 0.01 mm. The width and 
thickness of each tibiotarsal joint were measured and averaged to provide the mean 
caliper value. Baseline swelling levels of each group were measured prior to infection 
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on day 0, and the changes in swelling from these baseline levels were determined every 
other day after infection and at the time of euthanasia.   
 
Determination of Treg cell frequency 
At day 7, 14, or 32 after infection, mice were anesthetized with isoflurane in a nose-and-
mouth cup, and blood was collected via terminal cardiac puncture. Peripheral blood 
mononuclear cells (PBMCs) and plasma were isolated from whole blood using 
Histopaque-1077 (Sigma-Aldrich, St. Louis, MO). 1 x 106 PBMCs were incubated with 
Fc block (anti-CD16/CD32) before staining with fluorescein isothiocyanate (FITC)-
labeled anti-mouse CD4 (clone RM4-5) and phycoerythrin (PE)-labeled anti-mouse 
CD25 (PC61.5). Surface-labeled cells were fixed with 2% paraformaldehyde, 
permeabilized with 0.5% saponin, and stained with intracellular antibody 
allophycocyanin (APC)-labeled anti-mouse Foxp3 (clone FJK-16s). Appropriate 
fluorescently labeled isotype control antibodies were used to control for non-specific 
labeling of surface molecules. Treg cells were categorized as CD4+CD25-Foxp3+ and 
CD4+CD25+FoxP3+. Quantification was conducted using a BD FACSCaliber flow 
cytometer with FlowJo software. All reagents were obtained from eBioscience 
(eBioscience, San Diego, CA). 
 
Histological examination 
Following euthanasia on day 7, 14, or 32, one hind paw from each mouse was 
amputated above the knee joint. Paws were placed in cryptically coded tissue-
embedding cassettes and fixed in 10% buffered zinc formalin before being embedded in 
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paraffin. The paraffin-embedded tissues were cut in 4 µm sections, placed on glass 
slides, and stained with hematoxylin and eosin.  Unbiased histological examination of 
the tissues was conducted by a board-certified pathologist (Dr. Michael Lawlor, 
Children’s Hospital of Wisconsin, Milwaukee, WI).  Histopathological changes were 
scored according to the following scale: 0, no pathology; 1, mild lymphocyte infiltration 
restricted to joint surfaces; 2, mild lymphocyte infiltration restricted to subcutaneous soft 
tissue; and 3, mild lymphocyte infiltration of muscle and soft tissue (Figure 1). 
 
Assessment of cytokine production  
Spleens were harvested on day 7, 14, or 32 after infection, and single-cell suspensions 
of splenocytes were created by passing the tissue through a nylon mesh screen (BD 
Falcon, BD Biosciences, San Jose, CA) into cold Dulbecco’s Modified Eagle Medium 
(DMEM). 1 x 106 cells were incubated at 37 °C in 5% CO2 in the absence or presence of 
1 x 105 viable B. burgdorferi strain B31-A3 organisms.  Cell culture supernatants were 
collected after 24, 48, and 72 hours of incubation. Levels of IL-17, IFN-γ, and IL-10 in 
the cell culture supernatants were determined using IL-17A, IFN-γ, or IL-10 Ready-Set-
Go! ELISA kits (eBiosciences, San Diego, CA), respectively, according to the 
manufacturer’s instructions.  Plates were read at an absorbance of 450 nm. Standard 
curves were used to calculate the cytokine amount in each sample as pg/ml.   
 
Quantification of spirochetes by PCR 
Bacterial load was determined as described by Ristow et al. (2012). One hind paw was 
collected at the time of euthanasia, frozen in liquid nitrogen, and stored at -80°C until 
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the time of DNA isolation. DNA was isolated using the QIAamp genomic DNA and RNA 
kit (Qiagen, Valencia, CA) according to the manufacturer’s instructions. Both B. 
burgdorferi genome copies and mouse genome copies were enumerated. PCR 
amplification was performed in 20 µl reaction mixtures containing 5 µl DNA, 10 µl of 
PowerUp SYBR Green Master Mix (Life Technologies, Carlsbad, CA), 2 µl magnesium 
chloride, 1 µl water, and 1 µl of both forward and reverse primer for either B. burgdorferi 
recA (forward: 5’- GCAGCTATCCCACCTTCTTT-3’, reverse: 5’- ATGAGGCTCT-
CGGCATTG-3’) or Mus musculus β-actin (forward: ‘5-TCACCCACACTGTGC-
CCATCTACGA-3’, reverse: 5’-GGATGCCACAGGATTCCATACCCA-3’).  The thermal 
cycling profile consisted of one two-minute cycle at 50°C and one two-minute cycle at 
95°C, followed by 40 cycles of 95°C for 15 seconds and 60°C for 1 minute.  A melting 
curve was acquired by heating the product to 95°C for 15 seconds, cooling to 60°C for 1 
minute, and heating to 95°C for 15 seconds.  B. burgdorferi recA gene copies were 
normalized to mouse β-actin after being calculated from standard curves using 
StepOnePlus Real-Time PCR System. 
 
Quantification of antibody production 
Pooled sera from each group were analyzed in duplicate for B. burgdorferi-specific IgG 
and IgM antibody content by a protocol adapted from Yang et al. (2011). Briefly, 96-well 
plates were coated with 5 µg/ml sonicated B. burgdorferi B31-A3 and incubated 
overnight at 4°C.  Control wells were coated with goat anti-mouse IgM or IgG isotype 
control antibodies.  Plates were washed three times with PBS containing 0.05% Tween 
20 before blocking for 1 hour at room temperature with PBS containing 10% fetal bovine 
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serum and 0.2% Tween 20. After blocking, plates were washed once.  1:2 serial 
dilutions of serum ranging from undiluted to 1:65,536 were added to wells and 
incubated for 2 hours at room temperature. Murine IgM or IgG isotype control antibodies 
were added to wells coated with goat anti-mouse IgM or IgG as positive controls.  
Plates were washed 3 times before addition of goat anti-mouse IgM or IgG antibodies 
conjugated with horseradish peroxidase.  Wells were developed with 3,3’,5,5’-
tetramethyl-benzidine (eBioscience). After 5 minutes, the reaction was stopped with 2 N 
sulfuric acid. Optical density was measured at 450 nm. Reciprocal endpoint dilutions 
were determined from average titration curves and defined as twofold above the buffer 
background (Coligan 1991). All antibodies were obtained from Southern Biotech 
(Birmingham, AL). 
 
Statistics 
Data were analyzed using two-way ANOVA followed by the Bonferroni correction for 
post hoc analysis when a significant F value indicated reliable mean differences. Paired 
data were analyzed using two-tailed Student’s t test. Data were analyzed using 
GraphPad Prism. The alpha level was set at 0.05 prior to initiation of experiments. Data 
are expressed as mean ± standard error of the mean (SEM) unless otherwise stated. 
 
Results 
Effect of diphtheria toxin administration on Treg cell frequency 
 
First, we verified that injection of DTx leads to depletion of Foxp3+ Treg cells in vivo.  
DEREG mice were injected with 1 µg DTx per mouse for two consecutive days and 
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blood was collected 3 days later. Analysis of pooled PBMCs based on light scatter 
gating revealed that 3.12% of lymphocytes were Foxp3+ in DEREG mice injected with 
PBS (Figure 2).  By contrast, 0.75% of lymphocytes were Foxp3+ in DEREG mice 
administered DTx (Figure 2).  DTx treatment resulted in a 75% reduction in the 
frequency of Foxp3+ T cells. 
 
Administration of DTx has been shown to cause a reduction in the body weight of mice 
beginning the second day of DTx administration (zu Hörste et al. 2010).  Therefore, we 
measured the weight of mice throughout the study to ensure that the toxin did not 
adversely cause weight loss in the mice. Mice injected with PBS displayed a steady 
weight gain throughout the course of the experiment (Figure 3).  By contrast, mice 
administered DTx maintained, but did not gain, weight during the first two weeks of the 
experiment (Figure 3). At day 16 after infection, mice administered DTx two weeks prior 
experienced a rapid increase in weight, with overall weight increases being equivalent 
to those in mice injected with PBS (Figure 3).  Both groups then gained weight at the 
same rate through day 32 after infection (Figure 3).  Uninfected mice administered DTx 
displayed the same pattern of weight gain as mice that received DTx prior to infection 
(data not shown).   
 
Effect of DTx administration on hind paw swelling and arthritis 
Baseline levels of hind paw size were determined by measuring the width and thickness 
of tibiotarsal joints prior to infection with B. burgdorferi.  Paw size was measured every 
other day, and baseline measurements were subtracted to determine the average 
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change in paw size.   Mice injected with PBS prior to infection experienced minimal paw 
swelling throughout the course of infection (Figure 4).  By contrast, mice depleted of 
Treg cells prior to infection with B. burgdorferi displayed significantly greater paw 
swelling (P≤0.05) than PBS-injected mice beginning 10 days after infection (Figure 4).  
The increased change in hind paw size observed in Treg cell-depleted mice persisted 
through day 22 of infection and was significantly greater than B. burgdorferi-infected 
mice injected with PBS on days 10, 12, 14, and 22 after infection (Figure 4). No paw 
swelling was observed in mice administered DTx that were not infected (data not 
shown).    
 
Histopathology of hind paws was assessed.  Minimal histopathological changes limited 
strictly to joint surfaces were observed seven days after infection in mice injected with 
PBS (Figure 5A).  Similarly, minimal histopathological changes were observed 7 days 
after infection in mice depleted of Treg cells (Figure 5A).  By day 14 after infection, mice 
previously injected with PBS continued to display minimal histopathological changes 
(Figure 5B), with only mild infiltration of the joint surface in one mouse (Figure 5D).  
Mice depleted of Treg cells prior to infection, however, developed inflammation in the 
muscle and dermal tissues and inflammation of the ligaments of the joint (Figure 5D). 
No histopathological changes were observed in either group 32 days after infection 
(Figure 5C). In addition, no pathology was observed in diphtheria toxin-injected, 
uninfected mice at any time point (data not shown).   
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Effect of Treg cell depletion on cytokine production  
We investigated the role of Treg cell ablation on the production of cytokines at various 
time points after infection with B. burgdorferi.  Spleen cells harvested seven days after 
B. burgdorferi infection from mice previously injected with PBS produced undetectable 
levels of IL-17 after incubation in media for 24 hours (Figure 6A, left). Similarly, cells 
from mice depleted of Treg cells prior to infection did not produce any detectable 
amounts of IL-17.  In vitro stimulation with live B. burgdorferi for 24 hours did not affect 
IL-17 production by cells from PBS-injected mice.  By contrast, stimulated cells from 
mice depleted of Treg cells prior to infection produced a greater amount of IL-17 than 
unstimulated cells. However, this increased IL-17 production was not statistically 
significant.  After 48 hours of incubation, no significant differences were observed in IL-
17 production between cells from PBS-injected or Treg cell-depleted mice in both 
unstimulated and stimulated cultures (Figure 6A, middle). After 72 hours of incubation, 
simulated cells from PBS-injected mice produced significantly more IL-17 than 
stimulated cells from Treg cell-depleted, B. burgdorferi-infected mice (p<0.01; Figure 
6A, right). Additionally, stimulation of cells isolated from PBS-injected, B. burgdorferi-
infected mice 72 hours of incubation led to significantly greater production of IL-17 
compared to unstimulated cells (p<0.05).  By contrast, stimulation had no effect on IL-17 
production by cells from Treg cell-depleted mice.  
 
Additionally, IFN-γ was measured in the cell culture supernatants of the same cells, 
which were harvested after 7 days of infection.  No significant differences in IFN-γ 
production were observed in supernatants of cells from PBS-injected or Treg cell-
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depleted mice after 24 hours (Figure 6B, left).  Additionally, no differences were 
observed due to Treg cell depletion after 48 (Figure 6B, middle) or 72 (Figure 6B, right) 
hours. However, in vitro stimulation resulted in significantly increased IFN-γ production 
by cells from both PBS-injected and Treg cell-depleted mice infected with B. burgdorferi 
at all incubation times.  
 
Production of IL-10 was also assessed from the same cell culture supernatants.   
Spleen cells harvested from mice injected with PBS prior to B. burgdorferi infection 
produced large amounts of IL-10 after 24 hours of incubation in media (Figure 6C, left). 
Cells from mice that were depleted of Treg cells prior to infection produced lower levels 
of IL-10 compared to cells from PBS-injected mice.  However, this decrease in IL-10 
production was not statically significant. Stimulation of these cells for 24 hours resulted 
in increased IL-10 production by cells from both PBS-injected and Treg cell-depleted 
mice.  Cells from mice depleted of Treg cells 7 days prior produced significantly less IL-
10 than cells from PBS-injected mice after 24 hours of stimulation (p<0.05).  After 48 
hours of incubation, cells from mice injected with PBS prior to B. burgdorferi infection 
and mice depleted of Treg cells prior to infection produced low levels of IL-10 (Figure 
6C, middle). Stimulation with viable B. burgdorferi led to a significant increase in IL-10 
production in both groups; however, there was no difference in IL-10 production by cells 
isolated from PBS-injected and Treg-depleted mice.  After 72 hours of incubation, 
unstimulated cells from mice injected with PBS or DTx before infection produced 
moderate amounts of IL-10 after 72 hours of incubation (Figure 6C, right).  Stimulation 
with B. burgdorferi resulted in an increase in IL-10 production by cells from PBS-injected 
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mice, but the increase was not statistically significant.  However, stimulation induced a 
statistically significant increase in IL-10 production from cells of Treg cell-depleted mice 
(p<0.05).  
 
Spleen cells harvested 14 days after infection from PBS-injected mice produced low 
amounts of IL-17 after 24 hours of incubation (Figure 7A, left).  Cells from Treg cell-
depleted mice produced similar amounts of IL-17. Stimulation of these cells with B. 
burgdorferi for 24 hours had no effect on IL-17 production.  After 48 and 72 hours of 
incubation, production of IL-17 remained low (Figure 7A, middle and right).  No 
differences in IL-17 production were observed between PBS-injected and Treg cell-
depleted mice, regardless of stimulation.   
 
Production of IFN-γ was not detected from supernatants of cells harvested from PBS-
injected and Treg cell-depleted mice 14 days after infection following 24, 48, and 72 
hours of incubation in media (Figure 7B).  IFN-γ production was increased following in 
vitro stimulation at all incubation times; however, the increases were not statistically 
significant. No differences in IFN-γ production from cells of PBS-injected and Treg cell-
depleted mice were observed. Additionally, no significant differences in IL-10 production 
between cells from PBS-injected and Treg cell-depleted mice were observed at any 
incubation time (Figure 7C).   
 
Spleen cells harvested after 32 days of infection produced low amounts of IL-17 at all 
time points, with no significant differences occurring due to stimulation or Treg cell 
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depletion (Figure 8A).  Additionally, IFN-γ was undetectable at most incubation times 
(Figure 8B).  Moreover, no significant differences were observed in IL-10 production due 
to Treg cell depletion (Figure 8C). 
 
Effect of Treg cell ablation on antibody production 
B. burgdorferi B31-A3-specific total IgM antibody levels were determined by ELISA 
using pooled sera harvested from mice at 7, 14, or 32 days after infection. Sera 
collected 7 days after infection from PBS-injected mice had an average IgM endpoint 
dilution of 1:1024 (Figure 9A).  By contrast, sera from Treg cell-depleted mice had a 
greater IgM average endpoint dilution of 1:2048. After 14 days of infection, PBS-injected 
mice had an average IgM endpoint dilution of 1:256 (Figure 9B).  IgM serum levels of 
Treg cell-depleted mice were again greater, with an average endpoint dilution of 1:512.  
After 32 days of infection, PBS-injected mice had an average IgM endpoint dilution of 
1:32.  Once again, sera from Treg cell-depleted mice had greater IgM levels, with an 
average endpoint dilution of 1:256.   Overall, Treg cell depletion prior to infection 
increased IgM antibody production.  
 
IgG levels were also determined in serum samples.  Seven days after infection, sera 
from PBS-injected mice had an average IgG endpoint dilution of 1:16 (Figure 10A).  
Sera from mice depleted of Treg cells had a lower IgG endpoint dilution of 1:8. Fourteen 
days after infection, sera from PBS-injected mice had an average endpoint dilution of 
1:8 (Figure 10B).  By contrast, sera from Treg cell-depleted mice had greater IgG 
antibody production, with an average endpoint dilution of 1:16. Thirty-two days after 
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infection, sera from PBS-injected mice had an average endpoint dilution of 1:16 (Figure 
10C).  Sera from mice depleted of Treg cells had a greater endpoint dilution of 1:32. 
Overall, sera from Treg cell-depleted mice had increased IgG antibody levels.   
 
Effect of Treg ablation on bacterial load 
We determined the amount of bacteria within the tibiotarsal joints of mice injected with 
PBS or depleted of Treg cells before infection to assess the impact of Treg cells on 
dissemination of the spirochete to these tissues.  After 7 days of infection, no difference 
in the number of B. burgdorferi genomes per 104 mouse genomes was observed in the 
joints of mice previously injected with PBS or depleted of Treg cells (Figure 11A). 
Additionally, 14 days after infection, no differences were observed in joints of PBS-
injected mice and the joints of Treg cell-depleted mice (Figure 11B).  However, more B. 
burgdorferi DNA was detected on day 14 than on day 7.  Also, no significant difference 
in the colonization of tibiotarsal joints was observed between PBS-injected and Treg 
cell-depleted mice on day 32 after infection (Figure 11C).  
 
Discussion 
In this report, we examined the effects of early Treg cell ablation on the development of 
B. burgdorferi-induced arthritis.  We found that depletion of Treg cells prior to infection 
with B. burgdorferi led to increased joint swelling and pathological changes indicative of 
arthritis.  These findings support our hypothesis that Treg cells prevent the onset of 
arthritis following B. burgdorferi infection.  Additionally, Treg cell depletion was 
associated with an increase in IgM antibody production and an early decrease in IgG 
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production followed by an increased IgG response.  Collectively, these findings provide 
evidence that Treg cells prevent arthritis and affect the immune response to B. 
burgdorferi in a model of natural resistance to disease.  
 
Previous studies have suggested that regulatory immune cells affect B. burgdorferi-
induced arthritis.  Neutralization of IL-17 in IFN-γ-deficient mice reduced the severity of 
disease in a model of B. burgdorferi-induced, T cell-driven arthritis (Burchill et al. 2003).  
The severity of arthritis correlated with the number of CD4+CD25+ putative Treg cells in 
the draining lymph nodes (Nardelli et al. 2004).  Additionally, depletion of CD25+ cells in 
infected mice in the absence of IL-17 led to severe arthritis (Nardelli et al. 2004). 
Adoptive transfer of CD4+CD25+ cells that developed in infected mice in which IL-17 
was neutralized was shown to prevent the development of arthritis following adoptive 
transfer into mice infected with B. burgdorferi (Nardelli et al. 2004).  However, depletion 
of CD25+ cells in Borrelia-infected mice in which IL-17 was not neutralized did not affect 
the development of arthritis (Nardelli et al. 2006).  These findings suggest that different 
populations of CD4+CD25+ T cells developed in the presence and absence of IL-17.  
Although Foxp3 expression was not recognized as the definitive Treg cell marker at the 
time of these studies, it is likely that they were Treg cells.  Th17 and Treg cells are 
derived from a common precursor, and differentiation is reciprocal and dependent on 
the cytokine environment (Bettelli et al. 2006).  It is likely that neutralization of IL-17 in 
these experiments may have promoted the development of Treg cells. These findings 
suggest that Treg cells likely reduce the inflammatory response to B. burgdorferi, 
ameliorating the severity of Lyme arthritis.   
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Other studies support a role for Treg cells in antibiotic-refractory Lyme arthritis. Patients 
in whom arthritis failed to resolve despite antibiotic treatment were found to have fewer 
numbers of Treg cells in the synovial fluid than those in whom arthritis responded to 
treatment (Vudattu et al. 2013).  Additionally, the Treg cells in these patients do not 
effectively inhibit the pro-inflammatory response (Vudattu et al. 2013).  Moreover, in 
patients with antibiotic-refractory arthritis, a higher percentage of Treg cells was 
associated with a faster resolution of arthritis (Shen et al. 2010).  Overall, these findings 
suggest that Treg cells are important for the eventual resolution of antibiotic-refractory 
Lyme arthritis.   
 
C57BL/6 mice are naturally resistant to B. burgdorferi-induced arthritis (Schaible et al. 
1990).  This is attributed to decreased levels of IFN-γ and increased levels of IL-10 
(Brown et al. 1999, Ganapamo et al. 2000).  Also, IL-10, the major cytokine produced by 
Treg cells, is known to attenuate B. burgdorferi-induced arthritis though suppression of 
inflammatory cytokine production by macrophages (Brown et al. 1999).  While reduced 
levels of IL-10 during initial infection may be beneficial to induce a robust immune 
response against the bacterial infection, the prolonged inflammation can result in 
induced pathology.  Previous studies have not addressed if Treg cells are responsible 
for resistance to arthritis in C57BL/6 mice.   
We examined the role of Treg cells in Lyme arthritis by depleting Treg cells prior to 
infection with B. burgdorferi.  Using the DEREG mouse model, which allows for the 
selective depletion of Foxp3+ Treg cells, we demonstrate that Treg cell depletion prior 
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to infection results in greater hind paw swelling and the development of arthritis. 
Differences in hind paw swelling, however, did not become evident until 10 days after 
infection.  Our findings are consistent with swelling patterns in arthritis-susceptible C3H 
mice, which develop significant paw swelling 14 days after infection (Ma et al. 1998).  
By day 14 after infection, not only were differences in hind paw swelling observed, but, 
also, histopathological changes indicative of arthritis were evident in mice depleted of 
Treg cells.  Only one of four B. burgdorferi-infected mice administered PBS displayed 
even minimal histopathological changes 14 days after infection.  By contrast, all four 
mice depleted of Treg cells prior to infection had lymphocyte infiltration into the joint 
tissue.  Our findings are supported by the findings of others, as Treg cells have been 
shown to limit severity of disease by inhibiting pulmonary pathology associated with 
lymphocyte infiltration in respiratory syncytial virus infection (Fulton et al. 2010).  The 
exact mechanisms by which Treg cells inhibit inflammation during B. burgdorferi 
infection require further examination.  It is possible that the initial depletion of Treg cells 
resulted in a persistent or gradually excessive immune response that caused pathology. 
Our findings that IL-10 production by spleen cells harvested 7 days after infection was 
significantly decreased in mice depleted of Treg cells supports this idea (Figure 6C).  
However, regulation of the inflammatory response eventually led to resolution of 
pathology, as Treg cell depletion in our model is likely only temporary.  Our findings 
provide strong support that Treg cells modulate the severity of Lyme arthritis.  
 
Others have suggested that the induction of Treg cells following B. burgdorferi infection 
leads to immune suppression that is responsible for chronic symptoms.  Specifically, 
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patients with chronic neuroborreliosis were found to have an increased Treg cell 
response to B. burgdorferi protein NapA that led to greater production of IL-10 (Amedei 
et al. 2013).  Additionally, patients with chronic neuroborreliosis were found to have 
increased Foxp3 mRNA in the blood compared to healthy controls (Jarefors et al. 2007). 
These findings suggest that Treg cells may also function by inhibiting the immune 
response to B. burgdorferi, thereby leading to chronic symptoms.  Our findings contrast 
with these previous studies by providing evidence that the presence of Treg cells 
correlated with disease resolution.    However, our model does not allow for long-term 
Treg cell depletion.  
 
We expected Treg cell depletion to result in greater inflammatory cytokine production, 
as Treg cells can limit pathology through inhibition of inflammatory T cells.  After 7 days 
of infection, we found that depletion of Treg cells prior to B. burgdorferi infection 
resulted in significantly lower IL-17 production by spleen cells after 72 hours of 
incubation.  While surprising, our results may be explained by the temporary depletion 
of Treg cells.  A newly emerging Treg population on day 7 may inhibit IL-17 production 
in the in vitro environment.  In support of this, we found that cells of Treg cell-depleted 
mice harvested on day 7 produced increasing levels of IL-10 throughout incubation 
(Figure 6C).  After 72 hours of incubation, IL-10 production by cells of Treg cell-depleted 
mice was significantly greater than that of PBS-injected mice (Figure 6C).  At the same 
time, we found that cells from Treg cell-depleted mice produced significantly less IL-17 
than cells from PBS-injected mice (Figure 6A).  These findings are consistent with our 
previous work, in which we demonstrated that IL-10 inhibits IL-17 production during B. 
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burgdorferi infection (Hansen et al. 2013).  Alternatively, decreased IL-17 production 
following Treg cell depletion may occur due to the effects of IL-17+Foxp3+ Treg cells, 
known as Tr17 cells (Beriou et al. 2009).  Tr17 cells produce IL-17 and display 
suppressive functions (Beriou et al. 2009).  In fact, Tr17 cells have a stronger 
suppressive capacity on effector T cells than IL-17- Treg cells (Li et al. 2012). 
Administration of DTx would have also depleted the Tr17 population, and could account 
for both the decreased levels of IL-17 observed in our cultures and the increase in 
pathology.  Notably, increased percentages of Tr17 cells have been described in a 
mouse model of collagen-induced arthritis and in humans with rheumatoid arthritis 
(Komatsu et al. 2014).  It is also possible that IL-17 is not a significant contributor to 
Lyme arthritis, as mice deficient in IL-17 or its receptor still develop arthritis (Kuo et al. 
2016, Lasky et al. 2015).  Additionally, reduced levels of IL-17 in humans were not 
found to correlate with protection from induction of Lyme arthritis (Oosting et al. 2011).  
In the event that IL-17 may not be a contributing factor in arthritis, severe or persistent 
disease may reflect an inability of Treg cells to properly regulate the effects of other 
cytokines.   
 
Later-stage Lyme arthritis is caused, in part, by the inflammatory effects of type 1 T 
helper (Th1) cells through the production IFN-γ.  We found that depletion of Treg cells 
prior to infection with B. burgdorferi had no effect on IFN-γ production. Limited effects of 
Treg cell depletion on IFN-γ production have been described in other bacterial 
infections. For example, Treg cell depletion had no significant effect on IFN-γ production 
by lymph node cells from mice infected with Helicobacter pylori (Kaparakis et al. 2006).  
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Additionally, spleen cells harvested from Mycobacterium bovis-infected mice produced 
similar amounts of IFN-γ, regardless of Treg cell depletion (Berod et al. 2014).  Notably, 
B. burgdorferi-induced arthritis occurs even in the absence of IFN-γ (Brown & Reiner 
1999, Christopherson et al. 2003).  Our findings further demonstrate that IFN-γ is not 
the sole cytokine responsible for the development of pathology.  Further, our findings 
indicate that Treg cells may have limited suppressive effects on IFN-γ during B. 
burgdorferi infection.   
 
One mechanism by which Treg cells may limit paw swelling and pathology is through IL-
10 production.  Notably, IL-10-deficient C57BL/6 mice develop greater paw swelling and 
histopathological changes than wild-type C57BL/6 mice (Brown et al. 1999). Our 
findings are consistent with these, as we observed a significant decrease in IL-10 
production after 24 hours of incubation from spleen cells harvested seven days after 
infection from Treg cell-depleted mice (Figure 6C).  Notably, it was at this time at which 
paw swelling began (Figure 4).  However, no differences in IL-10 production were 
observed at any other times.  The increase in IL-10 production by cells from Treg cell-
depleted mice seen after 48 and 72 hours may have been due to the presence of other 
IL-10-secreting cell located within the spleen (Yanaba et al. 2009, Ostroukhova et al. 
2004, Saraiva & O’Garra 2010).  Alternatively, remaining IL-10 producing cells, or, 
possibly, reemerging Treg cells, may have proliferated during the incubation time, 
resulting in more IL-10 production at later time points. Overall, we found that Treg cell 
depletion resulted in a significantly decrease in their main cytokine, IL-10.   
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Interestingly, no differences in cytokine levels due to Treg cell depletion were observed 
after 14 days of infection, when pathology was observed.  It is possible that differences 
in cytokine production are transient in the DEREG mouse and occur much earlier than 1 
week after infection, as Treg cell populations recover to normal levels by day 6 after 
depletion (Christiaansen et al. 2014).  The lack of a Treg response may have resulted in 
increased inflammation in early infection that eventually resulted in increased 
lymphocyte infiltration of the tissue seen after 14 days. Additionally, our measurement of 
cytokine production by spleen cells may not necessarily reflect the immune response 
within the joint.  Notably, significantly larger numbers of Th1 and Treg cells are present 
in the synovial fluid than the peripheral blood in patients with Lyme arthritis (Shen et al. 
2010).  By measuring cytokine production by spleen cells, we investigated systemic 
differences due to Treg cell depletion.  Further investigation may reveal a more robust 
effect of Treg cell depletion on cytokine levels within the joint tissue.   
 
In addition to inhibiting inflammation, Treg cells directly suppress the immunoglobulin 
response (Lim et al. 2005).  Therefore, we investigated the effect of Treg cells on B. 
burgdorferi-specific antibody production.  We found that Treg cell depletion results in an 
increased IgM and IgG response. Our findings are consistent with the findings of others, 
as Treg cell depletion using antibodies to CD25 selectively increased IgG1 antibody 
titers (Kaparakis et al. 2006).  While the use of anti-CD25 antibodies does not 
selectively deplete Foxp3-expressing cells, it is possible that the increased antibody 
response following Treg cell depletion is a result of an enhanced effector T cell 
response. For example, C57BL/6 mice depleted of CD4+ T cells had reduced IgM and 
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IgG production 10 days following B. burgdorferi infection (Hastey et al. 2012).  We 
surmise that enhanced effector function in the absence of Treg cells increases the 
antibody response.  It is known that Treg cells can suppress antibody production 
through suppression of germinal center reactions (Chung et al. 2011) and inhibition of 
CD4+ T-follicular helper cells (Wing et al. 2014).  T-follicular helper cells are important 
for the conversion of B cells to antibody-secreting plasma cells (Vinuesa et al. 2005).  
Notably, depletion of Treg cells using the DEREG mouse model resulted in increased 
numbers of T-follicular helper cells and increased IgG antibody production (Wing et al. 
2014).  We speculate that Treg cells may suppress T-follicular helper cells within the 
germinal centers of lymph nodes following B. burgdorferi-infection, thereby decreasing 
antibody production.  Our hypothesis would explain why both the IgM and IgG antibody 
responses were increased following Treg cell depletion. In general, our findings suggest 
that Treg cells existing prior to infection may inhibit the antibody response to B. 
burgdorferi.   
 
Moreover, we found that Treg cell depletion did not have an effect on bacterial burden in 
the joint tissue at any of the time points following infection that we investigated. Others 
have also shown that depletion of Treg cells does not affect bacterial burden.  For 
example, Treg cell depletion did not alter bacterial burden in murine infection with M. 
bovis (Berod et al. 2014) or Staphylococcus aureus (Tebartz et al. 2015).  Additionally, 
Treg cell depletion had no effect on bacterial dissemination or bacterial burden in a 
murine model of sepsis (Kuhlhorn et al. 2013). Together, these studies support our 
findings that Treg cells do not impact bacterial burden. Perhaps the suppressive 
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mechanisms utilized by Treg cells do not affect bacterial clearance. It is known that 
C57BL/6 mice are resistant to the development of arthritis following B. burgdorferi 
infection, in part, due to increased production of IL-10 (Brown et al. 1999). However, 
C57BL/6 mice and C3H, arthritis-susceptible, mice display a similar bacterial burden in 
the joints (Brown et al. 1999), which suggests that Treg cell production of IL-10 may not 
affect spirochete load. Additionally, IL-10-deficient mice develop severe swelling of the 
hind paws and arthritis, yet have a lower bacterial burden in the joint (Brown et al. 
1999).  Together, these findings suggest that Treg cell modulation of arthritis may be 
unrelated to spirochete numbers in the joint tissue. Our findings further suggest that 
Treg cells present prior to infection do not affect B. burgdorferi burden in the joint tissue.  
However, we are currently assessing the effect of Treg cell depletion on bacterial 
burden of other tissues.  It may be that while Treg cells do not affect bacterial burden, 
they may inhibit dissemination of the bacteria.  We found that heart tissue isolated from 
infected mice injected with PBS became culture positive after 3 weeks (unpublished 
data).  By contrast, mice administered DTx had culture positive heart tissue after only 2 
weeks. These findings suggest that Treg cells may impede bacterial dissemination to 
some tissue sites.  Additional studies are needed to define the effects of Treg cells on 
dissemination of spirochetes within the host.   
 
We did not find any correlation between the effects of Treg cell depletion on antibody 
production and bacterial load.  Our findings are not surprising, since total antibodies 
against B. burgdorferi differ from borreliacidal antibodies. Borreliacidal antibodies are 
important for clearance of the spirochete via induction of complement-mediated killing 
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(Schmitz et al. 1991).  Borreliacidal antibody titers correlate with the severity of arthritis 
(Schmitz et al. 1991) and wane rapidly after clearance of infection (Creson et al. 1996).  
By contrast, the total antibody response remains elevated for months after infection 
(Padilla et al. 1996). Although depletion of Treg cells resulted in increased antibody 
production, we hypothesize that borreliacidal antibody production would not be affected 
in the absence of Treg cells. Our hypothesis is based on our previous reports, which 
found that IL-10 does not affect borreliacidal production (Hansen et al. 2013).  It is 
possible, however, that Treg cells may affect borreliacidal antibody production via other 
suppressive mechanisms.   
 
In conclusion, we provide evidence that depletion of Treg cells existing prior to infection 
with B. burgdorferi results in significantly greater paw swelling and development of 
arthritis along with an increased B. burgdorferi-specific antibody response. However, we 
observed limited effects on the production of certain inflammatory cytokines.  
Additionally, we found that Treg cells have no effect on Borrelia DNA in the joint tissue.  
These findings add to accumulating knowledge regarding the immunomodulatory 
function of Treg cells in B. burgdorferi-induced arthritis, as well as provide additional 
considerations for the impact of Treg cells on the inhibition of the antibody response. 
More importantly, our findings suggest that individuals with decreased numbers of Treg 
cells may be more likely to develop arthritis after infection with B. burgdorferi. Further 
studies examining the role of Treg cells in B. burgdorferi infection is vital for 
understanding how a dysregulated immune response leads to joint pathology, which 
could lead to new therapies for the prevention of Lyme arthritis.    
  161 
Figure 1. 
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Figure 1. Representative images of the severity of pathology in the tibiotarsal 
joint of mice infected with B. burgdorferi rated on a 4-point scale. 0 = no detectable 
pathology across the entire section, 1 = mild chronic inflammation restricted to the joint 
surface, 2 = mild chronic inflammation restricted to subcutaneous soft tissue, 3 = mild 
chronic inflammation of the muscle and soft tissue.   
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Figure 2. 
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Figure 2. Efficiency of Foxp3+ cell depletion in DEREG mice. DEREG mice were 
treated i.p. with PBS (left panel) or 1 µg of DTx (right panel) to deplete Treg cells on two 
consecutive days. Three days later, percentage of CD4+Foxp3+ cells in the blood was 
determined by flow cytometry. Numbers indicate percentage of Foxp3+ cells. 75% of 
Treg cells were depleted in DEREG mice 3 days after administration of DTx.   
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Figure 3. 
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Figure 3. Diphtheria toxin (DTx) induces a transient delay in weight gain. Mice 
were injected on days -2 and -1 with PBS (closed circles) or 1 µg DTx (open circles).  
Additionally, mice were infected with 2x104 viable B. burgdorferi strain B31-A3 on day 0.  
Weight gain was delayed in mice administered DTx, but eventually recovered to that 
occurring in mice injected with PBS 16 days later.   Data are mean weights ± SEM   
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Figure 4. 
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Figure 4. Administration of diphtheria toxin significantly increased hind paw 
swelling in B. burgdorferi-infected DEREG mice.  DEREG mice were administered 
PBS (black circles) or DTx (white circles) two consecutive days prior to infection with B. 
burgdorferi.  DTx administration caused a significant increase in hind paw swelling that 
was evident on day 10 after infection. No changes in hind paw measurements in 
DEREG mice administered DTx that were not infected (not shown).  Data are mean 
changes in paw swelling relative to baseline ± SEM. * P < 0.05.  
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Figure 5. 
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Figure 5. Administration of diphtheria toxin increases joint pathology in B. 
burgdorferi-infected DEREG mice. Histopathology in H&E-stained longitudinal 
sections of the tibiotarsal joints of B. burgdorferi-infected DEREG mice injected with 
PBS or administered DTx on two consecutive days prior to infection were assessed as 
described in Materials and Methods.  A: Mean pathology scores 7 days after infection. 
B: Mean pathology scores 14 days after infection. C: Mean pathology scores 32 days 
after infection.  D: Representative images of pathology observed 14 days after infection.  
Error bars indicate SEM.  * = P <0.05 
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Figure 6. 
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Figure 6. Effects of Treg cell depletion on production of cytokines after 7 days of 
B. burgdorferi-infected mice. Spleen cells obtained from DEREG mice administered 
PBS (black bars) and DTx (white bars) seven days after infection with B. burgdorferi 
cultured in the presence (+) or absence (-) of the spirochete.  Levels of IL-17 (A), IFN-γ 
(B), and IL-10 (C) were measured after 24, 48, and 72 hours of incubation.  Data are 
mean levels of the cytokines/ml culture supernatant ± SEM. *P < 0.05.  
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Figure 7.  
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Figure 7. Effects of Treg cell depletion on production of cytokines after 14 days of 
B. burgdorferi-infected mice. Spleen cells obtained from DEREG mice administered 
PBS (black bars) and DTx (white bars) 14 days after infection of B. burgdorferi cultured 
in the presence (+) or absence (-) of the spirochete.  Levels of IL-17 (A), IFN-γ (B), and 
IL-10 (C) were measured after 24, 48, and 72 hours of incubation.  Data are mean 
levels of the cytokines/ml culture supernatant ± SEM. No significant differences in 
cytokine production were detected.   
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Figure 8. 
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Figure 8. Effects of Treg cell depletion on production of cytokines after 32 days of 
B. burgdorferi-infected mice. Spleen cells obtained from DEREG mice administered 
PBS (black bars) and DTx (white bars) 32 days after infection of B. burgdorferi cultured 
in the presence (+) or absence (-) of the spirochete.  Levels of IL-17 (A), IFN-γ (B), and 
IL-10 (C) were measured after 24, 48, and 72 hours of incubation.  Data are mean 
levels of the cytokines/ml culture supernatant ± SEM. No significant differences in 
cytokine production were detected.   
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Figure 9. 
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Figure 9.  Effect of Treg cell depletion on IgM antibody production in B. 
burgdorferi-infected mice.  Pooled sera collected from DEREG mice administered 
PBS (closed circles) or DTx (open circles) on 2 consecutive days prior to B. burgdorferi 
infection were assessed for IgM antibody production after 7 (A), 14 (B), and 32 (C) days 
after infection.  Values are expressed as the absorbance at 450 nm (Ab450). Error bars 
indicate SEM. 
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Figure 10.  
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Figure 10.  Effect of Treg cell depletion on IgG antibody production in B. 
burgdorferi-infected mice.  Pooled sera collected from DEREG mice administered 
PBS (closed circles) or DTx (open circles) on 2 consecutive days prior to B. burgdorferi 
infection were assessed for IgM antibody production after 7 (A), 14 (B), and 32 (C) days 
after infection.  Values are expressed as the absorbance at 450 nm (Ab450). Error bars 
indicate SEM. 
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Figure 11. 
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Figure 11.  Effect of Treg cell depletion on bacterial burden in the tibiotarsal joint 
in B. burgdorferi-infected mice.  The number of bacterial genomes was determined in 
the tibiotarsal joints of DEREG mice administered PBS (black bars) or DTx (white bars) 
for 2 consecutive days prior to infection with B. burgdorferi after 7 (A), 14 (B), or 32 (C) 
days of infection.  Data are mean number of B. burgdorferi genomes per 104 mouse 
genomes ± SEM. No significant differences in bacterial burden between groups were 
detected. 
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CHAPTER 5: SPECIFIC AIM 4 
 
 
The Role of Regulatory T Cells During Borrelia burgdorferi Infection  
 
 
Abstract 
 
We previously showed that depletion of CD4+CD25+Foxp3+ regulatory T (Treg) cells 
prior to infection with B. burgdorferi results in increased paw swelling and arthritis in 
C57BL/6 mice.  Here, we demonstrate that depletion of Treg cells 7 days after infection 
with B. burgdorferi caused greater IL-17 production by spleen cells 14 days after 
infection. Additionally, depletion of Treg cells 21 days after infection resulted in 
decreased IL-10 production by spleen cells 28 days after infection.  Treg cell depletion 
at all time points resulted in significantly increased paw swelling in the week following 
depletion.  Despite changes in paw swelling, Treg cell depletion did not have an effect 
on the development of pathology at the time points we examined. We also found that 
Treg cells inhibit, or promote, B. burgdorferi-specific antibody production depending on 
the timing of Treg cell depletion.  Our findings indicate that Treg cells may inhibit the 
inflammatory response following B. burgdorferi infection that causes joint swelling.  
These findings support the need for further research into the role of Treg cells in Lyme 
arthritis.   
 
Introduction 
Regulatory T (Treg) cells are important mediators of the immune response by inhibiting  
inflammation and preventing tissue destruction.  We have shown that depletion of 
regulatory T (Treg) cells in arthritis-resistant C57BL/6 mice prior to infection with 
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Borrelia burgdorferi resulted in significantly greater paw swelling beginning 10 days after 
infection, which continued through day 22 after infection.  Additionally, Treg cell 
depletion followed by infection with B. burgdorferi also resulted in the development of 
arthritis 14 days after infection.  However, Treg cell depletion did not affect pathology 7 
days after infection or 32 days after infection.  These findings suggest that Treg cell 
depletion prior to infection affects the inflammatory response that leads to the 
development of pathology.  In addition, depletion of Treg cells led to an increase in B. 
burgdorferi-specific antibody production. These results suggest that Treg cells are 
central immunomodulatory cells that can affect the immune response to B. burgdorferi 
infection. 
 
Accumulating evidence supports our assertion that Treg cells modulate the immune 
response to prevent the development of B. burgdorferi-induced arthritis.  Neutralization 
of interleukin-17 (IL-17) in an interferon-γ (IFN-γ)-deficient mouse model of Lyme 
arthritis led to increased numbers of CD4+CD25+ putative Treg cells (Nardelli et al. 
2004).  Depletion of CD25-expressing cells that developed when IL-17 was neutralized 
resulted in destructive arthritis in infected mice (Nardelli et al. 2004).  By contrast, 
depletion of CD25+ cells when IL-17 was not depleted had no effect on the 
development of arthritis (Nardelli et al. 2006).  Adoptive transfer of CD4+CD25+ T cells 
induced by neutralization of IL-17 into B. burgdorferi-infected mice prevented the 
development of arthritis (Nardelli et al. 2005). Since Th17 and Treg cells differentiate 
from a common precursor (Bettelli et al. 2006), the putative CD4+CD25+ cells that 
developed in the absence of IL-17 were likely true Treg cells.  In addition, patients with 
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antibiotic-refractory Lyme arthritis have fewer numbers of Treg cells than patients who 
respond to treatment (Vudattu et al. 2013).  Overall, patients with antibiotic-refractory 
Lyme arthritis were also found to have Treg cells that were less effective in controlling 
the inflammatory immune response (Vudattu et al. 2013). Additionally, patients with 
antibiotic-refractory disease who have fewer numbers of Treg cells in the synovial fluid 
resolve symptoms of arthritis slower than patients whose arthritis resolved after 
antibiotic treatment (Shen et al. 2010). Treg cells isolated from patients with antibiotic-
refractory Lyme arthritis were functionally suppressive, yet were still unable to control 
inflammation to resolve arthritis (Shen et al. 2010).  Taken together, these studies 
suggest that Treg cells may inhibit the development of B. burgdorferi-induced arthritis.   
 
Here, we extend our previous findings by assessing the role of Treg cells during the 
course of B. burgdorferi infection.  We hypothesized that Treg cells present following B. 
burgdorferi infection decrease the severity of arthritis. Using the DEREG mouse model, 
we depleted Treg cells at different points following infection with B. burgdorferi. We 
found that Treg cell depletion led to an increased inflammatory response and paw 
swelling, but did not affect severity of arthritis, one week after depletion.  Additionally, 
Treg cell depletion resulted in an increased IgM antibody response, while depletion 
increased or decreased the IgG response depending on the timing of depletion. These 
results indicate that Treg cell populations mediate the immune response during B. 
burgdorferi infection.  
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Materials and Methods 
 
Mice 
 
Six-to-12 week old, male and female C57BL/6 DEREG mice (The Jackson Laboratory) 
were housed in a humidity-controlled environment at 21°C under a 12-hour light-and-
dark cycle at the University of Wisconsin-Milwaukee animal research facility. Mice had 
access to food and acidified water ad libitum. All experimental procedures were 
approved by the Institutional Animal Care and Use Committee at the University of 
Wisconsin-Milwaukee. 
 
Preparation of Bacteria 
B. burgdorferi strain B31-A3 organisms were provided by J. Coburn (Medical College of 
Wisconsin, Milwaukee, WI).  Low passage organisms were grown at 32°C in modified 
Barbour-Stoenner-Kelly (BSK) medium until they reached a concentration of 106 
microbes/ml before being aliquoted into 1.5-ml screw-cap tubes (Sarstedt, Newton, NC) 
and stored at -80°C.  On the day of infection, 1 mL frozen suspensions of spirochetes 
were thawed, washed, and resuspended in PBS supplemented with 0.2% non-immune 
serum as described by Ristow et al. (2012). Dark-field microscopy was used to 
determine motility and enumerate microbes using a Petroff-Hausser counting chamber. 
 
Infection of mice  
Naïve mice were anaesthetized with isoflourane in a nose-and-mouth cup and infected 
by subcutaneous injection between the scapulae with 2x104 viable B. burgdorferi strain 
B31-A3 organisms in a volume of 0.05 mL of PBS supplemented with 0.2% non-
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immune serum. Control groups consisted of DEREG mice injected with PBS 
supplemented with non-immune serum.  
 
Depletion of Treg cells 
Diphtheria toxin (Calbiochem, San Diego, CA) was reconstituted in filter-sterilized PBS.  
Mice were injected with 1 µg diphtheria toxin (Calbiochem, San Diego, CA) in 100 µl of 
PBS intraperitoneally (i.p.) on two consecutive days beginning at day 7, day 14, or day 
21 after infection with B. burgdorferi.  Control groups included infected DEREG mice 
injected with PBS and non-infected DEREG mice administered DTx at the same time 
points as experimental mice. Groups consisted of 3-4 mice each.   
 
Assessment of swelling  
 
Swelling of each hind paw was assessed every other day in order to determine changes 
in edema of the tibiotarsal joint following infection with B. burgdorferi using a digital 
caliper (Marathon, Richmond Hill, Ontario) with a sensitivity of 0.01 mm.   The width and 
thickness of each tibiotarsal joint were measured and averaged to provide the mean 
caliper value. Baseline swelling levels of each group were measured prior to infection, 
and the changes in swelling from these baseline levels were determined every other 
day after infection and at the time of euthanasia.   
 
Histological examination 
Mice were euthanized one week after administration of DTx, on days 14, 21, or 28 after 
infection. One hind paw from each mouse was amputated above the knee joint. Paws 
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were placed in cryptically coded tissue-embedding cassettes and fixed in 10% buffered 
zinc formalin before being embedded in paraffin. The paraffin-embedded tissues were 
cut in 4µm sections, placed on glass slides, and stained with hematoxylin and eosin.  
Unbiased histological examination of the tissues was conducted by a board-certified 
pathologist (Dr. Michael Lawlor, Children’s Hospital of Wisconsin, Milwaukee, WI).  
Histopathological changes were scored according to the following scale: 0, no 
pathology; 1, mild lymphocyte infiltration restricted to joint surfaces; 2, mild lymphocyte 
infiltration restricted to subcutaneous soft tissue; and 3, mild lymphocyte infiltration of 
muscle and soft tissue. 
 
Assessment of cytokine production  
Spleens were harvested on days 14, 21, or 28 after infection, and single-cell 
suspensions of splenocytes were created by passing the tissue through a nylon mesh 
screen (BD Falcon, BD Biosciences, San Jose, CA) into cold Dulbecco’s Modified Eagle 
Medium (DMEM). 1 x 106 cells were incubated at 37 °C in 5% CO2 in the absence or 
presence of 1 x 105 viable B. burgdorferi strain B31-A3 organisms.  Cell culture 
supernatants were collected after 24, 48, and 72 hours of incubation. Levels of IL-17, 
IFN-γ, and IL-10 in the cell culture supernatants were determined using IL-17A, IFN-
γ, or IL-10 Ready-Set-Go! ELISA kits (eBioscience, San Diego, CA), respectively, 
according to the manufacturer’s instructions.  Plates were read at an absorbance of 450 
nm. Standard curves were used to calculate the cytokine amount in each sample as 
pg/ml.  
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Quantification of spirochetes by PCR 
Bacterial load was determined as described by Ristow et al. (2012). One hind paw was 
collected at the time of euthanasia, frozen in liquid nitrogen, and stored at -80°C until 
the time of DNA isolation. DNA was isolated using the QIAamp genomic DNA and RNA 
kit (Qiagen, Valencia, CA) according to the manufacturer’s instructions. Both B. 
burgdorferi genome copies and mouse genome copies were enumerated. PCR 
amplification was performed in 20-µl reaction mixtures containing 5 µl DNA, 10 µl of 
PowerUp SYBR Green Master Mix (Life Technologies, Carlsbad, CA), 2 µl magnesium 
chloride, 1 µl water, and 1 µl of both forward and reverse primer for either B. burgdorferi 
recA (forward: 5’- GCAGCTATCCCACCTTCTTT-3’, reverse: 5’- ATGAGGCTC-
TCGGCATTG-3’) or Mus musculus β-actin (forward: ‘5-TCACCCACACTGTGC-
CCATCTACGA-3’, reverse: 5’-GGATGCCACAGGATTCCATACCCA-3’).  The thermal 
cycling profile consisted of one 2-minute cycle at 50°C and one 2-minute cycle at 95°C, 
followed by 40 cycles of 95°C for 15 seconds and 60°C for 1 minute.  A melting curve 
was acquired by heating the product to 95°C for 15 seconds, cooling to 60°C for 1 
minute, and heating to 95°C for 15 seconds.  B. burgdorferi recA gene copies were 
normalized to mouse β-actin after being calculated from standard curves using 
StepOnePlus Real-Time PCR System. 
 
Quantification of antibody production  
Pooled sera from each group were analyzed in duplicate for B. burgdorferi-specific IgG 
and IgM antibody content by a protocol adapted from Yang et al. (2011). Briefly, 96-well 
plates were coated overnight at 4°C with 5 µg/ml sonicated B. burgdorferi B31-A3. 
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Control wells were coated with goat anti-mouse IgM or IgG isotype control antibodies.  
Plates were washed three times with PBS containing 0.05% Tween 20 before blocking 
for 1 hour at room temperature with PBS containing 10% fetal bovine serum and 0.2% 
Tween 20. After blocking, plates were washed once.  1:2 serial dilutions of serum 
ranging from undiluted to 1:65,536 were added to wells and incubated for 2 hours at 
room temperature. Murine IgM or IgG isotype control antibodies were added to wells 
coated with goat anti-mouse IgM or IgG as positive controls. Plates were washed 3 
times before addition of goat anti-mouse IgM or IgG antibodies conjugated with 
horseradish peroxidase. Wells were developed with 3,3',5,5'-tetramethyl-benzidine 
(eBioscience). After 5 minutes, the reaction was stopped with 2 N sulfuric acid. Optical 
density was measured at 450 nm. Reciprocal endpoint dilutions were determined from 
average titration curves and defined as twofold above the buffer background (Coligan 
1991).  All antibodies were obtained from Southern Biotech (Birmingham, AL). 
 
Statistics 
Data were analyzed using two-way ANOVA followed by the Bonferroni correction for 
post hoc analysis when a significant F value indicated reliable mean differences. Paired 
data were analyzed using two-tailed Student’s t test. Data were analyzed using 
GraphPad Prism.  The alpha level was set at 0.05 prior to initiation of experiments.  
Data are expressed as mean ± standard error of the mean (SEM) unless otherwise 
stated. 
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Results 
Effect of diphtheria toxin administration 
We previously showed that administration of diphtheria toxin in DEREG mice reduced 
Treg cell populations by 75% (Chapter 4).  However, we previously showed that 
diphtheria toxin administration results in a maintenance in body weight shortly after 
injection, before eventually increasing to levels observed in untreated mice (Chapter 4).  
To ensure the health of the mice administered diphtheria toxin, we recorded body 
weight every other day following infection. Mice that were injected with PBS gained 
weight over the course of the experiment.  By contrast, mice administered DTx on days 
7 and 8 after infection exhibited a mild, statistically insignificant decrease in body weight 
beginning at day 10 until the end of the experiment on day 14 (Figure 1A).  Similarly, 
infected mice administered DTx on days 14 and 15 after infection exhibited decreased 
body weight 6 days later (Figure 1B).  In addition, infected mice administered DTx on 
days 21 and 22 displayed a decrease in body weight beginning at day 24 and 
continuing through day 28 (Figure 1C).  Naïve mice administered DTx displayed the 
same pattern of weight loss as infected mice that received DTx (data not shown).   
 
Effect of DTx administration on hind paw swelling and arthritis 
Baseline levels of hind paw size were determined by measuring the width and thickness 
of tibiotarsal joints prior to infection with B. burgdorferi.  Paw size was measured every 
other day, and baseline measurements were subtracted to determine average change 
in paw size.  Infected mice injected with PBS displayed minimal paw swelling in all 
cohorts.  By contrast, mice depleted of Treg cells beginning at day 7 after infection 
displayed significantly greater paw swelling than PBS-injected mice beginning at day 8 
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after infection (Figure 2A).  Mice depleted of Treg cells on day 7 after infection 
continued to display increased paw swelling until the end of the experiment, at day 14 
after infection (Figure 2A).  Mice depleted of Treg cells beginning at day 14 after 
infection also exhibited significantly greater paw swelling than PBS-injected mice 
beginning at day 18 after infection, which remained through the end of the experiment at 
day 21 after infection (Figure 2B).  Additionally, mice depleted of Treg cells beginning at 
day 21 after infection displayed greater paw swelling than PBS-injected mice at day 26 
after infection (Figure 2C).   
 
No histopathological changes were observed 14 days after infection in PBS-injected 
mice or mice depleted of Treg cells on day 7 after infection (Figure 3A).  PBS-injected 
mice displayed minimal histopathological changes on day 21 that were not significantly 
greater than the minimal pathology observed in mice depleted of Treg cells on day 14 
(Figure 3B).  Both PBS-injected mice and mice depleted of Treg cells on day 21 
displayed minimal histopathological changes on day 28 (Figure 3C).  No significant 
difference in pathology was observed due to Treg cell depletion at any time point.   
 
Effect of Treg cell depletion on cytokine production  
We investigated the role of Treg cell ablation on the production of cytokines at varying 
time points after infection with B. burgdorferi.  Spleen cells harvested 14 days after B. 
burgdorferi infection from mice injected with PBS on days 7 and 8 produced low levels 
of IL-17 after 24, 48, and 72 hours of incubation in media (Figure 4A).  Unstimulated 
spleen cells harvested on day 14 after infection from mice that were depleted of Treg 
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cells on day 7 after infection produced a greater amount of IL-17 after 24 and 48 hours 
of incubation than PBS-injected mice. However, the increases were not statistically 
significant. Upon in vitro stimulation with B. burgdorferi, cells from PBS-injected mice 
produced slightly greater levels of IL-17 at all time points than unstimulated cultures. 
However, these increases were not statistically significant. Additionally, after 48 hours of 
incubation, stimulated spleen cells from Treg cell-depleted mice produced a significantly 
greater amount of IL-17 than unstimulated cells (p<0.05).  Depletion of Treg cells had 
no effect on the production of IL-17 after 72 hours of incubation, regardless of 
stimulation. 
 
In addition, we measured IFN-γ production by the same spleen cells.  No differences 
were observed due to Treg cell depletion at any duration of incubation.  We found that 
IFN-γ production on day 14 after infection was similar between unstimulated cells from 
PBS-injected mice and Treg cell-depleted mice at all incubation times.  IFN-γ production 
was increased following in vitro stimulation of cells from PBS-injected mice after 24, 48, 
and 72 hours of incubation. However, the increases were not statistically significant 
(Figure 4B).  By contrast, stimulation led to significantly increased IFN-γ production by 
spleen cells isolated from mice depleted of Treg cells on day 7 after infection at all 
incubation times (p<0.05).  In addition, IL-10 production was measured in the same cell 
cultures.  Cells from PBS-injected mice and cells from Treg cell-depleted mice produced 
negligible amounts of IL-10 at all incubation times, regardless of stimulation (Figure 4C).   
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Cytokine production by spleen cells harvested 21 days after infection was also 
assessed in PBS-injected mice and mice depleted of Treg cells on day 14 after 
infection.  Spleen cells harvested 21 days after B. burgdorferi infection from mice 
injected with PBS produced low levels of IL-17 after 24, 48, and 72 hours of incubation 
in media (Figure 5A).  In addition, production of IL-17 was below the level of detection at 
all time points by spleen cells from mice that were depleted of Treg cells on days 14 
after infection.  Upon stimulation, spleen cells from PBS-injected mice produced greater, 
but not significantly different, amounts of IL-17 than stimulated cells isolated from Treg 
cell-depleted mice. In general, stimulation resulted in increased IL-17 production by 
cells from both PBS-injected and Treg cell-depleted mice; however, the increases were 
not statistically significant.   
 
Unstimulated spleen cells from PBS-injected mice produced levels of IFN-γ that were 
below the level of detection after 24, 48, and 72 hours of incubation (Figure 5B).  By 
contrast, unstimulated cells from Treg cell-depleted mice produced detectable IFN-γ at 
all incubation times.  Stimulation did not significantly increase IFN-γ production by cells 
from PBS-injected mice after 24 hours, as levels remained undetectable. Stimulation did 
increase IFN-γ production by these cells after 48 and 72 hours of incubation, although 
the increase was not statistically significant.  Stimulation also resulted in increased, but 
not significantly greater, IFN-γ production by cells from Treg cell-depleted mice. 
Additionally, IL-10 production by the same cells was assessed. In addition, no 
differences in IL-10 production were observed due to Treg cell depletion (Figure 5C), 
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and cells from PBS-injected mice and cells from Treg cell-depleted mice produced 
negligible amounts of IL-10 at all incubation times, regardless of stimulation.  
 
We further assessed cytokine production by spleen cells harvested 28 days after 
infection in PBS-injected mice and mice depleted of Treg cells on day 21 after infection. 
Unstimulated cells harvested 28 days after infection with B. burgdorferi from both PBS-
injected and mice depleted of Treg cells on day 21 after infection produced similarly low 
levels of IL-17 at all incubation times (Figure 6A).  While no significant differences were 
observed due to Treg cell depletion, stimulated cultures of cells from Treg cell-depleted 
mice produced less IL-17 than cell from PBS-injected mice at all incubation times.  
Stimulation of cells from both PBS-injected mice and mice depleted of Treg cells 
resulted in increased IL-17 production that was not statistically significant.  
 
Twenty-eight days after infection, no statistically significant differences were observed 
due to Treg cell depletion in unstimulated or stimulated cultures after 24, 48, or 72 hours 
of incubation (Figure 6B).  IFN-γ production by unstimulated cells isolated from PBS-
injected mice was below the level of detection after 24 and 48 hours of incubation, with 
low, but detectable, levels produced after 72 hours.  By contrast, unstimulated cells from 
mice depleted of Treg cells produced a greater, though not statistically significant, 
amount of IFN-γ at all incubation times than cells from PBS-injected mice.  Following 
stimulation, cells from both PBS-injected and Treg cell-depleted mice produced similar 
amounts of IFN-γ at all incubation times. These stimulated cells produced significantly 
greater amounts of IFN-γ (P<0.05) than their unstimulated counterparts. 
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Spleen cells isolated from PBS-injected mice produced large amounts of IL-10 after 24 
hours of incubation (Figure 6C). IL-10 production by both stimulated and unstimulated 
cells from PBS-injected mice was significantly greater than that of cells isolated from 
Treg cell-depleted mice (p<0.05). After 48 hours of incubation, cells from PBS-injected 
mice produced negligible levels of IL-10, and unstimulated cells from Treg cell-depleted 
mice produced low, but measurable, amounts of IL-10. Stimulation had no effect on IL-
10 production by cells from PBS-injected or Treg cell-depleted mice after 48 hours.  No 
detectable IL-10 was produced by cells from PBS-injected or Treg cell-depleted mice 
after 72 hours of incubation.   
 
Effect of Treg cell ablation on antibody production 
B. burgdorferi B31-A3-specific total IgM antibody levels were determined by ELISA 
using pooled sera. Mice were injected with PBS or depleted of Treg cells on days 7, 14, 
or 21 after infection, and sera were harvested one week later, at 14, 21, and 28 days 
after infection, respectively. Sera collected 14 days after infection from PBS-injected 
mice had an average IgM endpoint dilution of 1:1024 (Figure 7A).  By contrast, sera 
collected 14 days after infection from mice depleted of Treg cells on day 7 after infection 
had a greater IgM average endpoint dilution of 1:2048.  Twenty-one days after infection, 
sera from PBS-injected mice had an average endpoint dilution of 1:1024 (Figure 7B).  
IgM serum levels of Treg cell-depleted mice were again greater, with an average 
endpoint dilution of 1:2048.  Twenty-eight days after infection, sera from PBS-injected 
mice had an average IgM endpoint dilution of 1:2048 (Figure 7C). Sera from Treg cell-
depleted mice had a lower IgM average endpoint dilution of 1:512.  Overall, Treg cell 
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depletion on days 7 or 14 after infection increased IgM antibody production at 14 and 21 
days, respectively.  However, Treg cell depletion 21 days after infection resulted in 
decreased antibody production on day 28.   
 
IgG levels in serum samples were also determined.  On day 14 after infection, sera from 
PBS-injected mice had an average IgG endpoint dilution of 1:4 (Figure 8A).  By 
contrast, sera from mice depleted of Treg cells on day 7 after infection had a greater 
average endpoint dilution of 1:8 on day 14 after infection.  Twenty-one days after 
infection, sera from PBS-injected mice had an average IgG endpoint dilution of 1:8 
(Figure 8B).  Sera from mice depleted of Treg cells on day 14 after infection also had an 
average endpoint dilution of 1:8 21 days after infection. Twenty-eight days after 
infection, sera from PBS-injected mice had an average end point dilution of 1:32 (Figure 
8C).  By contrast, sera from Treg cell-depleted mice had a lower IgG average endpoint 
dilution of 1:2.  Overall, depletion of Treg cells 1 week after infection slightly increased 
IgG production, but depletion of Treg cells 3 weeks after infection substantially reduced 
IgG production.    
 
Effect of Treg cell ablation on bacterial load 
We determined the number of bacterial genomes within the tibiotarsal joints of B. 
burgdorferi-infected mice injected with PBS and infected mice depleted of Treg cells to 
assess the impact of Treg cells on dissemination of the spirochete to the joints. B. 
burgdorferi DNA was measured 7 days after injection with PBS or Treg cell depletion on 
days 7, 14, or 21after infection. No differences in borrelial load were observed in the 
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joints of PBS-injected mice and the joints of Treg cell-depleted mice after 14 days of 
infection (Figure 9A), 21 days of infection (Figure 9B), or 28 days of infection (Figure 
9C).   
 
Discussion	  
In this report, we examined the effects of Treg cells on the immune response to during 
B. burgdorferi in an arthritis-resistant mouse model by depleting them at different time 
points following infection.  We found that depletion of Treg cells after infection with B. 
burgdorferi resulted in increased swelling of the hind paws, but did not increase arthritis 
7 days after depletion.  Also, depletion of Treg cells after 7 days of infection led to an 
increased capacity to produce IL-17 and IFN-γ, and depletion of Treg cells after 21 days 
of infection led to a decrease in IL-10 production.  Additionally, Treg cell depletion 7 
days after infection increased B. burgdorferi-specific antibody production 14 days after 
infection. However, Treg cell depletion 21 days after infection decreased antibody 
production 28 days after infection.  These findings partially support our hypothesis by 
demonstrating that Treg cells inhibit swelling and inflammatory cytokine production 
following infection with B. burgdorferi. 
 
Previous reports have suggested a role for Treg cells in modulating arthritis in B. 
burgdorferi infection.  Neutralization of IL-17 in IFN-γ-deficient mice delayed the onset of 
swelling and prevented histopathological changes in a model of severe Lyme arthritis 
(Burchill et al. 2003).  Reduced arthritis in these mice was associated with an increase 
in the number of CD4+CD25+ putative Treg cells in the draining lymph nodes beginning 
  207 
2 days after infection (Nardelli et al. 2004).  The addition of anti-CD25 antibody in anti-
IL-17 antibody, IFN-γ-deficient mice led to the induction of pathology when administered 
prior to infection, though later administration of anti-CD25 had less pronounced effects 
(Nardelli et al. 2004).    Additionally, adoptive transfer of CD4+CD25+ T cells from IFN-
γ-deficient, anti-IL-17 antibody-treated mice prevented the development of arthritis in 
infected recipients, whereas pathology was observed in infected mice that received 
CD4+CD25- cells (Nardelli et al. 2005).  In addition, administration of anti-CD25 
antibody when IL-17 is not neutralized had no effect on pathology; however, 
CD4+CD25+ populations were reduced (Nardelli et al. 2006). Foxp3 expression was not 
determined in these studies, as it had not yet been identified as the Treg cell-specific 
transcription factor. However, the increased presence of CD4+CD25+ cells following IL-
17 neutralization suggests these may be Treg cells, as Treg cells and Th17 cells have a 
reciprocal relationship and arise from a common lineage (Bettelli et al. 2006). Treg cells 
may not only influence the development of arthritis, but may also contribute to the 
resolution of disease.  Notably, mice deficient in CD28 have decreased numbers of 
CD4+CD25+ T cells (Tang et al. 2003) along with increased production of IFN-γ 
(Shanafelt et al. 1998). Additionally, mice deficient in CD28 develop more severe 
arthritis (Iliopoulou et al. 2007).  These findings suggest that Treg cells are important 
regulators of inflammation throughout the course of Lyme arthritis.   
 
Reduced numbers of Treg cells may be a contributing factor as to why some patients 
with Lyme disease fail to resolve inflammation following antibiotic treatment.  Analysis of 
T cell populations in patients who continued to experience symptoms of Lyme arthritis 
  208 
following antibiotic therapy supports this notion.  Patients with slow-resolving Lyme 
arthritis following antibiotic treatment were found to have lower numbers of Treg cells in 
the synovial fluid than patients whose symptoms resolved after antibiotic therapy (Shen 
et al. 2010).  In addition, patients with antibiotic-refractory Lyme arthritis were also found 
to have low numbers of Treg cells, in addition to having Treg cells that were less 
effective in suppressing inflammatory cytokine production (Vudattu et al. 2013).  
Together, these studies indicate that patients with Lyme arthritis and who have fewer 
functional Treg cells develop an excessive inflammatory response that leads to the 
inability to resolve arthritis, even after clearance of the infection.   
 
Treg cells are also important mediators of the immune response by inhibiting 
inflammation and preventing tissue destruction.  In order to directly examine the effect 
of Treg cells during infection with B. burgdorferi, we utilized the DEREG mouse model.  
The DEREG mouse model allows for the selective depletion of Foxp3+ Treg cells 
following administration of diphtheria toxin.  We previously showed that depletion of 
Treg cells prior to infection with B. burgdorferi results in increased paw swelling and 
arthritis in an arthritis-resistant mouse model.  Here, we administered diphtheria toxin at 
different times after establishment of infection.  We found that depletion of Treg cells on 
day 7, day 14, or day 21 after infection led to significant increases in hind paw swelling 
compared to mice in which Treg cells were not depleted.  Our findings are consistent 
with our previous work, in which we found increased paw swelling following depletion of 
Treg cells prior to B. burgdorferi-infection.  However, when Treg cells were depleted 
prior to infection with B. burgdorferi, increased paw swelling did not occur until 12 days 
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after infection.  Here, we found that Treg cells depleted after infection results in a rapid 
increase in paw swelling, regardless of the time of depletion.  Our findings suggest that 
paw swelling that occurs following B. burgdorferi infection is controlled by Treg cells 
throughout the course of infection.   
 
Despite changes in paw swelling, Treg cell depletion did not have an effect on the 
development of pathology 7 days later.  Previously, we found that depletion of Treg cells 
prior to infection with B. burgdorferi led to the development of pathology in arthritis-
resistant mice.  However, histopathological findings were not observed until 14 days 
after infection, and disease resolved by 32 days after infection.  In arthritis-susceptible 
mice, arthritis generally peaks approximately 21 days after infection (Barthold 1996).  
Therefore, we assessed the effects of Treg cell depletion 7 days later, on days 14, 21, 
and 28 after infection, in order to capture these events. In our previous study, pathology 
was not observed until 2 weeks after depletion.  Therefore, it is possible that the paw 
swelling seen in our current experiment due to Treg cell depletion indicates that 
pathology is developing, and a longer duration after depletion may be needed for 
pathological changes to be observed.  Swelling likely occurred more rapidly when Treg 
cells were depleted after establishment of B. burgdorferi infection because an immune 
response to the spirochete had already been generated. Thus, the depletion of Treg 
cells prior to infection may not have affected swelling as quickly because of the time 
needed to generate a substantial immune response.  Alternatively, depletion of Treg 
cells at these various times following infection may not affect pathology, as Treg cells 
present during the time of infection may have already suppressed inflammatory T cells 
and cytokine production that would have caused pathology.  In other models of arthritis, 
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exacerbated pathology was observed when Treg cells were depleted during disease 
(Atkinson et al. 2016, Irmler et al. 2014). However, our findings suggest that Treg cells 
present following infection control paw swelling, but reducing their numbers after B. 
burgdorferi infection may not increase the severity of arthritis if disease is already 
established.  Despite this, the impact of Treg cells during B. burgdorferi infection may 
still be important.  Approximately 18% of patients with Lyme disease may present with 
joint pain without evidence of inflammation (Steere et al. 1987).  Treg cells may inhibit 
immune reactions involved in pain and swelling that are independent of hypercellularity 
of the joint tissue.    
 
We also investigated the effect of Treg cell depletion on the production of certain T cell-
associated cytokines by splenocytes.  Treg cell depletion on day 7 after infection 
resulted in increased IL-17 production by stimulated cells harvested at 14 days after 
infection.  It is possible that Th17 cells are the source of IL-17 in these cultures.  Our 
hypothesis is supported by the findings of Bettelli et al., which demonstrated that Th17 
and Treg cells arise from a common precursor (2006). Additionally, the neutralization of 
IL-17 in mice infected with B. burgdorferi was found to increase the number of 
CD4+CD25+ T cells with suppressive functions (Nardelli et al. 2004).  In addition, we 
previously showed that spleen cells from mice deficient in IL-10 produced increased 
levels of IL-17 following B. burgdorferi infection than wild-type mice (Hansen et al. 
2013). Collectively, these findings suggest that depletion of Treg cells, which produce 
IL-10, may have increased the number of Th17 cells, thereby resulting in increased IL-
17 production.   
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Additionally, we noticed a trend of decreased IL-17 production by cells from mice 
depleted of Treg cells on day 14 and day 21 after infection when harvested on day 21 
and day 28 after infection, respectively.  These trends in decreased IL-17 production 
occurred when trends in increased IFN-γ production were also observed.  The source of 
IL-17 and IFN-γ in these cultures may have been CD4+ T cells, as Th1 and Th17 cells 
can have an antagonistic relationship (Damsker et al. 2010).  This would explain why 
increased levels of IFN-γ were observed with decreased production of IL-17 by cells 
from Treg cell-depleted mice. Our assertions are supported by the fact that the Th1/IFN-
γ response is a more prominent contributor to the development of Lyme arthritis 
compared to the Th17/IL-17 response.  Therefore, our findings may also suggest an 
important role for Treg cells in the control of IFN-γ production during B. burgdorferi 
infection.  
 
In addition to affecting IL-17 production, Treg cell depletion also impacted the level of 
IFN-γ production by spleen cells.  We found that cells harvested on day 14 from mice 
depleted of Treg cells on day 7 produced significantly greater levels of IFN-γ following 
stimulation.  While cells from PBS-injected mice did produce more IFN-γ following 
stimulation, the increase was not significant.  At day 21 after infection, we also noticed a 
trend toward increased IFN-γ production by unstimulated spleen cells from mice 
depleted of Treg cells on day 14 after infection. Collectively, these findings suggest that 
depletion of Treg cells may increase the inflammatory capacity of T helper type 1 cells 
during B. burgdorferi infection.  Others have shown that depletion of Treg cells results in 
increased IFN-γ production by spleen cells during bacterial infection (Raghavan et al. 
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2003); however, the effects of Treg cell depletion could only be observed after Treg cell 
depletion at day 3 and were no longer evident by day 7 (Prajeeth et al. 2014, Veiga-
Parga et al. 2012).  It has been shown that replenishment of Treg cells following 
depletion initiates 3 days after administration of DTx (Christiaansen et al. 2014).  As a 
result, the effects of Treg cell depletion on cytokine production may not be evident at 
extended times after infection. Previously, we found that depletion of Treg cells prior to 
infection did not have a sustained effect on the production of inflammatory cytokines, 
despite resulting in increased paw swelling and arthritis.  It is possible that Treg cells do 
not play a major role in suppressing effector T cells during B. burgdorferi infection; 
however, this seems unlikely.  Overall, our findings suggest that Treg cells may not 
extensively inhibit T cell-associated inflammatory cytokine production throughout B. 
burgdorferi infection in our system, but, rather, may function in this capacity at an earlier 
time after infection.  
 
Treg cells can modulate inflammation through the production of IL-10.  It is known that 
Treg cells contribute to production of IL-10 in response to B. burgdorferi infection 
(Amedei et al. 2013). Therefore, we investigated the effects of Treg cell depletion on IL-
10 production during B. burgdorferi infection. We found that spleen cells harvested at 
day 28 from mice depleted of Treg cells on days 21 after infection had significantly 
lower production of IL-10 compared to cells from mice injected with PBS. The effects of 
Treg cell depletion on IL-10 production occurring at day 28 are particularly interesting.  
During the course of B. burgdorferi infection in mice, arthritis typically peaks around day 
28 and then subsides rapidly (Ma et al. 1998).  Our findings suggest that IL-10 produced 
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by Treg cells may be important for the control of inflammation at later times.  Despite 
displaying reduced levels of IL-10 and increased paw swelling, mice depleted of Treg 
cells did not develop increased pathology 7 days later.  By contrast, we and others have 
shown that a lack of IL-10 results in increased pathology during B. burgdorferi infection.  
Specifically, IL-10-deficient mice develop more severe arthritis following B. burgdorferi 
infection than wild-type mice (Brown et al. 1999). In addition, IL-10 was found to 
attenuate arthritis following B. burgdorferi infection in a model of Lyme arthritis by 
decreasing the IL-17 response (Hansen et al. 2013).  Perhaps the presence of other IL-
10-producing cells mediated the development of arthritis in our experiments.  Notably, 
macrophages are also a significant producer of IL-10 and help regulate the 
inflammatory response during infection with B. burgdorferi (Brown et al. 1999, Chung et 
al. 2013). Treg cells decrease the inflammatory effects of macrophages (Taams et al. 
2005), and the ability of Treg cells to inhibit macrophages may explain why we saw 
arthritis when Treg cells were depleted prior to infection, but not when Treg cells were 
depleted at later times. Alternatively, Treg cells may have a more substantial impact in 
later infection, after initial regulation has already limited the extent of inflammation. In 
addition, we may observe disease if we examine pathology at later time points after 
Treg cell depletion.  Collectively, our previous findings, along with our current report, 
suggest that Treg cell-derived IL-10 limits paw swelling in B. burgdorferi infection.  
However, additional work is needed to determine the effects of Treg cell depletion on 
pathology.  
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Treg cells have also been reported to suppress the antibody response (Lim et al. 2005).  
As such, we investigated the effect of Treg cell depletion on the production of B. 
burgdorferi-specific antibodies.  We found that depletion of Treg cells on day 7 or day 
14 led to increased IgM antibody production one week later, at 14 and 21 days after 
infection with B. burgdorferi, respectively. Treg cell depletion on day 7 also resulted in 
increased IgG antibody production at day 14 after infection, while Treg cell depletion on 
day 14 did not affect IgG production on day 21 after infection.  Treg cell depletion 21 
days after infection resulted in decreased IgM and IgG at 28 days after infection. We 
previously reported that depletion of Treg cells prior to infection caused increased 
production of IgM throughout the course of disease.  We postulated that depletion of 
Treg cells enhanced the ability of effector T cells and/or T-follicular helper cells to 
enhance antibody production.  Why, then, would delayed Treg cell depletion have 
different effects on antibody production depending on the time of depletion? While 
mainly described as suppressive, Treg cells can also enhance the antibody response 
(Vendetti et al. 2010).  In fact, Treg cells can differentiate into T-follicular helper cells 
(Tsuji et al. 2009). We have already suggested that Treg cells may have a more 
profound effect in inhibiting inflammation during early infection.  Perhaps, in late 
infection, when inflammation has already been limited, Treg cells become T-follicular 
helper cells to enhance antibody production.  Or, after inflammation has been 
controlled, Treg cell numbers are reduced, thereby reversing the inhibition of antibody 
suppression.  Overall, our findings suggest Treg cells inhibit antibody production in early 
B. burgdorferi infection, but may contribute to antibody production at later times.   
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We also investigated the ability of Treg cells to control clearance of B. burgdorferi within 
the joint tissue.  We found that Treg cell depletion had no effect on bacterial burden in 
the tibiotarsal joint. Others have also shown that depletion of Treg cells in other 
infections had no effect on clearance of bacterial.  For example, Treg cell depletion had 
no effect on clearance of Mycobacterium bovis (Berod et al. 2014) or Staphylococcus 
aureus infection (Tebartz et al. 2014). Additionally, we previously showed that depletion 
of Treg cells prior to infection with B. burgdorferi did not affect bacterial load in the 
tibiotarsal joints.  Together, these findings indicate that Treg cells may not affect the 
clearance of B. burgdorferi from affected tissues.  However, additional investigation of 
spirochete viability by other methods, such as culture of tissue, is required to affirm 
these findings. 
 
In summary, we showed that the depletion of Treg cells after infection with B. 
burgdorferi results in significantly greater paw swelling, along with a greater capacity for 
IL-17 and IFN-γ production and decreased IL-10 production.  Additionally, our findings 
indicate that cells from mice depleted of Treg cells display an increased potential for an 
inflammatory response following stimulation.  We also found that Treg cells inhibit 
antibody production early after infection but increase antibody production at later times.  
However, we also found that Treg cell depletion had no effect on the B. burgdorferi 
levels in the joint tissue or the development of pathology 7 days later. These findings 
add to accumulating knowledge regarding the immunomodulatory function of Treg cells 
in B. burgdorferi infection.  They also provide evidence of inhibitory and, possibly, 
effector function of Treg cells.  More importantly, our findings suggest that Treg cells 
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display an anti-inflammatory effect and exert an initial control of inflammation during the 
development of Lyme arthritis.  Additional research is required to determine the effects 
of Treg cells on the resolution of arthritis.  Our findings provide additional support for the 
role of Treg cells in B. burgdorferi-induced arthritis, and provide a greater understanding 
of how a dysregulated immune response contributes to Lyme arthritis.  Our findings 
suggest that Treg cells inhibit the early production of antibodies, which may affect 
vaccine development or the interpretation or serological diagnostic tests. Importantly, 
our findings may also provide new targets for the treatments of antibiotic-refractory 
Lyme arthritis, thereby reducing unnecessary antibiotic use.   
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Figure 1. 
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Figure 1. Diphtheria toxin (DTx) induces weight loss. Mice were infected with 2x104 
viable B. burgdorferi strain B31-A3 on day 0. Additionally, mice were injected for 2 
consecutive days beginning at day 7 (A), day 14 (B), or day 21 (C) with PBS (closed 
circles) or 1 µg DTx (open circles). Weight loss occurred in mice administered DTx, but 
not in mice injected with PBS.  Mice that were administered DTx, but were not infected, 
also displayed weight loss (data not shown). Arrows indicate days of DTx 
administration. Data are mean weights ± SEM.  * P < 0.05. 
 
 
 
  
  219 
Figure 2. 
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Figure 2. Administration of diphtheria toxin significantly increased hind paw 
swelling in B. burgdorferi-infected DEREG mice.  DEREG mice were administered 
PBS (black circles) or DTx (white circles) two consecutive days beginning at day 7 (A), 
14 (B), or 21 (C) after infection with B. burgdorferi.  DTx administration caused a 
significant increase in hind paw swelling, regardless of time of administration. No 
swelling of hind paws occurred in uninfected DEREG mice administered DTx (not 
shown).  Arrows indicate days of DTx administration. Data are mean changes in paw 
swelling relative to baseline ± SEM. * P < 0.05.  
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Figure 3. 
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Figure 3. Administration of diphtheria toxin does not affect joint pathology in B. 
burgdorferi-infected DEREG mice after 7 days. Histopathology in the tibiotarsal joints 
of B. burgdorferi-infected DEREG mice injected with PBS or administered DTx on two 
consecutive days after infection beginning at day 7 (A), day 14 (B), or day 21 (C).  
Pathology was assessed as described in Materials and Methods. Error bars indicate 
SEM.   
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Figure 4.  
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Figure 4. Effects of Treg cell depletion 7 days after B. burgdorferi infection on 
cytokine production 14 days after infection. Spleen cells obtained from DEREG mice 
administered PBS (black bars) and DTx (white bars) 14 days after infection with B. 
burgdorferi were cultured in the presence (+) or absence (-) of the spirochete.  Levels of 
IL-17 (A), IFN-γ (B), and IL-10 (C) were measured after 24, 48, and 72 hours of 
incubation.  Data are mean levels of the cytokines/ml culture supernatant ± SEM. * P < 
0.05. 
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Figure 5. 
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Figure 5. Effects of Treg cell depletion 14 days after B. burgdorferi infection on 
cytokine production 21 days after infection. Spleen cells obtained from DEREG mice 
administered PBS (black bars) and DTx (white bars) 21 days after infection with B. 
burgdorferi were cultured in the presence (+) or absence (-) of the spirochete.  Levels of 
IL-17 (A), IFN-γ (B), and IL-10 (C) were measured after 24, 48, and 72 hours of 
incubation.  Data are mean levels of the cytokines/ml culture supernatant ± SEM. No 
significant differences in cytokine production were detected.   
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Figure 6. 
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Figure 6. Effects of Treg cell depletion 21 days after B. burgdorferi infection on 
cytokine production 28 days after infection. Spleen cells obtained from DEREG mice 
administered PBS (black bars) and DTx (white bars) 28 days after infection with B. 
burgdorferi were cultured in the presence (+) or absence (-) of the spirochete.  Levels of 
IL-17 (A), IFN-γ (B), and IL-10 (C) were measured after 24, 48, and 72 hours of 
incubation.  Data are mean levels of the cytokines/ml culture supernatant ± SEM. * P < 
0.05. 
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Figure 7.  
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Figure 7. Effect of Treg cell depletion on IgM antibody production in B. 
burgdorferi-infected mice.  Pooled sera collected from DEREG mice administered 
PBS (closed circles) or DTx (open circles) on 2 consecutive days prior to B. burgdorferi 
infection beginning at day 7 (A), 14 (B), or 21 (C) were assessed for IgM antibody 
production.  Values are expressed as the absorbance at 450 nm (Ab450). Error bars 
indicate SEM. 
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Figure 8. 
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Figure 8. Effect of Treg cell depletion on IgG antibody production in B. 
burgdorferi-infected mice.  Pooled sera collected from DEREG mice administered 
PBS (closed circles) or DTx (open circles) on 2 consecutive days prior to B. burgdorferi 
infection beginning at day 7 (A), 14 (B), or 21 (C) were assessed for IgG antibody 
production.  Values are expressed as the absorbance at 450 nm (Ab450). Error bars 
indicate SEM. 
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Figure 9. 
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Figure 9.  Effect of Treg cell depletion on bacterial burden in the tibiotarsal joint in 
B. burgdorferi-infected mice.  The number of bacterial genomes was determined in 
the tibiotarsal joints of DEREG mice administered PBS (black bars) or DTx (white bars) 
for 2 consecutive days beginning at day 7 (A), 14 (B), or 21 (C) after infection with B. 
burgdorferi.  Data are mean number of B. burgdorferi genomes per 104 mouse genomes 
± SEM. No significant differences in bacterial burden between groups were detected. 
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CHAPTER 6:  SUMMARY AND CONCLUSIONS 
 
The purpose of this research was to identify novel regulatory mechanisms of the 
inflammatory immune response upon infection with the causative agent of Lyme 
disease, Borrelia burgdorferi.  Our findings may assist in the development of new 
therapeutic strategies for patients with Lyme arthritis.  We hypothesized that a 
dysregulated immune response results in an excessive inflammatory response and the 
development of arthritis following B. burgdorferi infection.  To this end, we tested the 
following hypotheses: 
 
1.  IL-10 modulates the inflammatory immune response in Lyme arthritis through 
inhibition of IL-17.  
2.  IL-10 reduces CD4+ cell-derived IL-17 production in Lyme arthritis.   
3.  Treg cells prevent the onset of arthritis following infection with B. burgdorferi.  
4.  Treg cells present following B. burgdorferi infection reduce arthritis severity.  
 
C57BL/6 mice are genetically resistant to the development of arthritis following infection 
with B. burgdorferi, which is attributed, in part, to increased levels of IL-10 (Brown et al. 
1999, Ganapamo et al. 2000). IL-10 is an anti-inflammatory cytokine with a variety of 
suppressive effects.  Here, we examined a possible mechanism by which IL-10 
modulates arthritis in B. burgdorferi infection. In accordance with previous studies, we 
observed that infection of IL-10-deficient mice results in moderate swelling of the hind 
paws and greater histopathological changes of the ankle joint.  We also observed that 
cells from B. burgdorferi-infected wild-type mice produce less IL-17 early after infection 
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than cells from uninfected mice, which suggests that the bacteria induce anti-
inflammatory mechanisms in initial infection.  We further showed that spleen cells 
obtained from IL-10-deficient C57BL/6 mice produce more IL-17 at the time of arthritic 
manifestations, indicating that IL-10 inhibits IL-17 production during B. burgdorferi 
infection. We further showed that the significant hind paw swelling and histopathological 
changes observed in B. burgdorferi-infected, IL-10-deficient C57BL/6 mice were 
partially inhibited by administration of anti-IL-17 antibody. Our observations add to a 
growing body of data showing that IL-17 contributes to Lyme arthritis. Collectively, these 
findings support our first hypothesis, that IL-10 regulates inflammation in Lyme arthritis 
through inhibition of the IL-17 response.   
 
We also examined the ability of IL-10 to regulate IL-17 production in a model of 
dysregulated Borrelia-induced arthritis.   Lyme arthritis is thought to result, in part, from 
a dysregulated immune response (Nardelli et al. 2004, Steere & Glickstein 2004, 
Nardelli et al. 2008).  Here, we combined the use of a model of dysregulation due to 
lack of IL-10 (Sondergger et al. 2012) and a model of T cell-driven arthritis that 
incorporates both innate and adaptive immune events that contribute to pathology 
(Burchill et al. 2003, Christopherson et al. 2003).  We found that Borrelia-priming and 
infection resulted in decreased IL-17 production by spleen cells from mice infected for 
one day. Our findings are consistent with our previous findings that indicate B. 
burgdorferi induces downregulation of the immune response in early infection.  After 8 
days of infection, spleen cells from primed and infected mice deficient in IL-10 produced 
significantly greater levels of IL-17 than cells from primed and infected wild-type mice.  
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Moreover, we demonstrated that addition of anti-CD4-antibodies to spleen cell cultures 
significantly decreased IL-17 production, which indicates that CD4+ cells are a source of 
IL-17 in B. burgdorferi-induced arthritis.  Additionally, mice deficient in IL-10 developed 
severe hind paw swelling, which was reduced by administration of IL-17 antibodies.   
Our findings support our second hypothesis, that IL-10 reduces CD4+ cell-derived IL-17 
production in Lyme arthritis.  These results suggest that Borrelia-primed, IL-17-
producing CD4+ cells may contribute to the histopathologic effects of a dysregulated 
response to the spirochete.  Coupled with our previous results, our findings provide 
further evidence that Th17-related pathology contributes to Lyme arthritis and that IL-10 
regulates these events.  
 
CD4+CD25+Foxp3+ regulatory T (Treg) cells are important mediators of the 
inflammatory response, in part, through production of IL-10 (Rubtsov et al. 2008). 
Therefore, we further investigated the effects of immune dysregulation by directly 
addressing the role of Foxp3+ Treg cells in the prevention of arthritis.  Here, we utilized 
the DEREG mouse model, which allows for the selective depletion of Foxp3+ cells 
following administration of diphtheria toxin (Lahl & Sparwasser 2011). We found that 
depletion of Treg cells existing prior to infection results in significantly greater paw 
swelling and development of arthritis.  We also demonstrated that Treg cell depletion 
resulted in an increased B. burgdorferi-specific antibody response, suggesting that Treg 
cells may inhibit the development of a protective immune response to B. burgdorferi.  
Our findings support our third hypothesis, that Treg cells prevent the onset of arthritis 
following infection with B. burgdorferi. More importantly, our findings suggest that 
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individuals with decreased numbers of Treg cells may be more likely to develop arthritis 
after infection with B. burgdorferi.   
 
Finally, we investigated the role of Treg cells during the course of B. burgdorferi 
infection.  We found that Treg cell depletion at 7, 14, or 21 days after infection caused 
an increase in paw swelling at days 14, 21, or 28 after infection, respectively.  Treg cell 
depletion, however, did not cause pathology 7 days after depletion. The potential for the 
development of arthritis requires further investigation.  We also found an increased 
potential to make IL-17 and IFN-γ, along with a significant decrease in IL-10 production.  
We also provided additional support that Treg cells inhibit antibody production in early 
disease; however, Treg cells may enhance antibody production at later times.  These 
findings are important for understanding how regulation of the immune response during 
B. burgdorferi infection prevents joint swelling.  Additionally, our findings suggest that 
Treg cells may also possess effector functions under certain conditions.  These findings 
partially support our fourth hypothesis by demonstrating that Treg cells inhibit paw 
swelling following infection with B. burgdorferi.  Together with our previous findings, this 
suggests that Treg cells possess an anti-inflammatory effect in initial B. burgdorferi 
infection to prevent arthritis, but may not contribute to the resolution of disease.  
 
In summary, this work demonstrates that intact, functioning, immunoregulatory 
mechanisms are vital to control the immune response to B. burgdorferi and prevent the 
development of Lyme arthritis.  We provided additional evidence for the role of IL-17 in 
Lyme arthritis and identified IL-10 as a regulator of its inflammatory effects.  We also 
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identified CD4+ T cells as a source of IL-17 in Lyme arthritis, suggesting that Th17 cells 
contribute to disease.  We then demonstrated that Treg cells prevent the onset of 
arthritis in B. burgdorferi infection.  We further determined that Treg cells inhibit paw 
swelling and inflammatory cytokine production during B. burgdorferi infection. 
 
In conclusion, our findings collectively suggest that a dysregulated immune response 
results in an excessive inflammatory response and the development of arthritis following 
B. burgdorferi infection (Figure 1).  Additional research is needed to fully elucidate the 
regulatory mechanisms that inhibit the development and promote resolution of Lyme 
arthritis. Understanding the immune events that contribute to Lyme arthritis would 
reduce unnecessary antibiotic use and identify new strategies for treatment.   The 
effects of Treg cells on the humoral response to B. burgdorferi should be considered in 
the context of new treatments for Lyme borreliosis, the development of new vaccines, 
and the use of serological diagnostic testing.  Our findings suggest that individuals with 
decreased numbers of Treg cells may be more likely to develop arthritis after infection 
with B. burgdorferi.  Finally, our findings are important for understanding the immune 
mechanisms involved in the immune response to B. burgdorferi, which has significant 
implications for the development of strategies to prevent or treat Lyme borreliosis.   
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Figure 1. 
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Figure 1. Proposed regulatory mechanisms in B. burgdorferi-induced arthritis. 
Infection with B. burgdorferi results in activation of Th1 and Th17 cells, which contribute 
to inflammation and the development of Lyme arthritis.  We propose that Treg cells, 
through production of IL-10, limit the inflammatory potential of Th1 and Th17 cells to 
control inflammation and prevent the development of Lyme arthritis.   
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